The Journal of Family Practice is a peer-reviewed and indexed journal that provides its 95,000 family physician readers with timely, practical, and evidence-based information that they can immediately put into practice. Research and applied evidence articles, plus patient-oriented departments like Practice Alert, PURLs, and Clinical Inquiries can be found in print and at jfponline.com. The Web site, which logs an average of 125,000 visitors every month, also offers audiocasts by physician specialists and interactive features like Instant Polls and Photo Rounds Friday—a weekly diagnostic puzzle.

Theme
medstat_jfp
Top Sections
Case Reports
Clinical Inquiries
HelpDesk
Photo Rounds
Practice Alert
PURLs
jfp
Main menu
JFP Main Menu
Explore menu
JFP Explore Menu
Proclivity ID
18805001
Unpublish
Citation Name
J Fam Pract
Negative Keywords
gaming
gambling
compulsive behaviors
ammunition
assault rifle
black jack
Boko Haram
bondage
child abuse
cocaine
Daech
drug paraphernalia
explosion
gun
human trafficking
ISIL
ISIS
Islamic caliphate
Islamic state
mixed martial arts
MMA
molestation
national rifle association
NRA
nsfw
pedophile
pedophilia
poker
porn
pornography
psychedelic drug
recreational drug
sex slave rings
slot machine
terrorism
terrorist
Texas hold 'em
UFC
substance abuse
abuseed
abuseer
abusees
abuseing
abusely
abuses
aeolus
aeolused
aeoluser
aeoluses
aeolusing
aeolusly
aeoluss
ahole
aholeed
aholeer
aholees
aholeing
aholely
aholes
alcohol
alcoholed
alcoholer
alcoholes
alcoholing
alcoholly
alcohols
allman
allmaned
allmaner
allmanes
allmaning
allmanly
allmans
alted
altes
alting
altly
alts
analed
analer
anales
analing
anally
analprobe
analprobeed
analprobeer
analprobees
analprobeing
analprobely
analprobes
anals
anilingus
anilingused
anilinguser
anilinguses
anilingusing
anilingusly
anilinguss
anus
anused
anuser
anuses
anusing
anusly
anuss
areola
areolaed
areolaer
areolaes
areolaing
areolaly
areolas
areole
areoleed
areoleer
areolees
areoleing
areolely
areoles
arian
arianed
arianer
arianes
arianing
arianly
arians
aryan
aryaned
aryaner
aryanes
aryaning
aryanly
aryans
asiaed
asiaer
asiaes
asiaing
asialy
asias
ass
ass hole
ass lick
ass licked
ass licker
ass lickes
ass licking
ass lickly
ass licks
assbang
assbanged
assbangeded
assbangeder
assbangedes
assbangeding
assbangedly
assbangeds
assbanger
assbanges
assbanging
assbangly
assbangs
assbangsed
assbangser
assbangses
assbangsing
assbangsly
assbangss
assed
asser
asses
assesed
asseser
asseses
assesing
assesly
assess
assfuck
assfucked
assfucker
assfuckered
assfuckerer
assfuckeres
assfuckering
assfuckerly
assfuckers
assfuckes
assfucking
assfuckly
assfucks
asshat
asshated
asshater
asshates
asshating
asshatly
asshats
assholeed
assholeer
assholees
assholeing
assholely
assholes
assholesed
assholeser
assholeses
assholesing
assholesly
assholess
assing
assly
assmaster
assmastered
assmasterer
assmasteres
assmastering
assmasterly
assmasters
assmunch
assmunched
assmuncher
assmunches
assmunching
assmunchly
assmunchs
asss
asswipe
asswipeed
asswipeer
asswipees
asswipeing
asswipely
asswipes
asswipesed
asswipeser
asswipeses
asswipesing
asswipesly
asswipess
azz
azzed
azzer
azzes
azzing
azzly
azzs
babeed
babeer
babees
babeing
babely
babes
babesed
babeser
babeses
babesing
babesly
babess
ballsac
ballsaced
ballsacer
ballsaces
ballsacing
ballsack
ballsacked
ballsacker
ballsackes
ballsacking
ballsackly
ballsacks
ballsacly
ballsacs
ballsed
ballser
ballses
ballsing
ballsly
ballss
barf
barfed
barfer
barfes
barfing
barfly
barfs
bastard
bastarded
bastarder
bastardes
bastarding
bastardly
bastards
bastardsed
bastardser
bastardses
bastardsing
bastardsly
bastardss
bawdy
bawdyed
bawdyer
bawdyes
bawdying
bawdyly
bawdys
beaner
beanered
beanerer
beaneres
beanering
beanerly
beaners
beardedclam
beardedclamed
beardedclamer
beardedclames
beardedclaming
beardedclamly
beardedclams
beastiality
beastialityed
beastialityer
beastialityes
beastialitying
beastialityly
beastialitys
beatch
beatched
beatcher
beatches
beatching
beatchly
beatchs
beater
beatered
beaterer
beateres
beatering
beaterly
beaters
beered
beerer
beeres
beering
beerly
beeyotch
beeyotched
beeyotcher
beeyotches
beeyotching
beeyotchly
beeyotchs
beotch
beotched
beotcher
beotches
beotching
beotchly
beotchs
biatch
biatched
biatcher
biatches
biatching
biatchly
biatchs
big tits
big titsed
big titser
big titses
big titsing
big titsly
big titss
bigtits
bigtitsed
bigtitser
bigtitses
bigtitsing
bigtitsly
bigtitss
bimbo
bimboed
bimboer
bimboes
bimboing
bimboly
bimbos
bisexualed
bisexualer
bisexuales
bisexualing
bisexually
bisexuals
bitch
bitched
bitcheded
bitcheder
bitchedes
bitcheding
bitchedly
bitcheds
bitcher
bitches
bitchesed
bitcheser
bitcheses
bitchesing
bitchesly
bitchess
bitching
bitchly
bitchs
bitchy
bitchyed
bitchyer
bitchyes
bitchying
bitchyly
bitchys
bleached
bleacher
bleaches
bleaching
bleachly
bleachs
blow job
blow jobed
blow jober
blow jobes
blow jobing
blow jobly
blow jobs
blowed
blower
blowes
blowing
blowjob
blowjobed
blowjober
blowjobes
blowjobing
blowjobly
blowjobs
blowjobsed
blowjobser
blowjobses
blowjobsing
blowjobsly
blowjobss
blowly
blows
boink
boinked
boinker
boinkes
boinking
boinkly
boinks
bollock
bollocked
bollocker
bollockes
bollocking
bollockly
bollocks
bollocksed
bollockser
bollockses
bollocksing
bollocksly
bollockss
bollok
bolloked
bolloker
bollokes
bolloking
bollokly
bolloks
boner
bonered
bonerer
boneres
bonering
bonerly
boners
bonersed
bonerser
bonerses
bonersing
bonersly
bonerss
bong
bonged
bonger
bonges
bonging
bongly
bongs
boob
boobed
boober
boobes
boobies
boobiesed
boobieser
boobieses
boobiesing
boobiesly
boobiess
boobing
boobly
boobs
boobsed
boobser
boobses
boobsing
boobsly
boobss
booby
boobyed
boobyer
boobyes
boobying
boobyly
boobys
booger
boogered
boogerer
boogeres
boogering
boogerly
boogers
bookie
bookieed
bookieer
bookiees
bookieing
bookiely
bookies
bootee
booteeed
booteeer
booteees
booteeing
booteely
bootees
bootie
bootieed
bootieer
bootiees
bootieing
bootiely
booties
booty
bootyed
bootyer
bootyes
bootying
bootyly
bootys
boozeed
boozeer
boozees
boozeing
boozely
boozer
boozered
boozerer
boozeres
boozering
boozerly
boozers
boozes
boozy
boozyed
boozyer
boozyes
boozying
boozyly
boozys
bosomed
bosomer
bosomes
bosoming
bosomly
bosoms
bosomy
bosomyed
bosomyer
bosomyes
bosomying
bosomyly
bosomys
bugger
buggered
buggerer
buggeres
buggering
buggerly
buggers
bukkake
bukkakeed
bukkakeer
bukkakees
bukkakeing
bukkakely
bukkakes
bull shit
bull shited
bull shiter
bull shites
bull shiting
bull shitly
bull shits
bullshit
bullshited
bullshiter
bullshites
bullshiting
bullshitly
bullshits
bullshitsed
bullshitser
bullshitses
bullshitsing
bullshitsly
bullshitss
bullshitted
bullshitteded
bullshitteder
bullshittedes
bullshitteding
bullshittedly
bullshitteds
bullturds
bullturdsed
bullturdser
bullturdses
bullturdsing
bullturdsly
bullturdss
bung
bunged
bunger
bunges
bunging
bungly
bungs
busty
bustyed
bustyer
bustyes
bustying
bustyly
bustys
butt
butt fuck
butt fucked
butt fucker
butt fuckes
butt fucking
butt fuckly
butt fucks
butted
buttes
buttfuck
buttfucked
buttfucker
buttfuckered
buttfuckerer
buttfuckeres
buttfuckering
buttfuckerly
buttfuckers
buttfuckes
buttfucking
buttfuckly
buttfucks
butting
buttly
buttplug
buttpluged
buttpluger
buttpluges
buttpluging
buttplugly
buttplugs
butts
caca
cacaed
cacaer
cacaes
cacaing
cacaly
cacas
cahone
cahoneed
cahoneer
cahonees
cahoneing
cahonely
cahones
cameltoe
cameltoeed
cameltoeer
cameltoees
cameltoeing
cameltoely
cameltoes
carpetmuncher
carpetmunchered
carpetmuncherer
carpetmuncheres
carpetmunchering
carpetmuncherly
carpetmunchers
cawk
cawked
cawker
cawkes
cawking
cawkly
cawks
chinc
chinced
chincer
chinces
chincing
chincly
chincs
chincsed
chincser
chincses
chincsing
chincsly
chincss
chink
chinked
chinker
chinkes
chinking
chinkly
chinks
chode
chodeed
chodeer
chodees
chodeing
chodely
chodes
chodesed
chodeser
chodeses
chodesing
chodesly
chodess
clit
clited
cliter
clites
cliting
clitly
clitoris
clitorised
clitoriser
clitorises
clitorising
clitorisly
clitoriss
clitorus
clitorused
clitoruser
clitoruses
clitorusing
clitorusly
clitoruss
clits
clitsed
clitser
clitses
clitsing
clitsly
clitss
clitty
clittyed
clittyer
clittyes
clittying
clittyly
clittys
cocain
cocaine
cocained
cocaineed
cocaineer
cocainees
cocaineing
cocainely
cocainer
cocaines
cocaining
cocainly
cocains
cock
cock sucker
cock suckered
cock suckerer
cock suckeres
cock suckering
cock suckerly
cock suckers
cockblock
cockblocked
cockblocker
cockblockes
cockblocking
cockblockly
cockblocks
cocked
cocker
cockes
cockholster
cockholstered
cockholsterer
cockholsteres
cockholstering
cockholsterly
cockholsters
cocking
cockknocker
cockknockered
cockknockerer
cockknockeres
cockknockering
cockknockerly
cockknockers
cockly
cocks
cocksed
cockser
cockses
cocksing
cocksly
cocksmoker
cocksmokered
cocksmokerer
cocksmokeres
cocksmokering
cocksmokerly
cocksmokers
cockss
cocksucker
cocksuckered
cocksuckerer
cocksuckeres
cocksuckering
cocksuckerly
cocksuckers
coital
coitaled
coitaler
coitales
coitaling
coitally
coitals
commie
commieed
commieer
commiees
commieing
commiely
commies
condomed
condomer
condomes
condoming
condomly
condoms
coon
cooned
cooner
coones
cooning
coonly
coons
coonsed
coonser
coonses
coonsing
coonsly
coonss
corksucker
corksuckered
corksuckerer
corksuckeres
corksuckering
corksuckerly
corksuckers
cracked
crackwhore
crackwhoreed
crackwhoreer
crackwhorees
crackwhoreing
crackwhorely
crackwhores
crap
craped
craper
crapes
craping
craply
crappy
crappyed
crappyer
crappyes
crappying
crappyly
crappys
cum
cumed
cumer
cumes
cuming
cumly
cummin
cummined
cumminer
cummines
cumming
cumminged
cumminger
cumminges
cumminging
cummingly
cummings
cummining
cumminly
cummins
cums
cumshot
cumshoted
cumshoter
cumshotes
cumshoting
cumshotly
cumshots
cumshotsed
cumshotser
cumshotses
cumshotsing
cumshotsly
cumshotss
cumslut
cumsluted
cumsluter
cumslutes
cumsluting
cumslutly
cumsluts
cumstain
cumstained
cumstainer
cumstaines
cumstaining
cumstainly
cumstains
cunilingus
cunilingused
cunilinguser
cunilinguses
cunilingusing
cunilingusly
cunilinguss
cunnilingus
cunnilingused
cunnilinguser
cunnilinguses
cunnilingusing
cunnilingusly
cunnilinguss
cunny
cunnyed
cunnyer
cunnyes
cunnying
cunnyly
cunnys
cunt
cunted
cunter
cuntes
cuntface
cuntfaceed
cuntfaceer
cuntfacees
cuntfaceing
cuntfacely
cuntfaces
cunthunter
cunthuntered
cunthunterer
cunthunteres
cunthuntering
cunthunterly
cunthunters
cunting
cuntlick
cuntlicked
cuntlicker
cuntlickered
cuntlickerer
cuntlickeres
cuntlickering
cuntlickerly
cuntlickers
cuntlickes
cuntlicking
cuntlickly
cuntlicks
cuntly
cunts
cuntsed
cuntser
cuntses
cuntsing
cuntsly
cuntss
dago
dagoed
dagoer
dagoes
dagoing
dagoly
dagos
dagosed
dagoser
dagoses
dagosing
dagosly
dagoss
dammit
dammited
dammiter
dammites
dammiting
dammitly
dammits
damn
damned
damneded
damneder
damnedes
damneding
damnedly
damneds
damner
damnes
damning
damnit
damnited
damniter
damnites
damniting
damnitly
damnits
damnly
damns
dick
dickbag
dickbaged
dickbager
dickbages
dickbaging
dickbagly
dickbags
dickdipper
dickdippered
dickdipperer
dickdipperes
dickdippering
dickdipperly
dickdippers
dicked
dicker
dickes
dickface
dickfaceed
dickfaceer
dickfacees
dickfaceing
dickfacely
dickfaces
dickflipper
dickflippered
dickflipperer
dickflipperes
dickflippering
dickflipperly
dickflippers
dickhead
dickheaded
dickheader
dickheades
dickheading
dickheadly
dickheads
dickheadsed
dickheadser
dickheadses
dickheadsing
dickheadsly
dickheadss
dicking
dickish
dickished
dickisher
dickishes
dickishing
dickishly
dickishs
dickly
dickripper
dickrippered
dickripperer
dickripperes
dickrippering
dickripperly
dickrippers
dicks
dicksipper
dicksippered
dicksipperer
dicksipperes
dicksippering
dicksipperly
dicksippers
dickweed
dickweeded
dickweeder
dickweedes
dickweeding
dickweedly
dickweeds
dickwhipper
dickwhippered
dickwhipperer
dickwhipperes
dickwhippering
dickwhipperly
dickwhippers
dickzipper
dickzippered
dickzipperer
dickzipperes
dickzippering
dickzipperly
dickzippers
diddle
diddleed
diddleer
diddlees
diddleing
diddlely
diddles
dike
dikeed
dikeer
dikees
dikeing
dikely
dikes
dildo
dildoed
dildoer
dildoes
dildoing
dildoly
dildos
dildosed
dildoser
dildoses
dildosing
dildosly
dildoss
diligaf
diligafed
diligafer
diligafes
diligafing
diligafly
diligafs
dillweed
dillweeded
dillweeder
dillweedes
dillweeding
dillweedly
dillweeds
dimwit
dimwited
dimwiter
dimwites
dimwiting
dimwitly
dimwits
dingle
dingleed
dingleer
dinglees
dingleing
dinglely
dingles
dipship
dipshiped
dipshiper
dipshipes
dipshiping
dipshiply
dipships
dizzyed
dizzyer
dizzyes
dizzying
dizzyly
dizzys
doggiestyleed
doggiestyleer
doggiestylees
doggiestyleing
doggiestylely
doggiestyles
doggystyleed
doggystyleer
doggystylees
doggystyleing
doggystylely
doggystyles
dong
donged
donger
donges
donging
dongly
dongs
doofus
doofused
doofuser
doofuses
doofusing
doofusly
doofuss
doosh
dooshed
doosher
dooshes
dooshing
dooshly
dooshs
dopeyed
dopeyer
dopeyes
dopeying
dopeyly
dopeys
douchebag
douchebaged
douchebager
douchebages
douchebaging
douchebagly
douchebags
douchebagsed
douchebagser
douchebagses
douchebagsing
douchebagsly
douchebagss
doucheed
doucheer
douchees
doucheing
douchely
douches
douchey
doucheyed
doucheyer
doucheyes
doucheying
doucheyly
doucheys
drunk
drunked
drunker
drunkes
drunking
drunkly
drunks
dumass
dumassed
dumasser
dumasses
dumassing
dumassly
dumasss
dumbass
dumbassed
dumbasser
dumbasses
dumbassesed
dumbasseser
dumbasseses
dumbassesing
dumbassesly
dumbassess
dumbassing
dumbassly
dumbasss
dummy
dummyed
dummyer
dummyes
dummying
dummyly
dummys
dyke
dykeed
dykeer
dykees
dykeing
dykely
dykes
dykesed
dykeser
dykeses
dykesing
dykesly
dykess
erotic
eroticed
eroticer
erotices
eroticing
eroticly
erotics
extacy
extacyed
extacyer
extacyes
extacying
extacyly
extacys
extasy
extasyed
extasyer
extasyes
extasying
extasyly
extasys
fack
facked
facker
fackes
facking
fackly
facks
fag
faged
fager
fages
fagg
fagged
faggeded
faggeder
faggedes
faggeding
faggedly
faggeds
fagger
fagges
fagging
faggit
faggited
faggiter
faggites
faggiting
faggitly
faggits
faggly
faggot
faggoted
faggoter
faggotes
faggoting
faggotly
faggots
faggs
faging
fagly
fagot
fagoted
fagoter
fagotes
fagoting
fagotly
fagots
fags
fagsed
fagser
fagses
fagsing
fagsly
fagss
faig
faiged
faiger
faiges
faiging
faigly
faigs
faigt
faigted
faigter
faigtes
faigting
faigtly
faigts
fannybandit
fannybandited
fannybanditer
fannybandites
fannybanditing
fannybanditly
fannybandits
farted
farter
fartes
farting
fartknocker
fartknockered
fartknockerer
fartknockeres
fartknockering
fartknockerly
fartknockers
fartly
farts
felch
felched
felcher
felchered
felcherer
felcheres
felchering
felcherly
felchers
felches
felching
felchinged
felchinger
felchinges
felchinging
felchingly
felchings
felchly
felchs
fellate
fellateed
fellateer
fellatees
fellateing
fellately
fellates
fellatio
fellatioed
fellatioer
fellatioes
fellatioing
fellatioly
fellatios
feltch
feltched
feltcher
feltchered
feltcherer
feltcheres
feltchering
feltcherly
feltchers
feltches
feltching
feltchly
feltchs
feom
feomed
feomer
feomes
feoming
feomly
feoms
fisted
fisteded
fisteder
fistedes
fisteding
fistedly
fisteds
fisting
fistinged
fistinger
fistinges
fistinging
fistingly
fistings
fisty
fistyed
fistyer
fistyes
fistying
fistyly
fistys
floozy
floozyed
floozyer
floozyes
floozying
floozyly
floozys
foad
foaded
foader
foades
foading
foadly
foads
fondleed
fondleer
fondlees
fondleing
fondlely
fondles
foobar
foobared
foobarer
foobares
foobaring
foobarly
foobars
freex
freexed
freexer
freexes
freexing
freexly
freexs
frigg
frigga
friggaed
friggaer
friggaes
friggaing
friggaly
friggas
frigged
frigger
frigges
frigging
friggly
friggs
fubar
fubared
fubarer
fubares
fubaring
fubarly
fubars
fuck
fuckass
fuckassed
fuckasser
fuckasses
fuckassing
fuckassly
fuckasss
fucked
fuckeded
fuckeder
fuckedes
fuckeding
fuckedly
fuckeds
fucker
fuckered
fuckerer
fuckeres
fuckering
fuckerly
fuckers
fuckes
fuckface
fuckfaceed
fuckfaceer
fuckfacees
fuckfaceing
fuckfacely
fuckfaces
fuckin
fuckined
fuckiner
fuckines
fucking
fuckinged
fuckinger
fuckinges
fuckinging
fuckingly
fuckings
fuckining
fuckinly
fuckins
fuckly
fucknugget
fucknuggeted
fucknuggeter
fucknuggetes
fucknuggeting
fucknuggetly
fucknuggets
fucknut
fucknuted
fucknuter
fucknutes
fucknuting
fucknutly
fucknuts
fuckoff
fuckoffed
fuckoffer
fuckoffes
fuckoffing
fuckoffly
fuckoffs
fucks
fucksed
fuckser
fuckses
fucksing
fucksly
fuckss
fucktard
fucktarded
fucktarder
fucktardes
fucktarding
fucktardly
fucktards
fuckup
fuckuped
fuckuper
fuckupes
fuckuping
fuckuply
fuckups
fuckwad
fuckwaded
fuckwader
fuckwades
fuckwading
fuckwadly
fuckwads
fuckwit
fuckwited
fuckwiter
fuckwites
fuckwiting
fuckwitly
fuckwits
fudgepacker
fudgepackered
fudgepackerer
fudgepackeres
fudgepackering
fudgepackerly
fudgepackers
fuk
fuked
fuker
fukes
fuking
fukly
fuks
fvck
fvcked
fvcker
fvckes
fvcking
fvckly
fvcks
fxck
fxcked
fxcker
fxckes
fxcking
fxckly
fxcks
gae
gaeed
gaeer
gaees
gaeing
gaely
gaes
gai
gaied
gaier
gaies
gaiing
gaily
gais
ganja
ganjaed
ganjaer
ganjaes
ganjaing
ganjaly
ganjas
gayed
gayer
gayes
gaying
gayly
gays
gaysed
gayser
gayses
gaysing
gaysly
gayss
gey
geyed
geyer
geyes
geying
geyly
geys
gfc
gfced
gfcer
gfces
gfcing
gfcly
gfcs
gfy
gfyed
gfyer
gfyes
gfying
gfyly
gfys
ghay
ghayed
ghayer
ghayes
ghaying
ghayly
ghays
ghey
gheyed
gheyer
gheyes
gheying
gheyly
gheys
gigolo
gigoloed
gigoloer
gigoloes
gigoloing
gigololy
gigolos
goatse
goatseed
goatseer
goatsees
goatseing
goatsely
goatses
godamn
godamned
godamner
godamnes
godamning
godamnit
godamnited
godamniter
godamnites
godamniting
godamnitly
godamnits
godamnly
godamns
goddam
goddamed
goddamer
goddames
goddaming
goddamly
goddammit
goddammited
goddammiter
goddammites
goddammiting
goddammitly
goddammits
goddamn
goddamned
goddamner
goddamnes
goddamning
goddamnly
goddamns
goddams
goldenshower
goldenshowered
goldenshowerer
goldenshoweres
goldenshowering
goldenshowerly
goldenshowers
gonad
gonaded
gonader
gonades
gonading
gonadly
gonads
gonadsed
gonadser
gonadses
gonadsing
gonadsly
gonadss
gook
gooked
gooker
gookes
gooking
gookly
gooks
gooksed
gookser
gookses
gooksing
gooksly
gookss
gringo
gringoed
gringoer
gringoes
gringoing
gringoly
gringos
gspot
gspoted
gspoter
gspotes
gspoting
gspotly
gspots
gtfo
gtfoed
gtfoer
gtfoes
gtfoing
gtfoly
gtfos
guido
guidoed
guidoer
guidoes
guidoing
guidoly
guidos
handjob
handjobed
handjober
handjobes
handjobing
handjobly
handjobs
hard on
hard oned
hard oner
hard ones
hard oning
hard only
hard ons
hardknight
hardknighted
hardknighter
hardknightes
hardknighting
hardknightly
hardknights
hebe
hebeed
hebeer
hebees
hebeing
hebely
hebes
heeb
heebed
heeber
heebes
heebing
heebly
heebs
hell
helled
heller
helles
helling
hellly
hells
hemp
hemped
hemper
hempes
hemping
hemply
hemps
heroined
heroiner
heroines
heroining
heroinly
heroins
herp
herped
herper
herpes
herpesed
herpeser
herpeses
herpesing
herpesly
herpess
herping
herply
herps
herpy
herpyed
herpyer
herpyes
herpying
herpyly
herpys
hitler
hitlered
hitlerer
hitleres
hitlering
hitlerly
hitlers
hived
hiver
hives
hiving
hivly
hivs
hobag
hobaged
hobager
hobages
hobaging
hobagly
hobags
homey
homeyed
homeyer
homeyes
homeying
homeyly
homeys
homo
homoed
homoer
homoes
homoey
homoeyed
homoeyer
homoeyes
homoeying
homoeyly
homoeys
homoing
homoly
homos
honky
honkyed
honkyer
honkyes
honkying
honkyly
honkys
hooch
hooched
hoocher
hooches
hooching
hoochly
hoochs
hookah
hookahed
hookaher
hookahes
hookahing
hookahly
hookahs
hooker
hookered
hookerer
hookeres
hookering
hookerly
hookers
hoor
hoored
hoorer
hoores
hooring
hoorly
hoors
hootch
hootched
hootcher
hootches
hootching
hootchly
hootchs
hooter
hootered
hooterer
hooteres
hootering
hooterly
hooters
hootersed
hooterser
hooterses
hootersing
hootersly
hooterss
horny
hornyed
hornyer
hornyes
hornying
hornyly
hornys
houstoned
houstoner
houstones
houstoning
houstonly
houstons
hump
humped
humpeded
humpeder
humpedes
humpeding
humpedly
humpeds
humper
humpes
humping
humpinged
humpinger
humpinges
humpinging
humpingly
humpings
humply
humps
husbanded
husbander
husbandes
husbanding
husbandly
husbands
hussy
hussyed
hussyer
hussyes
hussying
hussyly
hussys
hymened
hymener
hymenes
hymening
hymenly
hymens
inbred
inbreded
inbreder
inbredes
inbreding
inbredly
inbreds
incest
incested
incester
incestes
incesting
incestly
incests
injun
injuned
injuner
injunes
injuning
injunly
injuns
jackass
jackassed
jackasser
jackasses
jackassing
jackassly
jackasss
jackhole
jackholeed
jackholeer
jackholees
jackholeing
jackholely
jackholes
jackoff
jackoffed
jackoffer
jackoffes
jackoffing
jackoffly
jackoffs
jap
japed
japer
japes
japing
japly
japs
japsed
japser
japses
japsing
japsly
japss
jerkoff
jerkoffed
jerkoffer
jerkoffes
jerkoffing
jerkoffly
jerkoffs
jerks
jism
jismed
jismer
jismes
jisming
jismly
jisms
jiz
jized
jizer
jizes
jizing
jizly
jizm
jizmed
jizmer
jizmes
jizming
jizmly
jizms
jizs
jizz
jizzed
jizzeded
jizzeder
jizzedes
jizzeding
jizzedly
jizzeds
jizzer
jizzes
jizzing
jizzly
jizzs
junkie
junkieed
junkieer
junkiees
junkieing
junkiely
junkies
junky
junkyed
junkyer
junkyes
junkying
junkyly
junkys
kike
kikeed
kikeer
kikees
kikeing
kikely
kikes
kikesed
kikeser
kikeses
kikesing
kikesly
kikess
killed
killer
killes
killing
killly
kills
kinky
kinkyed
kinkyer
kinkyes
kinkying
kinkyly
kinkys
kkk
kkked
kkker
kkkes
kkking
kkkly
kkks
klan
klaned
klaner
klanes
klaning
klanly
klans
knobend
knobended
knobender
knobendes
knobending
knobendly
knobends
kooch
kooched
koocher
kooches
koochesed
koocheser
koocheses
koochesing
koochesly
koochess
kooching
koochly
koochs
kootch
kootched
kootcher
kootches
kootching
kootchly
kootchs
kraut
krauted
krauter
krautes
krauting
krautly
krauts
kyke
kykeed
kykeer
kykees
kykeing
kykely
kykes
lech
leched
lecher
leches
leching
lechly
lechs
leper
lepered
leperer
leperes
lepering
leperly
lepers
lesbiansed
lesbianser
lesbianses
lesbiansing
lesbiansly
lesbianss
lesbo
lesboed
lesboer
lesboes
lesboing
lesboly
lesbos
lesbosed
lesboser
lesboses
lesbosing
lesbosly
lesboss
lez
lezbianed
lezbianer
lezbianes
lezbianing
lezbianly
lezbians
lezbiansed
lezbianser
lezbianses
lezbiansing
lezbiansly
lezbianss
lezbo
lezboed
lezboer
lezboes
lezboing
lezboly
lezbos
lezbosed
lezboser
lezboses
lezbosing
lezbosly
lezboss
lezed
lezer
lezes
lezing
lezly
lezs
lezzie
lezzieed
lezzieer
lezziees
lezzieing
lezziely
lezzies
lezziesed
lezzieser
lezzieses
lezziesing
lezziesly
lezziess
lezzy
lezzyed
lezzyer
lezzyes
lezzying
lezzyly
lezzys
lmaoed
lmaoer
lmaoes
lmaoing
lmaoly
lmaos
lmfao
lmfaoed
lmfaoer
lmfaoes
lmfaoing
lmfaoly
lmfaos
loined
loiner
loines
loining
loinly
loins
loinsed
loinser
loinses
loinsing
loinsly
loinss
lubeed
lubeer
lubees
lubeing
lubely
lubes
lusty
lustyed
lustyer
lustyes
lustying
lustyly
lustys
massa
massaed
massaer
massaes
massaing
massaly
massas
masterbate
masterbateed
masterbateer
masterbatees
masterbateing
masterbately
masterbates
masterbating
masterbatinged
masterbatinger
masterbatinges
masterbatinging
masterbatingly
masterbatings
masterbation
masterbationed
masterbationer
masterbationes
masterbationing
masterbationly
masterbations
masturbate
masturbateed
masturbateer
masturbatees
masturbateing
masturbately
masturbates
masturbating
masturbatinged
masturbatinger
masturbatinges
masturbatinging
masturbatingly
masturbatings
masturbation
masturbationed
masturbationer
masturbationes
masturbationing
masturbationly
masturbations
methed
mether
methes
mething
methly
meths
militaryed
militaryer
militaryes
militarying
militaryly
militarys
mofo
mofoed
mofoer
mofoes
mofoing
mofoly
mofos
molest
molested
molester
molestes
molesting
molestly
molests
moolie
moolieed
moolieer
mooliees
moolieing
mooliely
moolies
moron
moroned
moroner
morones
moroning
moronly
morons
motherfucka
motherfuckaed
motherfuckaer
motherfuckaes
motherfuckaing
motherfuckaly
motherfuckas
motherfucker
motherfuckered
motherfuckerer
motherfuckeres
motherfuckering
motherfuckerly
motherfuckers
motherfucking
motherfuckinged
motherfuckinger
motherfuckinges
motherfuckinging
motherfuckingly
motherfuckings
mtherfucker
mtherfuckered
mtherfuckerer
mtherfuckeres
mtherfuckering
mtherfuckerly
mtherfuckers
mthrfucker
mthrfuckered
mthrfuckerer
mthrfuckeres
mthrfuckering
mthrfuckerly
mthrfuckers
mthrfucking
mthrfuckinged
mthrfuckinger
mthrfuckinges
mthrfuckinging
mthrfuckingly
mthrfuckings
muff
muffdiver
muffdivered
muffdiverer
muffdiveres
muffdivering
muffdiverly
muffdivers
muffed
muffer
muffes
muffing
muffly
muffs
murdered
murderer
murderes
murdering
murderly
murders
muthafuckaz
muthafuckazed
muthafuckazer
muthafuckazes
muthafuckazing
muthafuckazly
muthafuckazs
muthafucker
muthafuckered
muthafuckerer
muthafuckeres
muthafuckering
muthafuckerly
muthafuckers
mutherfucker
mutherfuckered
mutherfuckerer
mutherfuckeres
mutherfuckering
mutherfuckerly
mutherfuckers
mutherfucking
mutherfuckinged
mutherfuckinger
mutherfuckinges
mutherfuckinging
mutherfuckingly
mutherfuckings
muthrfucking
muthrfuckinged
muthrfuckinger
muthrfuckinges
muthrfuckinging
muthrfuckingly
muthrfuckings
nad
naded
nader
nades
nading
nadly
nads
nadsed
nadser
nadses
nadsing
nadsly
nadss
nakeded
nakeder
nakedes
nakeding
nakedly
nakeds
napalm
napalmed
napalmer
napalmes
napalming
napalmly
napalms
nappy
nappyed
nappyer
nappyes
nappying
nappyly
nappys
nazi
nazied
nazier
nazies
naziing
nazily
nazis
nazism
nazismed
nazismer
nazismes
nazisming
nazismly
nazisms
negro
negroed
negroer
negroes
negroing
negroly
negros
nigga
niggaed
niggaer
niggaes
niggah
niggahed
niggaher
niggahes
niggahing
niggahly
niggahs
niggaing
niggaly
niggas
niggased
niggaser
niggases
niggasing
niggasly
niggass
niggaz
niggazed
niggazer
niggazes
niggazing
niggazly
niggazs
nigger
niggered
niggerer
niggeres
niggering
niggerly
niggers
niggersed
niggerser
niggerses
niggersing
niggersly
niggerss
niggle
niggleed
niggleer
nigglees
niggleing
nigglely
niggles
niglet
nigleted
nigleter
nigletes
nigleting
nigletly
niglets
nimrod
nimroded
nimroder
nimrodes
nimroding
nimrodly
nimrods
ninny
ninnyed
ninnyer
ninnyes
ninnying
ninnyly
ninnys
nooky
nookyed
nookyer
nookyes
nookying
nookyly
nookys
nuccitelli
nuccitellied
nuccitellier
nuccitellies
nuccitelliing
nuccitellily
nuccitellis
nympho
nymphoed
nymphoer
nymphoes
nymphoing
nympholy
nymphos
opium
opiumed
opiumer
opiumes
opiuming
opiumly
opiums
orgies
orgiesed
orgieser
orgieses
orgiesing
orgiesly
orgiess
orgy
orgyed
orgyer
orgyes
orgying
orgyly
orgys
paddy
paddyed
paddyer
paddyes
paddying
paddyly
paddys
paki
pakied
pakier
pakies
pakiing
pakily
pakis
pantie
pantieed
pantieer
pantiees
pantieing
pantiely
panties
pantiesed
pantieser
pantieses
pantiesing
pantiesly
pantiess
panty
pantyed
pantyer
pantyes
pantying
pantyly
pantys
pastie
pastieed
pastieer
pastiees
pastieing
pastiely
pasties
pasty
pastyed
pastyer
pastyes
pastying
pastyly
pastys
pecker
peckered
peckerer
peckeres
peckering
peckerly
peckers
pedo
pedoed
pedoer
pedoes
pedoing
pedoly
pedophile
pedophileed
pedophileer
pedophilees
pedophileing
pedophilely
pedophiles
pedophilia
pedophiliac
pedophiliaced
pedophiliacer
pedophiliaces
pedophiliacing
pedophiliacly
pedophiliacs
pedophiliaed
pedophiliaer
pedophiliaes
pedophiliaing
pedophilialy
pedophilias
pedos
penial
penialed
penialer
peniales
penialing
penially
penials
penile
penileed
penileer
penilees
penileing
penilely
peniles
penis
penised
peniser
penises
penising
penisly
peniss
perversion
perversioned
perversioner
perversiones
perversioning
perversionly
perversions
peyote
peyoteed
peyoteer
peyotees
peyoteing
peyotely
peyotes
phuck
phucked
phucker
phuckes
phucking
phuckly
phucks
pillowbiter
pillowbitered
pillowbiterer
pillowbiteres
pillowbitering
pillowbiterly
pillowbiters
pimp
pimped
pimper
pimpes
pimping
pimply
pimps
pinko
pinkoed
pinkoer
pinkoes
pinkoing
pinkoly
pinkos
pissed
pisseded
pisseder
pissedes
pisseding
pissedly
pisseds
pisser
pisses
pissing
pissly
pissoff
pissoffed
pissoffer
pissoffes
pissoffing
pissoffly
pissoffs
pisss
polack
polacked
polacker
polackes
polacking
polackly
polacks
pollock
pollocked
pollocker
pollockes
pollocking
pollockly
pollocks
poon
pooned
pooner
poones
pooning
poonly
poons
poontang
poontanged
poontanger
poontanges
poontanging
poontangly
poontangs
porn
porned
porner
pornes
porning
pornly
porno
pornoed
pornoer
pornoes
pornography
pornographyed
pornographyer
pornographyes
pornographying
pornographyly
pornographys
pornoing
pornoly
pornos
porns
prick
pricked
pricker
prickes
pricking
prickly
pricks
prig
priged
priger
priges
priging
prigly
prigs
prostitute
prostituteed
prostituteer
prostitutees
prostituteing
prostitutely
prostitutes
prude
prudeed
prudeer
prudees
prudeing
prudely
prudes
punkass
punkassed
punkasser
punkasses
punkassing
punkassly
punkasss
punky
punkyed
punkyer
punkyes
punkying
punkyly
punkys
puss
pussed
pusser
pusses
pussies
pussiesed
pussieser
pussieses
pussiesing
pussiesly
pussiess
pussing
pussly
pusss
pussy
pussyed
pussyer
pussyes
pussying
pussyly
pussypounder
pussypoundered
pussypounderer
pussypounderes
pussypoundering
pussypounderly
pussypounders
pussys
puto
putoed
putoer
putoes
putoing
putoly
putos
queaf
queafed
queafer
queafes
queafing
queafly
queafs
queef
queefed
queefer
queefes
queefing
queefly
queefs
queer
queered
queerer
queeres
queering
queerly
queero
queeroed
queeroer
queeroes
queeroing
queeroly
queeros
queers
queersed
queerser
queerses
queersing
queersly
queerss
quicky
quickyed
quickyer
quickyes
quickying
quickyly
quickys
quim
quimed
quimer
quimes
quiming
quimly
quims
racy
racyed
racyer
racyes
racying
racyly
racys
rape
raped
rapeded
rapeder
rapedes
rapeding
rapedly
rapeds
rapeed
rapeer
rapees
rapeing
rapely
raper
rapered
raperer
raperes
rapering
raperly
rapers
rapes
rapist
rapisted
rapister
rapistes
rapisting
rapistly
rapists
raunch
raunched
rauncher
raunches
raunching
raunchly
raunchs
rectus
rectused
rectuser
rectuses
rectusing
rectusly
rectuss
reefer
reefered
reeferer
reeferes
reefering
reeferly
reefers
reetard
reetarded
reetarder
reetardes
reetarding
reetardly
reetards
reich
reiched
reicher
reiches
reiching
reichly
reichs
retard
retarded
retardeded
retardeder
retardedes
retardeding
retardedly
retardeds
retarder
retardes
retarding
retardly
retards
rimjob
rimjobed
rimjober
rimjobes
rimjobing
rimjobly
rimjobs
ritard
ritarded
ritarder
ritardes
ritarding
ritardly
ritards
rtard
rtarded
rtarder
rtardes
rtarding
rtardly
rtards
rum
rumed
rumer
rumes
ruming
rumly
rump
rumped
rumper
rumpes
rumping
rumply
rumprammer
rumprammered
rumprammerer
rumprammeres
rumprammering
rumprammerly
rumprammers
rumps
rums
ruski
ruskied
ruskier
ruskies
ruskiing
ruskily
ruskis
sadism
sadismed
sadismer
sadismes
sadisming
sadismly
sadisms
sadist
sadisted
sadister
sadistes
sadisting
sadistly
sadists
scag
scaged
scager
scages
scaging
scagly
scags
scantily
scantilyed
scantilyer
scantilyes
scantilying
scantilyly
scantilys
schlong
schlonged
schlonger
schlonges
schlonging
schlongly
schlongs
scrog
scroged
scroger
scroges
scroging
scrogly
scrogs
scrot
scrote
scroted
scroteed
scroteer
scrotees
scroteing
scrotely
scroter
scrotes
scroting
scrotly
scrots
scrotum
scrotumed
scrotumer
scrotumes
scrotuming
scrotumly
scrotums
scrud
scruded
scruder
scrudes
scruding
scrudly
scruds
scum
scumed
scumer
scumes
scuming
scumly
scums
seaman
seamaned
seamaner
seamanes
seamaning
seamanly
seamans
seamen
seamened
seamener
seamenes
seamening
seamenly
seamens
seduceed
seduceer
seducees
seduceing
seducely
seduces
semen
semened
semener
semenes
semening
semenly
semens
shamedame
shamedameed
shamedameer
shamedamees
shamedameing
shamedamely
shamedames
shit
shite
shiteater
shiteatered
shiteaterer
shiteateres
shiteatering
shiteaterly
shiteaters
shited
shiteed
shiteer
shitees
shiteing
shitely
shiter
shites
shitface
shitfaceed
shitfaceer
shitfacees
shitfaceing
shitfacely
shitfaces
shithead
shitheaded
shitheader
shitheades
shitheading
shitheadly
shitheads
shithole
shitholeed
shitholeer
shitholees
shitholeing
shitholely
shitholes
shithouse
shithouseed
shithouseer
shithousees
shithouseing
shithousely
shithouses
shiting
shitly
shits
shitsed
shitser
shitses
shitsing
shitsly
shitss
shitt
shitted
shitteded
shitteder
shittedes
shitteding
shittedly
shitteds
shitter
shittered
shitterer
shitteres
shittering
shitterly
shitters
shittes
shitting
shittly
shitts
shitty
shittyed
shittyer
shittyes
shittying
shittyly
shittys
shiz
shized
shizer
shizes
shizing
shizly
shizs
shooted
shooter
shootes
shooting
shootly
shoots
sissy
sissyed
sissyer
sissyes
sissying
sissyly
sissys
skag
skaged
skager
skages
skaging
skagly
skags
skank
skanked
skanker
skankes
skanking
skankly
skanks
slave
slaveed
slaveer
slavees
slaveing
slavely
slaves
sleaze
sleazeed
sleazeer
sleazees
sleazeing
sleazely
sleazes
sleazy
sleazyed
sleazyer
sleazyes
sleazying
sleazyly
sleazys
slut
slutdumper
slutdumpered
slutdumperer
slutdumperes
slutdumpering
slutdumperly
slutdumpers
sluted
sluter
slutes
sluting
slutkiss
slutkissed
slutkisser
slutkisses
slutkissing
slutkissly
slutkisss
slutly
sluts
slutsed
slutser
slutses
slutsing
slutsly
slutss
smegma
smegmaed
smegmaer
smegmaes
smegmaing
smegmaly
smegmas
smut
smuted
smuter
smutes
smuting
smutly
smuts
smutty
smuttyed
smuttyer
smuttyes
smuttying
smuttyly
smuttys
snatch
snatched
snatcher
snatches
snatching
snatchly
snatchs
sniper
snipered
sniperer
sniperes
snipering
sniperly
snipers
snort
snorted
snorter
snortes
snorting
snortly
snorts
snuff
snuffed
snuffer
snuffes
snuffing
snuffly
snuffs
sodom
sodomed
sodomer
sodomes
sodoming
sodomly
sodoms
spic
spiced
spicer
spices
spicing
spick
spicked
spicker
spickes
spicking
spickly
spicks
spicly
spics
spik
spoof
spoofed
spoofer
spoofes
spoofing
spoofly
spoofs
spooge
spoogeed
spoogeer
spoogees
spoogeing
spoogely
spooges
spunk
spunked
spunker
spunkes
spunking
spunkly
spunks
steamyed
steamyer
steamyes
steamying
steamyly
steamys
stfu
stfued
stfuer
stfues
stfuing
stfuly
stfus
stiffy
stiffyed
stiffyer
stiffyes
stiffying
stiffyly
stiffys
stoneded
stoneder
stonedes
stoneding
stonedly
stoneds
stupided
stupider
stupides
stupiding
stupidly
stupids
suckeded
suckeder
suckedes
suckeding
suckedly
suckeds
sucker
suckes
sucking
suckinged
suckinger
suckinges
suckinging
suckingly
suckings
suckly
sucks
sumofabiatch
sumofabiatched
sumofabiatcher
sumofabiatches
sumofabiatching
sumofabiatchly
sumofabiatchs
tard
tarded
tarder
tardes
tarding
tardly
tards
tawdry
tawdryed
tawdryer
tawdryes
tawdrying
tawdryly
tawdrys
teabagging
teabagginged
teabagginger
teabagginges
teabagginging
teabaggingly
teabaggings
terd
terded
terder
terdes
terding
terdly
terds
teste
testee
testeed
testeeed
testeeer
testeees
testeeing
testeely
testeer
testees
testeing
testely
testes
testesed
testeser
testeses
testesing
testesly
testess
testicle
testicleed
testicleer
testiclees
testicleing
testiclely
testicles
testis
testised
testiser
testises
testising
testisly
testiss
thrusted
thruster
thrustes
thrusting
thrustly
thrusts
thug
thuged
thuger
thuges
thuging
thugly
thugs
tinkle
tinkleed
tinkleer
tinklees
tinkleing
tinklely
tinkles
tit
tited
titer
tites
titfuck
titfucked
titfucker
titfuckes
titfucking
titfuckly
titfucks
titi
titied
titier
tities
titiing
titily
titing
titis
titly
tits
titsed
titser
titses
titsing
titsly
titss
tittiefucker
tittiefuckered
tittiefuckerer
tittiefuckeres
tittiefuckering
tittiefuckerly
tittiefuckers
titties
tittiesed
tittieser
tittieses
tittiesing
tittiesly
tittiess
titty
tittyed
tittyer
tittyes
tittyfuck
tittyfucked
tittyfucker
tittyfuckered
tittyfuckerer
tittyfuckeres
tittyfuckering
tittyfuckerly
tittyfuckers
tittyfuckes
tittyfucking
tittyfuckly
tittyfucks
tittying
tittyly
tittys
toke
tokeed
tokeer
tokees
tokeing
tokely
tokes
toots
tootsed
tootser
tootses
tootsing
tootsly
tootss
tramp
tramped
tramper
trampes
tramping
tramply
tramps
transsexualed
transsexualer
transsexuales
transsexualing
transsexually
transsexuals
trashy
trashyed
trashyer
trashyes
trashying
trashyly
trashys
tubgirl
tubgirled
tubgirler
tubgirles
tubgirling
tubgirlly
tubgirls
turd
turded
turder
turdes
turding
turdly
turds
tush
tushed
tusher
tushes
tushing
tushly
tushs
twat
twated
twater
twates
twating
twatly
twats
twatsed
twatser
twatses
twatsing
twatsly
twatss
undies
undiesed
undieser
undieses
undiesing
undiesly
undiess
unweded
unweder
unwedes
unweding
unwedly
unweds
uzi
uzied
uzier
uzies
uziing
uzily
uzis
vag
vaged
vager
vages
vaging
vagly
vags
valium
valiumed
valiumer
valiumes
valiuming
valiumly
valiums
venous
virgined
virginer
virgines
virgining
virginly
virgins
vixen
vixened
vixener
vixenes
vixening
vixenly
vixens
vodkaed
vodkaer
vodkaes
vodkaing
vodkaly
vodkas
voyeur
voyeured
voyeurer
voyeures
voyeuring
voyeurly
voyeurs
vulgar
vulgared
vulgarer
vulgares
vulgaring
vulgarly
vulgars
wang
wanged
wanger
wanges
wanging
wangly
wangs
wank
wanked
wanker
wankered
wankerer
wankeres
wankering
wankerly
wankers
wankes
wanking
wankly
wanks
wazoo
wazooed
wazooer
wazooes
wazooing
wazooly
wazoos
wedgie
wedgieed
wedgieer
wedgiees
wedgieing
wedgiely
wedgies
weeded
weeder
weedes
weeding
weedly
weeds
weenie
weenieed
weenieer
weeniees
weenieing
weeniely
weenies
weewee
weeweeed
weeweeer
weeweees
weeweeing
weeweely
weewees
weiner
weinered
weinerer
weineres
weinering
weinerly
weiners
weirdo
weirdoed
weirdoer
weirdoes
weirdoing
weirdoly
weirdos
wench
wenched
wencher
wenches
wenching
wenchly
wenchs
wetback
wetbacked
wetbacker
wetbackes
wetbacking
wetbackly
wetbacks
whitey
whiteyed
whiteyer
whiteyes
whiteying
whiteyly
whiteys
whiz
whized
whizer
whizes
whizing
whizly
whizs
whoralicious
whoralicioused
whoraliciouser
whoraliciouses
whoraliciousing
whoraliciously
whoraliciouss
whore
whorealicious
whorealicioused
whorealiciouser
whorealiciouses
whorealiciousing
whorealiciously
whorealiciouss
whored
whoreded
whoreder
whoredes
whoreding
whoredly
whoreds
whoreed
whoreer
whorees
whoreface
whorefaceed
whorefaceer
whorefacees
whorefaceing
whorefacely
whorefaces
whorehopper
whorehoppered
whorehopperer
whorehopperes
whorehoppering
whorehopperly
whorehoppers
whorehouse
whorehouseed
whorehouseer
whorehousees
whorehouseing
whorehousely
whorehouses
whoreing
whorely
whores
whoresed
whoreser
whoreses
whoresing
whoresly
whoress
whoring
whoringed
whoringer
whoringes
whoringing
whoringly
whorings
wigger
wiggered
wiggerer
wiggeres
wiggering
wiggerly
wiggers
woody
woodyed
woodyer
woodyes
woodying
woodyly
woodys
wop
woped
woper
wopes
woping
woply
wops
wtf
wtfed
wtfer
wtfes
wtfing
wtfly
wtfs
xxx
xxxed
xxxer
xxxes
xxxing
xxxly
xxxs
yeasty
yeastyed
yeastyer
yeastyes
yeastying
yeastyly
yeastys
yobbo
yobboed
yobboer
yobboes
yobboing
yobboly
yobbos
zoophile
zoophileed
zoophileer
zoophilees
zoophileing
zoophilely
zoophiles
anal
ass
ass lick
balls
ballsac
bisexual
bleach
causas
cheap
cost of miracles
cunt
display network stats
fart
fda and death
fda AND warn
fda AND warning
fda AND warns
feom
fuck
gfc
humira AND expensive
illegal
madvocate
masturbation
nuccitelli
overdose
porn
shit
snort
texarkana
abbvie
AbbVie
acid
addicted
addiction
adolescent
adult sites
Advocacy
advocacy
agitated states
AJO, postsurgical analgesic, knee, replacement, surgery
alcohol
amphetamine
androgen
antibody
apple cider vinegar
assistance
Assistance
association
at home
attorney
audit
ayurvedic
baby
ban
baricitinib
bed bugs
best
bible
bisexual
black
bleach
blog
bulimia nervosa
buy
cannabis
certificate
certification
certified
cervical cancer, concurrent chemoradiotherapy, intravoxel incoherent motion magnetic resonance imaging, MRI, IVIM, diffusion-weighted MRI, DWI
charlie sheen
cheap
cheapest
child
childhood
childlike
children
chronic fatigue syndrome
Cladribine Tablets
cocaine
cock
combination therapies, synergistic antitumor efficacy, pertuzumab, trastuzumab, ipilimumab, nivolumab, palbociclib, letrozole, lapatinib, docetaxel, trametinib, dabrafenib, carflzomib, lenalidomide
contagious
Cortical Lesions
cream
creams
crime
criminal
cure
dangerous
dangers
dasabuvir
Dasabuvir
dead
deadly
death
dementia
dependence
dependent
depression
dermatillomania
die
diet
Disability
Discount
discount
dog
drink
drug abuse
drug-induced
dying
eastern medicine
eat
ect
eczema
electroconvulsive therapy
electromagnetic therapy
electrotherapy
epa
epilepsy
erectile dysfunction
explosive disorder
fake
Fake-ovir
fatal
fatalities
fatality
fibromyalgia
financial
Financial
fish oil
food
foods
foundation
free
Gabriel Pardo
gaston
general hospital
genetic
geriatric
Giancarlo Comi
gilead
Gilead
glaucoma
Glenn S. Williams
Glenn Williams
Gloria Dalla Costa
gonorrhea
Greedy
greedy
guns
hallucinations
harvoni
Harvoni
herbal
herbs
heroin
herpes
Hidradenitis Suppurativa,
holistic
home
home remedies
home remedy
homeopathic
homeopathy
hydrocortisone
ice
image
images
job
kid
kids
kill
killer
laser
lawsuit
lawyer
ledipasvir
Ledipasvir
lesbian
lesions
lights
liver
lupus
marijuana
melancholic
memory loss
menopausal
mental retardation
military
milk
moisturizers
monoamine oxidase inhibitor drugs
MRI
MS
murder
national
natural
natural cure
natural cures
natural medications
natural medicine
natural medicines
natural remedies
natural remedy
natural treatment
natural treatments
naturally
Needy
needy
Neurology Reviews
neuropathic
nightclub massacre
nightclub shooting
nude
nudity
nutraceuticals
OASIS
oasis
off label
ombitasvir
Ombitasvir
ombitasvir/paritaprevir/ritonavir with dasabuvir
orlando shooting
overactive thyroid gland
overdose
overdosed
Paolo Preziosa
paritaprevir
Paritaprevir
pediatric
pedophile
photo
photos
picture
post partum
postnatal
pregnancy
pregnant
prenatal
prepartum
prison
program
Program
Protest
protest
psychedelics
pulse nightclub
puppy
purchase
purchasing
rape
recall
recreational drug
Rehabilitation
Retinal Measurements
retrograde ejaculation
risperdal
ritonavir
Ritonavir
ritonavir with dasabuvir
robin williams
sales
sasquatch
schizophrenia
seizure
seizures
sex
sexual
sexy
shock treatment
silver
sleep disorders
smoking
sociopath
sofosbuvir
Sofosbuvir
sovaldi
ssri
store
sue
suicidal
suicide
supplements
support
Support
Support Path
teen
teenage
teenagers
Telerehabilitation
testosterone
Th17
Th17:FoxP3+Treg cell ratio
Th22
toxic
toxin
tragedy
treatment resistant
V Pak
vagina
velpatasvir
Viekira Pa
Viekira Pak
viekira pak
violence
virgin
vitamin
VPak
weight loss
withdrawal
wrinkles
xxx
young adult
young adults
zoloft
financial
sofosbuvir
ritonavir with dasabuvir
discount
support path
program
ritonavir
greedy
ledipasvir
assistance
viekira pak
vpak
advocacy
needy
protest
abbvie
paritaprevir
ombitasvir
direct-acting antivirals
dasabuvir
gilead
fake-ovir
support
v pak
oasis
harvoni
direct\-acting antivirals
Negative Keywords Excluded Elements
header[@id='header']
section[contains(@class, 'nav-hidden')]
footer[@id='footer']
div[contains(@class, 'pane-pub-article-jfp')]
div[contains(@class, 'pane-pub-home-jfp')]
div[contains(@class, 'pane-pub-topic-jfp')]
div[contains(@class, 'panel-panel-inner')]
div[contains(@class, 'pane-node-field-article-topics')]
section[contains(@class, 'footer-nav-section-wrapper')]
Altmetric
DSM Affiliated
Display in offset block
Disqus Exclude
Best Practices
CE/CME
Education Center
Medical Education Library
Enable Disqus
Display Author and Disclosure Link
Publication Type
Clinical
Slot System
Featured Buckets
Disable Sticky Ads
Disable Ad Block Mitigation
Featured Buckets Admin
LayerRx MD-IQ Id
776
Show Ads on this Publication's Homepage
Consolidated Pub
Show Article Page Numbers on TOC
Use larger logo size
Off

Perineal and perianal pruritus

Article Type
Changed
Display Headline
Perineal and perianal pruritus

The biopsy revealed that the patient had Paget’s disease of the vulva. Paget’s disease of the external genitalia is an uncommon primary cutaneous adenocarcinoma of apocrine gland-bearing skin. Lesions present as geographic red macules that often appear excoriated or have an eczematoid appearance. Lesions may be dotted with small, white patches. Patients may also present with erythematous, eczematous, or leukoplakic plaques.

 

The most commonly involved site is the vulva, although perineal, perianal, scrotal, and penile skin may also be affected. Aside from the location, Paget’s disease of the vulva is morphologically and histologically identical to Paget’s disease of the nipple.

Up to 25% of patients with genital Paget’s disease have an underlying neoplasm. Associated malignancies include carcinomas of Bartholin’s glands, urethra, bladder, vagina, cervix, endometrium, and adnexal apocrine tissue. Only a small number of cases represent a direct extension of an underlying carcinoma.

In this case, the patient was sent to a gynecologic oncologist for a wide local excision of the involved area. The health care team planned to follow the patient closely to detect any recurrence at an early stage.

 

Photos and text for Photo Rounds Friday courtesy of Richard P. Usatine, MD. This case was adapted from: Mayeaux EJ. Paget disease of the external genitalia. In: Usatine R, Smith M, Mayeaux EJ, et al, eds. Color Atlas of Family Medicine. 2nd ed. New York, NY: McGraw-Hill; 2013:514-518.

To learn more about the Color Atlas of Family Medicine, see: http://www.amazon.com/Color-Family-Medicine-Richard-Usatine/dp/0071769641/

You can now get the second edition of the Color Atlas of Family Medicine as an app by clicking on this link: http://usatinemedia.com/

Issue
The Journal of Family Practice - 63(12)
Publications
Topics
Sections

The biopsy revealed that the patient had Paget’s disease of the vulva. Paget’s disease of the external genitalia is an uncommon primary cutaneous adenocarcinoma of apocrine gland-bearing skin. Lesions present as geographic red macules that often appear excoriated or have an eczematoid appearance. Lesions may be dotted with small, white patches. Patients may also present with erythematous, eczematous, or leukoplakic plaques.

 

The most commonly involved site is the vulva, although perineal, perianal, scrotal, and penile skin may also be affected. Aside from the location, Paget’s disease of the vulva is morphologically and histologically identical to Paget’s disease of the nipple.

Up to 25% of patients with genital Paget’s disease have an underlying neoplasm. Associated malignancies include carcinomas of Bartholin’s glands, urethra, bladder, vagina, cervix, endometrium, and adnexal apocrine tissue. Only a small number of cases represent a direct extension of an underlying carcinoma.

In this case, the patient was sent to a gynecologic oncologist for a wide local excision of the involved area. The health care team planned to follow the patient closely to detect any recurrence at an early stage.

 

Photos and text for Photo Rounds Friday courtesy of Richard P. Usatine, MD. This case was adapted from: Mayeaux EJ. Paget disease of the external genitalia. In: Usatine R, Smith M, Mayeaux EJ, et al, eds. Color Atlas of Family Medicine. 2nd ed. New York, NY: McGraw-Hill; 2013:514-518.

To learn more about the Color Atlas of Family Medicine, see: http://www.amazon.com/Color-Family-Medicine-Richard-Usatine/dp/0071769641/

You can now get the second edition of the Color Atlas of Family Medicine as an app by clicking on this link: http://usatinemedia.com/

The biopsy revealed that the patient had Paget’s disease of the vulva. Paget’s disease of the external genitalia is an uncommon primary cutaneous adenocarcinoma of apocrine gland-bearing skin. Lesions present as geographic red macules that often appear excoriated or have an eczematoid appearance. Lesions may be dotted with small, white patches. Patients may also present with erythematous, eczematous, or leukoplakic plaques.

 

The most commonly involved site is the vulva, although perineal, perianal, scrotal, and penile skin may also be affected. Aside from the location, Paget’s disease of the vulva is morphologically and histologically identical to Paget’s disease of the nipple.

Up to 25% of patients with genital Paget’s disease have an underlying neoplasm. Associated malignancies include carcinomas of Bartholin’s glands, urethra, bladder, vagina, cervix, endometrium, and adnexal apocrine tissue. Only a small number of cases represent a direct extension of an underlying carcinoma.

In this case, the patient was sent to a gynecologic oncologist for a wide local excision of the involved area. The health care team planned to follow the patient closely to detect any recurrence at an early stage.

 

Photos and text for Photo Rounds Friday courtesy of Richard P. Usatine, MD. This case was adapted from: Mayeaux EJ. Paget disease of the external genitalia. In: Usatine R, Smith M, Mayeaux EJ, et al, eds. Color Atlas of Family Medicine. 2nd ed. New York, NY: McGraw-Hill; 2013:514-518.

To learn more about the Color Atlas of Family Medicine, see: http://www.amazon.com/Color-Family-Medicine-Richard-Usatine/dp/0071769641/

You can now get the second edition of the Color Atlas of Family Medicine as an app by clicking on this link: http://usatinemedia.com/

Issue
The Journal of Family Practice - 63(12)
Issue
The Journal of Family Practice - 63(12)
Publications
Publications
Topics
Article Type
Display Headline
Perineal and perianal pruritus
Display Headline
Perineal and perianal pruritus
Sections
Disallow All Ads
Alternative CME

White vaginal discharge

Article Type
Changed
Display Headline
White vaginal discharge

The FP noted a strawberry cervix during the pelvic exam and the wet prep revealed the motile protozoan Trichomonas vaginalis, confirming the diagnosis of trichomoniasis.

 

The majority of men (90%) infected with T. vaginalis are asymptomatic, but many women (50%) report symptoms. The infection is predominantly transmitted via sexual contact. The organism can survive up to 48 hours at 50°F outside of the body, making transmission from shared undergarments or from infected hot tubs possible. Trichomonas infection is associated with low-birth-weight infants, premature rupture of membranes, and preterm delivery, so treatment is especially important in pregnant women.

In this case, the patient was treated with metronidazole 2 g in a single dose and was sent home with the same prescription for her partner, who didn’t come to the office. (According to the Centers for Disease Control and Prevention, sexual partners of patients with Trichomonas infection should be treated.)

Since the patient was at risk for other sexually transmitted diseases, the FP sent off tests for chlamydia and gonorrhea.


Photos and text for Photo Rounds Friday courtesy of Richard P. Usatine, MD. This case was adapted from: Mayeaux EJ, Usatine R. Trichomonas vaginitis. In: Usatine R, Smith M, Mayeaux EJ, et al, eds. Color Atlas of Family Medicine. 2nd ed. New York, NY: McGraw-Hill; 2013:504-508.

To learn more about the Color Atlas of Family Medicine, see: http://www.amazon.com/Color-Family-Medicine-Richard-Usatine/dp/0071769641/

You can now get the second edition of the Color Atlas of Family Medicine as an app by clicking on this link: http://usatinemedia.com/

Issue
The Journal of Family Practice - 63(12)
Publications
Topics
Sections

The FP noted a strawberry cervix during the pelvic exam and the wet prep revealed the motile protozoan Trichomonas vaginalis, confirming the diagnosis of trichomoniasis.

 

The majority of men (90%) infected with T. vaginalis are asymptomatic, but many women (50%) report symptoms. The infection is predominantly transmitted via sexual contact. The organism can survive up to 48 hours at 50°F outside of the body, making transmission from shared undergarments or from infected hot tubs possible. Trichomonas infection is associated with low-birth-weight infants, premature rupture of membranes, and preterm delivery, so treatment is especially important in pregnant women.

In this case, the patient was treated with metronidazole 2 g in a single dose and was sent home with the same prescription for her partner, who didn’t come to the office. (According to the Centers for Disease Control and Prevention, sexual partners of patients with Trichomonas infection should be treated.)

Since the patient was at risk for other sexually transmitted diseases, the FP sent off tests for chlamydia and gonorrhea.


Photos and text for Photo Rounds Friday courtesy of Richard P. Usatine, MD. This case was adapted from: Mayeaux EJ, Usatine R. Trichomonas vaginitis. In: Usatine R, Smith M, Mayeaux EJ, et al, eds. Color Atlas of Family Medicine. 2nd ed. New York, NY: McGraw-Hill; 2013:504-508.

To learn more about the Color Atlas of Family Medicine, see: http://www.amazon.com/Color-Family-Medicine-Richard-Usatine/dp/0071769641/

You can now get the second edition of the Color Atlas of Family Medicine as an app by clicking on this link: http://usatinemedia.com/

The FP noted a strawberry cervix during the pelvic exam and the wet prep revealed the motile protozoan Trichomonas vaginalis, confirming the diagnosis of trichomoniasis.

 

The majority of men (90%) infected with T. vaginalis are asymptomatic, but many women (50%) report symptoms. The infection is predominantly transmitted via sexual contact. The organism can survive up to 48 hours at 50°F outside of the body, making transmission from shared undergarments or from infected hot tubs possible. Trichomonas infection is associated with low-birth-weight infants, premature rupture of membranes, and preterm delivery, so treatment is especially important in pregnant women.

In this case, the patient was treated with metronidazole 2 g in a single dose and was sent home with the same prescription for her partner, who didn’t come to the office. (According to the Centers for Disease Control and Prevention, sexual partners of patients with Trichomonas infection should be treated.)

Since the patient was at risk for other sexually transmitted diseases, the FP sent off tests for chlamydia and gonorrhea.


Photos and text for Photo Rounds Friday courtesy of Richard P. Usatine, MD. This case was adapted from: Mayeaux EJ, Usatine R. Trichomonas vaginitis. In: Usatine R, Smith M, Mayeaux EJ, et al, eds. Color Atlas of Family Medicine. 2nd ed. New York, NY: McGraw-Hill; 2013:504-508.

To learn more about the Color Atlas of Family Medicine, see: http://www.amazon.com/Color-Family-Medicine-Richard-Usatine/dp/0071769641/

You can now get the second edition of the Color Atlas of Family Medicine as an app by clicking on this link: http://usatinemedia.com/

Issue
The Journal of Family Practice - 63(12)
Issue
The Journal of Family Practice - 63(12)
Publications
Publications
Topics
Article Type
Display Headline
White vaginal discharge
Display Headline
White vaginal discharge
Sections
Disallow All Ads
Alternative CME

Vaginal itching

Article Type
Changed
Display Headline
Vaginal itching

The wet prep revealed pseudohyphae with budding, the hallmark of a candida infection; the patient was given a diagnosis of vulvovaginal candidiasis (VVC).

 

VVC is a common fungal infection in women of childbearing age; it is not a sexually transmitted disease. Patients with VVC will complain of pruritus, accompanied by a thick, odorless, white vaginal discharge.

Based on clinical presentation, microbiology, host factors, and response to therapy, VVC can be classified as either uncomplicated or complicated:

  • Uncomplicated VVC is characterized by sporadic or infrequent symptoms that are mild to moderate. Patients are not immunocompromised.
  • Complicated VVC is characterized by recurrent (≥4 episodes in one year) or severe VVC and may involve non-albicans Candidiasis, or a patient who has uncontrolled diabetes, debilitation, or immunosuppression.

Treatment options include topical over-the-counter azole antifungal creams and a single dose of fluconazole 150 mg orally. In this case, the patient bought over-the-counter antifungal cream and her symptoms cleared quickly.

 

Photo and text for Photo Rounds Friday courtesy of Richard P. Usatine, MD. This case was adapted from: Mayeaux EJ, Usatine R. Candida vulvovaginitis. In: Usatine R, Smith M, Mayeaux EJ, et al, eds. Color Atlas of Family Medicine. 2nd ed. New York, NY: McGraw-Hill; 2013:499-503.

To learn more about the Color Atlas of Family Medicine, see: http://www.amazon.com/Color-Family-Medicine-Richard-Usatine/dp/0071769641/

You can now get the second edition of the Color Atlas of Family Medicine as an app by clicking on this link: http://usatinemedia.com/

Issue
The Journal of Family Practice - 63(12)
Publications
Topics
Sections

The wet prep revealed pseudohyphae with budding, the hallmark of a candida infection; the patient was given a diagnosis of vulvovaginal candidiasis (VVC).

 

VVC is a common fungal infection in women of childbearing age; it is not a sexually transmitted disease. Patients with VVC will complain of pruritus, accompanied by a thick, odorless, white vaginal discharge.

Based on clinical presentation, microbiology, host factors, and response to therapy, VVC can be classified as either uncomplicated or complicated:

  • Uncomplicated VVC is characterized by sporadic or infrequent symptoms that are mild to moderate. Patients are not immunocompromised.
  • Complicated VVC is characterized by recurrent (≥4 episodes in one year) or severe VVC and may involve non-albicans Candidiasis, or a patient who has uncontrolled diabetes, debilitation, or immunosuppression.

Treatment options include topical over-the-counter azole antifungal creams and a single dose of fluconazole 150 mg orally. In this case, the patient bought over-the-counter antifungal cream and her symptoms cleared quickly.

 

Photo and text for Photo Rounds Friday courtesy of Richard P. Usatine, MD. This case was adapted from: Mayeaux EJ, Usatine R. Candida vulvovaginitis. In: Usatine R, Smith M, Mayeaux EJ, et al, eds. Color Atlas of Family Medicine. 2nd ed. New York, NY: McGraw-Hill; 2013:499-503.

To learn more about the Color Atlas of Family Medicine, see: http://www.amazon.com/Color-Family-Medicine-Richard-Usatine/dp/0071769641/

You can now get the second edition of the Color Atlas of Family Medicine as an app by clicking on this link: http://usatinemedia.com/

The wet prep revealed pseudohyphae with budding, the hallmark of a candida infection; the patient was given a diagnosis of vulvovaginal candidiasis (VVC).

 

VVC is a common fungal infection in women of childbearing age; it is not a sexually transmitted disease. Patients with VVC will complain of pruritus, accompanied by a thick, odorless, white vaginal discharge.

Based on clinical presentation, microbiology, host factors, and response to therapy, VVC can be classified as either uncomplicated or complicated:

  • Uncomplicated VVC is characterized by sporadic or infrequent symptoms that are mild to moderate. Patients are not immunocompromised.
  • Complicated VVC is characterized by recurrent (≥4 episodes in one year) or severe VVC and may involve non-albicans Candidiasis, or a patient who has uncontrolled diabetes, debilitation, or immunosuppression.

Treatment options include topical over-the-counter azole antifungal creams and a single dose of fluconazole 150 mg orally. In this case, the patient bought over-the-counter antifungal cream and her symptoms cleared quickly.

 

Photo and text for Photo Rounds Friday courtesy of Richard P. Usatine, MD. This case was adapted from: Mayeaux EJ, Usatine R. Candida vulvovaginitis. In: Usatine R, Smith M, Mayeaux EJ, et al, eds. Color Atlas of Family Medicine. 2nd ed. New York, NY: McGraw-Hill; 2013:499-503.

To learn more about the Color Atlas of Family Medicine, see: http://www.amazon.com/Color-Family-Medicine-Richard-Usatine/dp/0071769641/

You can now get the second edition of the Color Atlas of Family Medicine as an app by clicking on this link: http://usatinemedia.com/

Issue
The Journal of Family Practice - 63(12)
Issue
The Journal of Family Practice - 63(12)
Publications
Publications
Topics
Article Type
Display Headline
Vaginal itching
Display Headline
Vaginal itching
Sections
Disallow All Ads
Alternative CME

Nontraumatic knee pain: A diagnostic & treatment guide

Article Type
Changed
Display Headline
Nontraumatic knee pain: A diagnostic & treatment guide

PRACTICE RECOMMENDATIONS

› Consider radiography for 
a patient with patellofemoral pain syndrome if examination reveals an effusion, the patient is age
 50 years or older, or the condition does not improve after 8 to 12 weeks of treatment. C
› Order plain radiography
for all patients with patellofemoral instability to assess for osseous trauma/deformity; consider magnetic resonance imaging if you suspect significant soft tissue damage or the patient does not respond to conservative therapy. C
› Perform joint aspiration with synovial fluid analysis for patients with painful knee effusion, and provide an orthopedic referral without delay when an infectious joint is suspected. A

Strength of recommendation (SOR)

A Good-quality patient-oriented evidence
B Inconsistent or limited-quality patient-oriented evidence
C Consensus, usual practice, opinion, disease-oriented evidence, case series

CASE › Jane T, age 42, comes to see you because of right knee pain that she’s had for about 6 months. She denies any trauma. Ms. T describes the pain as vague and poorly localized, but worse with activity. She says she started a walking/running program 9 months ago, when she was told she was overweight (body mass index, 29). She has lost 10 pounds since then, Ms. T says, and hopes to lose more by continuing to exercise. upon further review, you find that Ms. T has had increasing pain while ascending and descending stairs and that the pain is also exacerbated when she stands after prolonged sitting.

If Ms. T were your patient, what would you include in a physical examination and how would you diagnose and treat her?

Knee pain is a common presentation in primary care. While traumatic knee pain is frequently addressed in the medical literature, little has been written about chronic nontraumatic nonarthritic knee pain like that of Ms. T. Thus, while physical exam tests often lead to the correct diagnosis for traumatic knee pain, there is limited information on the use of such tests to determine the etiology of chronic knee pain.

This review was developed to fill that gap. In the pages that follow, we provide general guidance on the diagnosis and treatment of chronic nontraumatic knee pain. The conditions are presented anatomically—anterior, lateral, medial, or posterior—with common etiologies, history and physical exam findings, and diagnosis and treatment options for each (TABLE).1-31

Anterior knee pain

Patellofemoral pain syndrome

Patellofemoral pain syndrome is the most common cause of anterior knee pain. Taping or bracingalong with physical therapymay help reduce the pain.
Patellofemoral pain syndrome (PFPS), the most common cause of anterior knee pain, is a complex entity with an etiology that has not been well described.2 The quadriceps tendon, medial and lateral retinacula, iliotibial band (ITB), vastus medialis and lateralis, and the insertion of the patellar tendon on the anterior tibial tubercle all play a role in proper tracking of the patellofemoral joint; an imbalance in any of these forces leads to abnormal patellar tracking over the femoral condyles, and pain ensues. PFPS can also be secondary to joint overload, in which excessive physical activity (eg, running, lunges, or squats) overloads the patellofemoral joint and causes pain.

Risk factors for PFPS include strength imbalances in the quadriceps, hamstring, and hip muscle groups, and increased training, such as running longer distances.4,32 A recent review showed no relationship between an increased quadriceps (Q)-angle and PFPS, so that is no longer considered a major risk factor.5

Diagnosis. PFPS is a diagnosis of exclusion, and is primarily based on history and physical exam. Anterior knee pain that is exacerbated when seated for long periods of time (the “theater sign”) or by descending stairs is a classic indication of PFPS.1 Patients may complain of knee stiffness or “giving out” secondary to sharp knee pain and a sensation of popping or crepitus in the joint. Swelling is not a common finding.2

A recent meta-analysis revealed limited evidence for the use of any specific physical exam tests to diagnose PFPS. But pain during squatting and pain with a patellar tilt test were most consistent with a diagnosis of PFPS. (The patellar tilt test involves lifting the lateral edge of the patella superiorly while the patient lies supine with knee extended; pain with <20° of lift suggests a tight lateral retinaculum). Conversely, the absence of pain during squatting or the absence of lateral retinacular pain helps rule it out.2 A physical exam of the cruciate and collateral ligaments should be performed in a patient with a history of instability. Radiography is not needed for a diagnosis, but may be considered if examination reveals an effusion, the patient is age 50 years or older, or no improvement occurs after 8 to 12 weeks of treatment.33

 

 

Treatment. The most effective and strongly supported treatment for PFPS is a 6-week physiotherapy program focusing on strengthening the quadriceps and hip muscles and stretching the quadriceps, ITB, hamstrings, and hip flexors.4,5 There is limited information about the use of nonsteroidal anti-inflammatory drugs (NSAIDs), but they can be considered for short-term management.2

Patellar taping and bracing have shown some promise as adjunct therapies for PFPS, although the data for both are non-conclusive. There is a paucity of prospective randomized trials of patellar bracing and a 2012 Cochrane review found limited evidence of its efficacy.34 But a 2014 meta-analysis revealed moderate evidence in support of patellar taping early on to help decrease pain,6 and a recent review suggests that it can be helpful in both the short and long term.7

Taping or bracing may be useful when combined with a tailored physical therapy program. Evidence for treatments such as biofeedback, chiropractic manipulation, and orthotics is limited, and they should be used only as adjunctive therapy.4

CASE › When you examine Ms. T, you find no swelling of the affected knee. You perform the tilt test, which elicits pain. Squatting causes some pain, as well. You diagnose PFPS and provide a referral for 6 weeks of physiotherapy.

Patellar subluxation or chronic dislocation

Patellofemoral instability (PFI) occurs when the patella disengages completely from the trochlear groove.11 PFI’s etiology also relates to the complexity of the patellofemoral joint. Here, too, stability of the joint is achieved with a combination of soft tissue and bony restraints. At full extension and early flexion of the knee, however, the mechanisms of stability are limited, resulting in increased instability. Other associated factors include Q-angle, lateral pull from a tight ITB, and opposing forces from the vastus lateralis and vastus medialis obliquus (VMO).8-10

Risk factors for PFI. The most common predisposing factors for PFI are trochlear dysplasia, patella alta, and lateralization of the tibial tuberosity or patella.10,11 Older patients (mostly women) have an increased risk for patellofemoral instability. Older patients, predominately women, have an increased risk for PFI.9 Patients usually have a history of patellar subluxation or dislocation in their youth, with approximately 17% of those who had a first dislocation experiencing a recurrence.9 A family history of PFI is common, as well.10

Diagnosis. Patients with PFI often present with nonspecific anterior knee pain secondary to recurrent dislocation.13 Notable physical exam findings are:

  • a positive J sign (noted if the patella suddenly shifts medially during early knee flexion or laterally during full extension)
  • decreased quadriceps (specifically VMO) and hamstring strength and flexibility
  • patellar hypermobility, which should be no more than a quarter to a half of the patellar diameter bilaterally
  • pain during a patellar tilt test

  • a positive patellar apprehension test.10 (With the patient lying with the knee flexed to 20°, place thumbs on the medial patella and push laterally; the patient will straighten leg with pain or “apprehension” prior to patellar dislocation.)

Plain radiography should be ordered in all cases to assess for osseous trauma/ deformity and to help guide surgical consideration. Magnetic resonance imaging (MRI) can provide additional information when significant soft tissue damage is suspected or the patient does not improve with conservative therapy.8,11

Treatment. A recent Cochrane review showed that conservative treatment (VMO strengthening, bracing, and proprioceptive therapy) prevented future dislocations more effectively than surgical intervention.11 However, surgery is indicated when obvious predisposing anatomic conditions (osteochondral fracture, intra-articular deformity, or a major tear of a medial soft tissue stabilizer) are clearly shown on imaging.8,11

Patellar tendinopathy (jumper’s knee)

Patellar tendinopathy, an overuse injury often called “jumper’s knee” because it is associated with high-intensity jumping sports like volleyball and basketball, is an insertional tendinopathy with pain most commonly at the proximal patellar tendon.10 The pathology of the injury is poorly understood, but is believed to be the result of an impaired healing response to microtears.12,14

Diagnosis. Patients with patellar tendinopathy typically present with anterior suprapatellar pain aggravated by activity. Classically, the pain can occur in any of 4 phases:12 1. pain isolated after activity; 2. pain that occurs during activity but does not impede activity; 3. pain that occurs both during and after the activity and interferes with competition
; 4. a complete tendon disruption. 

Examination should include an assessment of the patellar tendon for localized thickening, nodularity, crepitus, and focal suprapatellar tenderness. The muscle-tendon function should be evaluated by assessing knee mobility and strength of the quads via straight leg raise, decline squat, or single leg squats.12 The Victorian Institute of Sport Assessment (VISA) questionnaire can be used to quantify the symptoms and to help track the patient’s progress throughout therapy.31 There are no proven special tests or radiologic studies to aid in the diagnosis of patellar tendinopathy,14 but magnetic resonance imaging (MRI) can be used for further evaluation when findings are equivocal.35

 

 

Treatment. A wide range of options, from eccentric training—eg, 3 sets of 15 repetitions performed twice a day for 12 weeks—and physical therapy to platelet-rich plasma (PRP) injections, sclerosing injections, and surgery, are available for the treatment of patellar tendinopathy.13-15 While no specific data have proven the superiority of any one therapy, expert consensus recommends eccentric exercise as initial therapy, performed for 12 weeks.14,15

Three weeks of platelet-rich plasma injections helped 75% of patients with patellar tendinopathy return to their pre-symptom activity level within 90 days. It’s also interesting to note that a recently published study showed that 3 weekly PRP injections helped 75% of patients—all of whom failed to respond to 4 months of eccentric therapy—return to their pre-symptom activity level within 90 days.16 Corticosteroid injections should not be used to treat patellar tendinopathy due to the risk of tendon rupture.15 Orthopedic referral for surgical intervention should be considered for patients who fail to respond after 3 to 6 months of conservative therapy.14

Lateral knee pain

Iliotibial band tendinopathy


Iliotibial band syndrome (ITBS) is a common source of lateral knee pain, particularly in runners, cyclists, and endurance athletes.17-19,36,37 The exact pathophysiology behind this diagnosis is debatable, but the most accepted etiology is inflammation generated from micro trauma to the soft tissues with inadequate healing time, resulting in persistent inflammation. ITBS is often associated with excessive overall running mileage, a sudden increase in mileage, or an abrupt change in training.18,37

Patients with ITBS often complain of persistent nontraumatic knee pain that worsens with repetitive knee flexion. Diagnosis. Patients often complain of persistent nontraumatic lateral knee pain that worsens with repetitive knee flexion (eg, running or cycling).17-19,37 A physical exam will often reveal pain over the lateral femoral condyle and a positive Noble’s test (FIGURE 1). A positive Ober’s test (FIGURE 2) is suggestive of ITBS, as well. The sensitivity and specificity of these tests are not well established, but in patients performing repetitive knee flexion activities with subjective lateral knee pain, pain over the lateral femoral condyle and a positive Ober’s and/or Noble’s test suggest an ITBS diagnosis.18 Imaging is not indicated initially, but MRI should be used in refractory cases to rule out other etiologies.17,19

Treatment. First-line therapy for ITBS is conservative,17-19,36,37 often involving a combination of techniques such as refraining from the activity that triggers the pain, NSAIDs, activity modification to reduce the strain over the ITB, myofascial release via foam rollers, and physical therapy focused on stretching the iliotibial band, tensor fasciae latae, and gluteus medius while strengthening the gluteus medius and core muscles.17 No single program has been shown to be better than another.

Corticosteroid injections are second-line therapy and have been shown to improve pain compared with placebo up to 2 weeks post injection.17,19 When symptoms persist for more than 6 months despite conservative treatment, surgical intervention may be indicated.18,19 Patients who experience temporary pain relief with corticosteroid injections often respond best to surgery.36

Medial knee pain

Medial plica syndrome

Because of its anatomic location, the medial plica—which can be palpated in up to 84% of the population20—is susceptible to impingement by the medial femoral condyle or the patellofemoral joint. Trauma with repetitive knee movement leads to inflammation and thickening of the plica, resulting in medial plica syndrome.20,38 Initial inflammation may be triggered by blunt trauma, a sudden increase in activity, or transient synovitis.22

Diagnosis. Medial plica syndrome is a challenging diagnosis. Patients generally have nonspecific complaints of aching medial knee pain, locking, and catching similar to complaints of a medial meniscal injury.20

A mediopatellar plica test was more accurate than an MRI in diagnosing medial plica syndrome, according to a recent systematic review. Evaluation should include the mediopatellar plica test, which is performed with the patient lying supine with the knee fully extended. Pressure is placed over the inferomedial patellofemoral joint, creating an impingement of the medial plica between the finger and the medial femoral condyle. Elimination or marked diminishing of pain with knee flexion to 90° is considered a positive test.21

A recent systematic review found this test to be more diagnostically accurate than an MRI (sensitivity of the test is 90% and specificity is 89%, vs 77% and 58%, respectively, for MRI) for detection of medial plica syndrome. Ultrasound is almost as accurate, with a sensitivity of 90% and specificity of 83%.39

Treatment of medial plica syndrome centers on physiotherapy and quadriceps strengthening,20 augmented with NSAIDs. Intra-articular corticosteroid injections are considered second-line treatment.20,22 An orthopedics referral is indicated to consider arthroscopic plica removal for refractory cases.20,22

 

 

Pes anserine bursitis

The anserine bursal complex, located approximately 5 cm distal to the medial joint line, is formed by the combined insertion of the sartorius, gracilis, and semitendinosus tendons,39 but the exact mechanism of pain is not well understood. Whether the pathophysiology is from an insertional tendonitis or overt bursitis is unknown, and no studies have focused on prevalence or risk factors. What is known is that overweight individuals and women with a wide pelvis seem to have a greater predilection and those with pes planus, diabetes, or knee osteoarthritis are at increased risk.23

Diagnosis. Medial knee pain reproduced on palpation of the anatomical site of insertion of the pes anserine tendon complex supports a diagnosis of pes anserine bursitis, with or without edema. Radiologic studies are not needed, but may be helpful if significant bony pathology is suspected. Ultrasound, computed tomography (CT), and MRI are not recommended.23

Treatment. Resting the affected knee, cryotherapy, NSAIDs, and using a pillow at night to relieve direct bursal pressure are recommended.33 Weight loss in obese patients, treatment of pes planus, and control of diabetes may be helpful, as well. Although the literature is limited and dated, corticosteroid injection has been found to reduce the pain and may be considered as second-line treatment.24-26

Posterior knee pain

Popliteal (Baker’s) cyst

The popliteal fossa contains 6 of the numerous bursa of the knee; the bursa beneath the medial head of the gastrocnemius muscle and the semimembranosus tendon is most commonly involved in the formation of a popliteal cyst.40 It is postulated that increased intra-articular pressure forces fluid into the bursa, leading to expansion and pain. This can be idiopathic or secondary to internal derangement or trauma to the knee.41 Older age, a remote history of knee trauma, or a coexisting joint disease such as osteoarthritis, meniscal pathology, or rheumatoid arthritis are significant risk factors for the development of popliteal cysts.27

Diagnosis. Most popliteal cysts are asymptomatic in adults and discovered incidentally after routine imaging to evaluate other knee pathology. However, symptomatic popliteal cysts present as a palpable mass in the popliteal fossa, resulting in pain and limited range of motion.

During the physical exam with the patient lying supine, a medial popliteal mass that is most prominent with the knee fully extended is common. A positive Foucher’s sign (the painful mass is palpated posteriorly in the popliteal fossa with the knee fully extended; pain is relieved and/or the mass reduced in size with knee flexion to 45°) suggests a diagnosis of popliteal cyst.27,28

Radiologic studies are generally not needed to diagnose a popliteal cyst. However, if diagnostic uncertainty remains after the history and physical exam, plain knee radiographs and ultrasound should be obtained. This combination provides complementary information and helps rule out a fracture, arthritis, and thrombosis as the cause of the pain.27 MRI is helpful if the diagnosis is still in doubt and for patients suspected of having significant internal derangement leading to cyst formation. Arthrography or CT is generally not needed.27,41

Treatment. As popliteal cysts are often associated with other knee pathology, management of the underlying condition often leads to cyst regression. Keeping the knee in flexion can decrease the available space and assist in pain control in the acute phase.27 Cold packs and NSAIDs can also be used initially. Cyst aspiration and intra-articular steroid injection have been shown to be effective for cysts that do not respond to this conservative approach.27 However, addressing and managing the underlying knee pathology (eg, osteoarthritis, meniscal pathology, or rheumatoid arthritis) will prevent popliteal cysts from recurring.

When the problem is painful knee effusion

A prompt orthopedic referral is essential when you suspect an infectious joint. Nontraumatic knee effusion can be the primary source of knee pain or the result of underlying pathology. We mention it here because clinical suspicion is paramount in diagnosing a septic joint, a serious cause of painful knee effusion that warrants prompt treatment.

As in other causes of knee pain, a detailed history of the character of the pain is essential. Septic arthritis and crystalline disease (gout, pseudogout) should be suspected in patients without a history of trauma who cannot bear weight. Systemic complaints point to an infection and, with the exception of a possible low-grade fever, are not typically seen in crystalline disease. Notable findings include an erythematous, hot, swollen knee and pain with both active and passive movement.

Plain radiographs of the knee should be ordered to rule out significant trauma or arthritis as the etiology. It is important to perform joint aspiration with synovial fluid analysis. Fluid analysis should include a white blood cell (WBC) count with differential, Gram stain and cultures, and polarized light microscopy (not readily available in an outpatient setting).29

 

 

Synovial fluid analysis characteristics suggestive of a septic joint include turbid quality, WBC >50,000 per mm3, an elevated protein content, and a low glucose concentration.30 Gram stain and culture will help identify the infectious agent. Orthopedic referral should not be delayed in patients with a suspected infectious joint. Corticosteroids should not be injected during aspiration if infection is being ruled out.

CASE › When Ms. T returns for a follow-up visit 8 weeks later, she states that the knee pain has resolved and that she has returned to running. She has lost an additional 8 pounds and continues to diet. And, at the advice of her physical therapist, she is continuing her physiotherapy regimen at home to prevent a recurrence of PFPS.

CORRESPONDENCE
Carlton J. Covey, MD, FAAFP, Nellis Family Medicine Residency Program, 4700 Las Vegas Boulevard North, Nellis Air Force Base, NV 89191; carlton.covey@us.af.mil

References

1. Earl JE, Vetter CS. Patellofemoral pain. Phys Med Rehabil Clin N Am. 2007;18:439-458,viii.

2. McGowan HJ, Beutler A. Patellofemoral syndrome. Essential Evidence Plus Web site. Available at: http://www.essentialevidenceplus.com. Accessed: March 20, 2014.

3. Nunes GS, Stapait EL, Kirsten MH, et al. Clinical test for diagnosis of patellofemoral pain syndrome: Systematic review with meta-analysis. Phys Ther Sport. 2013;14:54-59.

4. Rixe JA, Glick JE, Brady J, et al. A review of the management of patellofemoral pain syndrome. Phys Sportsmed. 2013;41: 19-28.

5. Bolgla LA, Boling MC. An update for the conservative management of patellofemoral pain syndrome: a systematic review of the literature from 2000 to 2010. Int J Sports Phys Ther. 2011;6:112-125.

6. Barton C, Balachandar V, Lack S, et al. Patellar taping for patellofemoral pain: a systematic review and meta-analysis to evaluate clinical outcomes and biomechanical mechanisms. Br J Sports Med. 2014;48:417-424.

7. Dutton RA, Khadavi MJ, Fredericson M. Update on rehabilitation of patellofemoral pain. Curr Sports Med Rep. 2014;13: 172-178.

8. Kapur S, Wissman RD, Robertson M, et al. Acute knee dislocation: review of an elusive entity. Curr Probl Diagn Radiol. 2009;38:237-250.

9. Colvin AC, West RV. Patellar instability. J Bone Joint Surg Am. 2008;90:2751-2762.

10. Tscholl PM, Koch PP, Fucentese SF. Treatment options for patellofemoral instability in sports traumatology. Orthop Rev (Pavia). 2013;5:e23.

11. Earhart C, Patel DB, White EA, et al. Transient lateral patellar dislocation: review of imaging findings, patellofemoral anatomy, and treatment options. Emerg Radiol. 2013;20:11-23.

12.  Tan SC, Chan O. Achilles and patellar tendinopathy: current understanding of pathophysiology and management. Disabil Rehabil. 2008;30:1608-1615.

13.  Gaida JE, Cook J. Treatment options for patellar tendinopathy: critical review. Curr Sports Med Rep. 2011;10:255-270.

14. Rodriguez-Merchan EC. The treatment of patellar tendinopathy. J Orthop Traumatol. 2013;14:77-81.

15. Childress MA, Beutler A. Management of chronic tendon injuries. Am Fam Physician. 2013;87:486-490.

16. Charousset C, Zaoui A, Bellaiche L, et al. Are multiple platelet-rich plasma injections useful for treatment of chronic patellar tendinopathy in athletes? A prospective study. Am J Sports Med. 2014;42:906-911.

17. Strauss EJ, Kim S, Calcei JG, et al. Iliotibial band syndrome: evaluation and management. J Am Acad Orthop Surg. 2011;19:728-736.

18. Bellary SS, Lynch G, Housman B, et al. Medial plica syndrome: a review of the literature. Clin Anat. 2012;25:423-428.

19. Hong JH, Kim JS. Diagnosis of iliotibial band friction syndrome and ultrasound guided steroid injection. Korean J Pain. 2013;26:387-391.

20. Bellary SS, Lynch G, Housman B, et al. Medial plica syndrome: a review of the literature. Clin Anat. 2012;25:423-428.

21. Kim SJ, Jeong JH, Cheon YM, et al. MPP test in the diagnosis of medial patellar plica syndrome. Arthroscopy. 2004;20: 1101-1103.

22. Schindler OS. ‘The Sneaky Plica’ revisited: morphology, pathophysiology and treatment of synovial plicae of the knee. Knee Surg Sports Traumatol Arthrosc. 2014;22:247-262.

23. Helfenstein M Jr, Kuromoto J. Anserine syndrome. Rev Bras Rheumatol. 2010;50:313-327.

24. Abeles M. Osteoarthritis of the knee: anserine bursitis as an extra-articular cause of pain. Clin Res. 1983;31:4471-4476.

25. Kang I, Han SW. Anserine bursitis in patients with osteoarthritis of the knee. South Med J. 2000;93:207-209.

26. Yoon HS, Kim SE, Suh YR, et al. Correlation between ultrasonographic findings and the response to corticosteroid injection in pes anserinus tendinobursitis syndrome in knee osteoarthritis patients. J Korean Med Sci. 2005;20:109-112.

27. Stein D, Cantlon M, MacKay B, et al. Cysts about the knee: evaluation and management. J Am Acad Orthop Surg. 2013;21: 469-479.

28. Canoso JJ, Goldsmith MR, Gerzof SG, et al. Foucher’s sign of the Baker’s cyst. Ann Rheum Dis. 1987;46:228-232.

29. Palmer T. Knee pain. Essential Evidence Plus Web site. Available at: http://www.essentialevidenceplus.com. Accessed: December 12, 2013.

30. Franks AG Jr. Rheumatologic aspects of knee disorders. In: Scott WN, ed. The Knee. St. Louis: Mosby; 1994:315-329.

31. Visentini PJ, Khan KM, Cook JL, et al. The VISA score: an index of severity of symptoms in patients with jumper’s knee (patellar tendinosis). Victorian Institute of Sport Tendon Study Group. J Sci Med Sport. 1998;1:22-28.

32. Halabchi F, Mazaheri R, Seif-Barghi T. Patellofemoral pain syndrome and modifiable intrinsic risk factors; how to assess and address? Asian J Sports Med. 2013;4:85-100.

33. Dixit S, DiFiori JP, Burton M, et al. Management of patellofemoral pain syndrome. Am Fam Physician. 2007;75:194-202.

34. Callaghan MJ, Selfe J. Patellar taping for patellofemoral pain syndrome in adults. Cochrane Database Syst Rev. 2012;4:CD006717.

35. Atanda AJ Jr, Ruiz D, Dodson CC, et al. Approach to the active patient with chronic anterior knee pain. Phys Sportsmed. 2012;40:41-50.

36. Ellis R, Hing W, Reid D. Iliotibial band friction syndrome—a systematic review. Man Ther. 2007;12:200-208.

37. Kirk KL, Kuklo T, Klemme W. Iliotibial band friction syndrome. Orthopedics. 2000;23:1209-1217.

38. Stubbings N, Smith T. Diagnostic test accuracy of clinical and radiological assessments for medial patella plica syndrome: a systematic review and meta-analysis. Knee. 2014;21: 486-490.

39. Alvarez-Nemegyei J, Canoso JJ. Evidence-based soft tissue rheumatology IV: anserine bursitis. J Clin Rheumatol. 2004;10:205-206.

40. Fritschy D, Fasel J, Imbert JC, et al. The popliteal cyst. Knee Surg Sports Traumatol Arthrosc. 2006;14:623-628.

41. Handy JR. Popliteal cysts in adults: a review. Semin Arthritis Rheum. 2001;31:108-118.

Article PDF
Author and Disclosure Information

Carlton J. Covey, MD, FAAFP
Matthew K. Hawks, MD

Nellis Family Medicine Residency Program, Nellis Air Force Base, Nev (Drs. Covey and Hawks); Uniformed Services University of the Health Sciences, Bethesda, Md (Dr. Covey)

carlton.covey@us.af.mil

The authors reported no potential conflict of interest relevant to this article.

The opinions and assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the US Air Force Medical Department or the US Air Force at large.

Issue
The Journal of Family Practice - 63(12)
Publications
Topics
Page Number
720-728
Legacy Keywords
nontraumatic knee pain; patellofemoral pain syndrome; PFPS; iliotibial band; ITB; patellofemoral instability (PFI); patellar tendinopathy; jumper's knee; iliotibial band syndrome; ITBS; Noble's test; Ober's test; popliteal cyst; Carlton J. Covey, MD, FAAFP; Matthew K. Hawks, MD
Sections
Author and Disclosure Information

Carlton J. Covey, MD, FAAFP
Matthew K. Hawks, MD

Nellis Family Medicine Residency Program, Nellis Air Force Base, Nev (Drs. Covey and Hawks); Uniformed Services University of the Health Sciences, Bethesda, Md (Dr. Covey)

carlton.covey@us.af.mil

The authors reported no potential conflict of interest relevant to this article.

The opinions and assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the US Air Force Medical Department or the US Air Force at large.

Author and Disclosure Information

Carlton J. Covey, MD, FAAFP
Matthew K. Hawks, MD

Nellis Family Medicine Residency Program, Nellis Air Force Base, Nev (Drs. Covey and Hawks); Uniformed Services University of the Health Sciences, Bethesda, Md (Dr. Covey)

carlton.covey@us.af.mil

The authors reported no potential conflict of interest relevant to this article.

The opinions and assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the US Air Force Medical Department or the US Air Force at large.

Article PDF
Article PDF
Related Articles

PRACTICE RECOMMENDATIONS

› Consider radiography for 
a patient with patellofemoral pain syndrome if examination reveals an effusion, the patient is age
 50 years or older, or the condition does not improve after 8 to 12 weeks of treatment. C
› Order plain radiography
for all patients with patellofemoral instability to assess for osseous trauma/deformity; consider magnetic resonance imaging if you suspect significant soft tissue damage or the patient does not respond to conservative therapy. C
› Perform joint aspiration with synovial fluid analysis for patients with painful knee effusion, and provide an orthopedic referral without delay when an infectious joint is suspected. A

Strength of recommendation (SOR)

A Good-quality patient-oriented evidence
B Inconsistent or limited-quality patient-oriented evidence
C Consensus, usual practice, opinion, disease-oriented evidence, case series

CASE › Jane T, age 42, comes to see you because of right knee pain that she’s had for about 6 months. She denies any trauma. Ms. T describes the pain as vague and poorly localized, but worse with activity. She says she started a walking/running program 9 months ago, when she was told she was overweight (body mass index, 29). She has lost 10 pounds since then, Ms. T says, and hopes to lose more by continuing to exercise. upon further review, you find that Ms. T has had increasing pain while ascending and descending stairs and that the pain is also exacerbated when she stands after prolonged sitting.

If Ms. T were your patient, what would you include in a physical examination and how would you diagnose and treat her?

Knee pain is a common presentation in primary care. While traumatic knee pain is frequently addressed in the medical literature, little has been written about chronic nontraumatic nonarthritic knee pain like that of Ms. T. Thus, while physical exam tests often lead to the correct diagnosis for traumatic knee pain, there is limited information on the use of such tests to determine the etiology of chronic knee pain.

This review was developed to fill that gap. In the pages that follow, we provide general guidance on the diagnosis and treatment of chronic nontraumatic knee pain. The conditions are presented anatomically—anterior, lateral, medial, or posterior—with common etiologies, history and physical exam findings, and diagnosis and treatment options for each (TABLE).1-31

Anterior knee pain

Patellofemoral pain syndrome

Patellofemoral pain syndrome is the most common cause of anterior knee pain. Taping or bracingalong with physical therapymay help reduce the pain.
Patellofemoral pain syndrome (PFPS), the most common cause of anterior knee pain, is a complex entity with an etiology that has not been well described.2 The quadriceps tendon, medial and lateral retinacula, iliotibial band (ITB), vastus medialis and lateralis, and the insertion of the patellar tendon on the anterior tibial tubercle all play a role in proper tracking of the patellofemoral joint; an imbalance in any of these forces leads to abnormal patellar tracking over the femoral condyles, and pain ensues. PFPS can also be secondary to joint overload, in which excessive physical activity (eg, running, lunges, or squats) overloads the patellofemoral joint and causes pain.

Risk factors for PFPS include strength imbalances in the quadriceps, hamstring, and hip muscle groups, and increased training, such as running longer distances.4,32 A recent review showed no relationship between an increased quadriceps (Q)-angle and PFPS, so that is no longer considered a major risk factor.5

Diagnosis. PFPS is a diagnosis of exclusion, and is primarily based on history and physical exam. Anterior knee pain that is exacerbated when seated for long periods of time (the “theater sign”) or by descending stairs is a classic indication of PFPS.1 Patients may complain of knee stiffness or “giving out” secondary to sharp knee pain and a sensation of popping or crepitus in the joint. Swelling is not a common finding.2

A recent meta-analysis revealed limited evidence for the use of any specific physical exam tests to diagnose PFPS. But pain during squatting and pain with a patellar tilt test were most consistent with a diagnosis of PFPS. (The patellar tilt test involves lifting the lateral edge of the patella superiorly while the patient lies supine with knee extended; pain with <20° of lift suggests a tight lateral retinaculum). Conversely, the absence of pain during squatting or the absence of lateral retinacular pain helps rule it out.2 A physical exam of the cruciate and collateral ligaments should be performed in a patient with a history of instability. Radiography is not needed for a diagnosis, but may be considered if examination reveals an effusion, the patient is age 50 years or older, or no improvement occurs after 8 to 12 weeks of treatment.33

 

 

Treatment. The most effective and strongly supported treatment for PFPS is a 6-week physiotherapy program focusing on strengthening the quadriceps and hip muscles and stretching the quadriceps, ITB, hamstrings, and hip flexors.4,5 There is limited information about the use of nonsteroidal anti-inflammatory drugs (NSAIDs), but they can be considered for short-term management.2

Patellar taping and bracing have shown some promise as adjunct therapies for PFPS, although the data for both are non-conclusive. There is a paucity of prospective randomized trials of patellar bracing and a 2012 Cochrane review found limited evidence of its efficacy.34 But a 2014 meta-analysis revealed moderate evidence in support of patellar taping early on to help decrease pain,6 and a recent review suggests that it can be helpful in both the short and long term.7

Taping or bracing may be useful when combined with a tailored physical therapy program. Evidence for treatments such as biofeedback, chiropractic manipulation, and orthotics is limited, and they should be used only as adjunctive therapy.4

CASE › When you examine Ms. T, you find no swelling of the affected knee. You perform the tilt test, which elicits pain. Squatting causes some pain, as well. You diagnose PFPS and provide a referral for 6 weeks of physiotherapy.

Patellar subluxation or chronic dislocation

Patellofemoral instability (PFI) occurs when the patella disengages completely from the trochlear groove.11 PFI’s etiology also relates to the complexity of the patellofemoral joint. Here, too, stability of the joint is achieved with a combination of soft tissue and bony restraints. At full extension and early flexion of the knee, however, the mechanisms of stability are limited, resulting in increased instability. Other associated factors include Q-angle, lateral pull from a tight ITB, and opposing forces from the vastus lateralis and vastus medialis obliquus (VMO).8-10

Risk factors for PFI. The most common predisposing factors for PFI are trochlear dysplasia, patella alta, and lateralization of the tibial tuberosity or patella.10,11 Older patients (mostly women) have an increased risk for patellofemoral instability. Older patients, predominately women, have an increased risk for PFI.9 Patients usually have a history of patellar subluxation or dislocation in their youth, with approximately 17% of those who had a first dislocation experiencing a recurrence.9 A family history of PFI is common, as well.10

Diagnosis. Patients with PFI often present with nonspecific anterior knee pain secondary to recurrent dislocation.13 Notable physical exam findings are:

  • a positive J sign (noted if the patella suddenly shifts medially during early knee flexion or laterally during full extension)
  • decreased quadriceps (specifically VMO) and hamstring strength and flexibility
  • patellar hypermobility, which should be no more than a quarter to a half of the patellar diameter bilaterally
  • pain during a patellar tilt test

  • a positive patellar apprehension test.10 (With the patient lying with the knee flexed to 20°, place thumbs on the medial patella and push laterally; the patient will straighten leg with pain or “apprehension” prior to patellar dislocation.)

Plain radiography should be ordered in all cases to assess for osseous trauma/ deformity and to help guide surgical consideration. Magnetic resonance imaging (MRI) can provide additional information when significant soft tissue damage is suspected or the patient does not improve with conservative therapy.8,11

Treatment. A recent Cochrane review showed that conservative treatment (VMO strengthening, bracing, and proprioceptive therapy) prevented future dislocations more effectively than surgical intervention.11 However, surgery is indicated when obvious predisposing anatomic conditions (osteochondral fracture, intra-articular deformity, or a major tear of a medial soft tissue stabilizer) are clearly shown on imaging.8,11

Patellar tendinopathy (jumper’s knee)

Patellar tendinopathy, an overuse injury often called “jumper’s knee” because it is associated with high-intensity jumping sports like volleyball and basketball, is an insertional tendinopathy with pain most commonly at the proximal patellar tendon.10 The pathology of the injury is poorly understood, but is believed to be the result of an impaired healing response to microtears.12,14

Diagnosis. Patients with patellar tendinopathy typically present with anterior suprapatellar pain aggravated by activity. Classically, the pain can occur in any of 4 phases:12 1. pain isolated after activity; 2. pain that occurs during activity but does not impede activity; 3. pain that occurs both during and after the activity and interferes with competition
; 4. a complete tendon disruption. 

Examination should include an assessment of the patellar tendon for localized thickening, nodularity, crepitus, and focal suprapatellar tenderness. The muscle-tendon function should be evaluated by assessing knee mobility and strength of the quads via straight leg raise, decline squat, or single leg squats.12 The Victorian Institute of Sport Assessment (VISA) questionnaire can be used to quantify the symptoms and to help track the patient’s progress throughout therapy.31 There are no proven special tests or radiologic studies to aid in the diagnosis of patellar tendinopathy,14 but magnetic resonance imaging (MRI) can be used for further evaluation when findings are equivocal.35

 

 

Treatment. A wide range of options, from eccentric training—eg, 3 sets of 15 repetitions performed twice a day for 12 weeks—and physical therapy to platelet-rich plasma (PRP) injections, sclerosing injections, and surgery, are available for the treatment of patellar tendinopathy.13-15 While no specific data have proven the superiority of any one therapy, expert consensus recommends eccentric exercise as initial therapy, performed for 12 weeks.14,15

Three weeks of platelet-rich plasma injections helped 75% of patients with patellar tendinopathy return to their pre-symptom activity level within 90 days. It’s also interesting to note that a recently published study showed that 3 weekly PRP injections helped 75% of patients—all of whom failed to respond to 4 months of eccentric therapy—return to their pre-symptom activity level within 90 days.16 Corticosteroid injections should not be used to treat patellar tendinopathy due to the risk of tendon rupture.15 Orthopedic referral for surgical intervention should be considered for patients who fail to respond after 3 to 6 months of conservative therapy.14

Lateral knee pain

Iliotibial band tendinopathy


Iliotibial band syndrome (ITBS) is a common source of lateral knee pain, particularly in runners, cyclists, and endurance athletes.17-19,36,37 The exact pathophysiology behind this diagnosis is debatable, but the most accepted etiology is inflammation generated from micro trauma to the soft tissues with inadequate healing time, resulting in persistent inflammation. ITBS is often associated with excessive overall running mileage, a sudden increase in mileage, or an abrupt change in training.18,37

Patients with ITBS often complain of persistent nontraumatic knee pain that worsens with repetitive knee flexion. Diagnosis. Patients often complain of persistent nontraumatic lateral knee pain that worsens with repetitive knee flexion (eg, running or cycling).17-19,37 A physical exam will often reveal pain over the lateral femoral condyle and a positive Noble’s test (FIGURE 1). A positive Ober’s test (FIGURE 2) is suggestive of ITBS, as well. The sensitivity and specificity of these tests are not well established, but in patients performing repetitive knee flexion activities with subjective lateral knee pain, pain over the lateral femoral condyle and a positive Ober’s and/or Noble’s test suggest an ITBS diagnosis.18 Imaging is not indicated initially, but MRI should be used in refractory cases to rule out other etiologies.17,19

Treatment. First-line therapy for ITBS is conservative,17-19,36,37 often involving a combination of techniques such as refraining from the activity that triggers the pain, NSAIDs, activity modification to reduce the strain over the ITB, myofascial release via foam rollers, and physical therapy focused on stretching the iliotibial band, tensor fasciae latae, and gluteus medius while strengthening the gluteus medius and core muscles.17 No single program has been shown to be better than another.

Corticosteroid injections are second-line therapy and have been shown to improve pain compared with placebo up to 2 weeks post injection.17,19 When symptoms persist for more than 6 months despite conservative treatment, surgical intervention may be indicated.18,19 Patients who experience temporary pain relief with corticosteroid injections often respond best to surgery.36

Medial knee pain

Medial plica syndrome

Because of its anatomic location, the medial plica—which can be palpated in up to 84% of the population20—is susceptible to impingement by the medial femoral condyle or the patellofemoral joint. Trauma with repetitive knee movement leads to inflammation and thickening of the plica, resulting in medial plica syndrome.20,38 Initial inflammation may be triggered by blunt trauma, a sudden increase in activity, or transient synovitis.22

Diagnosis. Medial plica syndrome is a challenging diagnosis. Patients generally have nonspecific complaints of aching medial knee pain, locking, and catching similar to complaints of a medial meniscal injury.20

A mediopatellar plica test was more accurate than an MRI in diagnosing medial plica syndrome, according to a recent systematic review. Evaluation should include the mediopatellar plica test, which is performed with the patient lying supine with the knee fully extended. Pressure is placed over the inferomedial patellofemoral joint, creating an impingement of the medial plica between the finger and the medial femoral condyle. Elimination or marked diminishing of pain with knee flexion to 90° is considered a positive test.21

A recent systematic review found this test to be more diagnostically accurate than an MRI (sensitivity of the test is 90% and specificity is 89%, vs 77% and 58%, respectively, for MRI) for detection of medial plica syndrome. Ultrasound is almost as accurate, with a sensitivity of 90% and specificity of 83%.39

Treatment of medial plica syndrome centers on physiotherapy and quadriceps strengthening,20 augmented with NSAIDs. Intra-articular corticosteroid injections are considered second-line treatment.20,22 An orthopedics referral is indicated to consider arthroscopic plica removal for refractory cases.20,22

 

 

Pes anserine bursitis

The anserine bursal complex, located approximately 5 cm distal to the medial joint line, is formed by the combined insertion of the sartorius, gracilis, and semitendinosus tendons,39 but the exact mechanism of pain is not well understood. Whether the pathophysiology is from an insertional tendonitis or overt bursitis is unknown, and no studies have focused on prevalence or risk factors. What is known is that overweight individuals and women with a wide pelvis seem to have a greater predilection and those with pes planus, diabetes, or knee osteoarthritis are at increased risk.23

Diagnosis. Medial knee pain reproduced on palpation of the anatomical site of insertion of the pes anserine tendon complex supports a diagnosis of pes anserine bursitis, with or without edema. Radiologic studies are not needed, but may be helpful if significant bony pathology is suspected. Ultrasound, computed tomography (CT), and MRI are not recommended.23

Treatment. Resting the affected knee, cryotherapy, NSAIDs, and using a pillow at night to relieve direct bursal pressure are recommended.33 Weight loss in obese patients, treatment of pes planus, and control of diabetes may be helpful, as well. Although the literature is limited and dated, corticosteroid injection has been found to reduce the pain and may be considered as second-line treatment.24-26

Posterior knee pain

Popliteal (Baker’s) cyst

The popliteal fossa contains 6 of the numerous bursa of the knee; the bursa beneath the medial head of the gastrocnemius muscle and the semimembranosus tendon is most commonly involved in the formation of a popliteal cyst.40 It is postulated that increased intra-articular pressure forces fluid into the bursa, leading to expansion and pain. This can be idiopathic or secondary to internal derangement or trauma to the knee.41 Older age, a remote history of knee trauma, or a coexisting joint disease such as osteoarthritis, meniscal pathology, or rheumatoid arthritis are significant risk factors for the development of popliteal cysts.27

Diagnosis. Most popliteal cysts are asymptomatic in adults and discovered incidentally after routine imaging to evaluate other knee pathology. However, symptomatic popliteal cysts present as a palpable mass in the popliteal fossa, resulting in pain and limited range of motion.

During the physical exam with the patient lying supine, a medial popliteal mass that is most prominent with the knee fully extended is common. A positive Foucher’s sign (the painful mass is palpated posteriorly in the popliteal fossa with the knee fully extended; pain is relieved and/or the mass reduced in size with knee flexion to 45°) suggests a diagnosis of popliteal cyst.27,28

Radiologic studies are generally not needed to diagnose a popliteal cyst. However, if diagnostic uncertainty remains after the history and physical exam, plain knee radiographs and ultrasound should be obtained. This combination provides complementary information and helps rule out a fracture, arthritis, and thrombosis as the cause of the pain.27 MRI is helpful if the diagnosis is still in doubt and for patients suspected of having significant internal derangement leading to cyst formation. Arthrography or CT is generally not needed.27,41

Treatment. As popliteal cysts are often associated with other knee pathology, management of the underlying condition often leads to cyst regression. Keeping the knee in flexion can decrease the available space and assist in pain control in the acute phase.27 Cold packs and NSAIDs can also be used initially. Cyst aspiration and intra-articular steroid injection have been shown to be effective for cysts that do not respond to this conservative approach.27 However, addressing and managing the underlying knee pathology (eg, osteoarthritis, meniscal pathology, or rheumatoid arthritis) will prevent popliteal cysts from recurring.

When the problem is painful knee effusion

A prompt orthopedic referral is essential when you suspect an infectious joint. Nontraumatic knee effusion can be the primary source of knee pain or the result of underlying pathology. We mention it here because clinical suspicion is paramount in diagnosing a septic joint, a serious cause of painful knee effusion that warrants prompt treatment.

As in other causes of knee pain, a detailed history of the character of the pain is essential. Septic arthritis and crystalline disease (gout, pseudogout) should be suspected in patients without a history of trauma who cannot bear weight. Systemic complaints point to an infection and, with the exception of a possible low-grade fever, are not typically seen in crystalline disease. Notable findings include an erythematous, hot, swollen knee and pain with both active and passive movement.

Plain radiographs of the knee should be ordered to rule out significant trauma or arthritis as the etiology. It is important to perform joint aspiration with synovial fluid analysis. Fluid analysis should include a white blood cell (WBC) count with differential, Gram stain and cultures, and polarized light microscopy (not readily available in an outpatient setting).29

 

 

Synovial fluid analysis characteristics suggestive of a septic joint include turbid quality, WBC >50,000 per mm3, an elevated protein content, and a low glucose concentration.30 Gram stain and culture will help identify the infectious agent. Orthopedic referral should not be delayed in patients with a suspected infectious joint. Corticosteroids should not be injected during aspiration if infection is being ruled out.

CASE › When Ms. T returns for a follow-up visit 8 weeks later, she states that the knee pain has resolved and that she has returned to running. She has lost an additional 8 pounds and continues to diet. And, at the advice of her physical therapist, she is continuing her physiotherapy regimen at home to prevent a recurrence of PFPS.

CORRESPONDENCE
Carlton J. Covey, MD, FAAFP, Nellis Family Medicine Residency Program, 4700 Las Vegas Boulevard North, Nellis Air Force Base, NV 89191; carlton.covey@us.af.mil

PRACTICE RECOMMENDATIONS

› Consider radiography for 
a patient with patellofemoral pain syndrome if examination reveals an effusion, the patient is age
 50 years or older, or the condition does not improve after 8 to 12 weeks of treatment. C
› Order plain radiography
for all patients with patellofemoral instability to assess for osseous trauma/deformity; consider magnetic resonance imaging if you suspect significant soft tissue damage or the patient does not respond to conservative therapy. C
› Perform joint aspiration with synovial fluid analysis for patients with painful knee effusion, and provide an orthopedic referral without delay when an infectious joint is suspected. A

Strength of recommendation (SOR)

A Good-quality patient-oriented evidence
B Inconsistent or limited-quality patient-oriented evidence
C Consensus, usual practice, opinion, disease-oriented evidence, case series

CASE › Jane T, age 42, comes to see you because of right knee pain that she’s had for about 6 months. She denies any trauma. Ms. T describes the pain as vague and poorly localized, but worse with activity. She says she started a walking/running program 9 months ago, when she was told she was overweight (body mass index, 29). She has lost 10 pounds since then, Ms. T says, and hopes to lose more by continuing to exercise. upon further review, you find that Ms. T has had increasing pain while ascending and descending stairs and that the pain is also exacerbated when she stands after prolonged sitting.

If Ms. T were your patient, what would you include in a physical examination and how would you diagnose and treat her?

Knee pain is a common presentation in primary care. While traumatic knee pain is frequently addressed in the medical literature, little has been written about chronic nontraumatic nonarthritic knee pain like that of Ms. T. Thus, while physical exam tests often lead to the correct diagnosis for traumatic knee pain, there is limited information on the use of such tests to determine the etiology of chronic knee pain.

This review was developed to fill that gap. In the pages that follow, we provide general guidance on the diagnosis and treatment of chronic nontraumatic knee pain. The conditions are presented anatomically—anterior, lateral, medial, or posterior—with common etiologies, history and physical exam findings, and diagnosis and treatment options for each (TABLE).1-31

Anterior knee pain

Patellofemoral pain syndrome

Patellofemoral pain syndrome is the most common cause of anterior knee pain. Taping or bracingalong with physical therapymay help reduce the pain.
Patellofemoral pain syndrome (PFPS), the most common cause of anterior knee pain, is a complex entity with an etiology that has not been well described.2 The quadriceps tendon, medial and lateral retinacula, iliotibial band (ITB), vastus medialis and lateralis, and the insertion of the patellar tendon on the anterior tibial tubercle all play a role in proper tracking of the patellofemoral joint; an imbalance in any of these forces leads to abnormal patellar tracking over the femoral condyles, and pain ensues. PFPS can also be secondary to joint overload, in which excessive physical activity (eg, running, lunges, or squats) overloads the patellofemoral joint and causes pain.

Risk factors for PFPS include strength imbalances in the quadriceps, hamstring, and hip muscle groups, and increased training, such as running longer distances.4,32 A recent review showed no relationship between an increased quadriceps (Q)-angle and PFPS, so that is no longer considered a major risk factor.5

Diagnosis. PFPS is a diagnosis of exclusion, and is primarily based on history and physical exam. Anterior knee pain that is exacerbated when seated for long periods of time (the “theater sign”) or by descending stairs is a classic indication of PFPS.1 Patients may complain of knee stiffness or “giving out” secondary to sharp knee pain and a sensation of popping or crepitus in the joint. Swelling is not a common finding.2

A recent meta-analysis revealed limited evidence for the use of any specific physical exam tests to diagnose PFPS. But pain during squatting and pain with a patellar tilt test were most consistent with a diagnosis of PFPS. (The patellar tilt test involves lifting the lateral edge of the patella superiorly while the patient lies supine with knee extended; pain with <20° of lift suggests a tight lateral retinaculum). Conversely, the absence of pain during squatting or the absence of lateral retinacular pain helps rule it out.2 A physical exam of the cruciate and collateral ligaments should be performed in a patient with a history of instability. Radiography is not needed for a diagnosis, but may be considered if examination reveals an effusion, the patient is age 50 years or older, or no improvement occurs after 8 to 12 weeks of treatment.33

 

 

Treatment. The most effective and strongly supported treatment for PFPS is a 6-week physiotherapy program focusing on strengthening the quadriceps and hip muscles and stretching the quadriceps, ITB, hamstrings, and hip flexors.4,5 There is limited information about the use of nonsteroidal anti-inflammatory drugs (NSAIDs), but they can be considered for short-term management.2

Patellar taping and bracing have shown some promise as adjunct therapies for PFPS, although the data for both are non-conclusive. There is a paucity of prospective randomized trials of patellar bracing and a 2012 Cochrane review found limited evidence of its efficacy.34 But a 2014 meta-analysis revealed moderate evidence in support of patellar taping early on to help decrease pain,6 and a recent review suggests that it can be helpful in both the short and long term.7

Taping or bracing may be useful when combined with a tailored physical therapy program. Evidence for treatments such as biofeedback, chiropractic manipulation, and orthotics is limited, and they should be used only as adjunctive therapy.4

CASE › When you examine Ms. T, you find no swelling of the affected knee. You perform the tilt test, which elicits pain. Squatting causes some pain, as well. You diagnose PFPS and provide a referral for 6 weeks of physiotherapy.

Patellar subluxation or chronic dislocation

Patellofemoral instability (PFI) occurs when the patella disengages completely from the trochlear groove.11 PFI’s etiology also relates to the complexity of the patellofemoral joint. Here, too, stability of the joint is achieved with a combination of soft tissue and bony restraints. At full extension and early flexion of the knee, however, the mechanisms of stability are limited, resulting in increased instability. Other associated factors include Q-angle, lateral pull from a tight ITB, and opposing forces from the vastus lateralis and vastus medialis obliquus (VMO).8-10

Risk factors for PFI. The most common predisposing factors for PFI are trochlear dysplasia, patella alta, and lateralization of the tibial tuberosity or patella.10,11 Older patients (mostly women) have an increased risk for patellofemoral instability. Older patients, predominately women, have an increased risk for PFI.9 Patients usually have a history of patellar subluxation or dislocation in their youth, with approximately 17% of those who had a first dislocation experiencing a recurrence.9 A family history of PFI is common, as well.10

Diagnosis. Patients with PFI often present with nonspecific anterior knee pain secondary to recurrent dislocation.13 Notable physical exam findings are:

  • a positive J sign (noted if the patella suddenly shifts medially during early knee flexion or laterally during full extension)
  • decreased quadriceps (specifically VMO) and hamstring strength and flexibility
  • patellar hypermobility, which should be no more than a quarter to a half of the patellar diameter bilaterally
  • pain during a patellar tilt test

  • a positive patellar apprehension test.10 (With the patient lying with the knee flexed to 20°, place thumbs on the medial patella and push laterally; the patient will straighten leg with pain or “apprehension” prior to patellar dislocation.)

Plain radiography should be ordered in all cases to assess for osseous trauma/ deformity and to help guide surgical consideration. Magnetic resonance imaging (MRI) can provide additional information when significant soft tissue damage is suspected or the patient does not improve with conservative therapy.8,11

Treatment. A recent Cochrane review showed that conservative treatment (VMO strengthening, bracing, and proprioceptive therapy) prevented future dislocations more effectively than surgical intervention.11 However, surgery is indicated when obvious predisposing anatomic conditions (osteochondral fracture, intra-articular deformity, or a major tear of a medial soft tissue stabilizer) are clearly shown on imaging.8,11

Patellar tendinopathy (jumper’s knee)

Patellar tendinopathy, an overuse injury often called “jumper’s knee” because it is associated with high-intensity jumping sports like volleyball and basketball, is an insertional tendinopathy with pain most commonly at the proximal patellar tendon.10 The pathology of the injury is poorly understood, but is believed to be the result of an impaired healing response to microtears.12,14

Diagnosis. Patients with patellar tendinopathy typically present with anterior suprapatellar pain aggravated by activity. Classically, the pain can occur in any of 4 phases:12 1. pain isolated after activity; 2. pain that occurs during activity but does not impede activity; 3. pain that occurs both during and after the activity and interferes with competition
; 4. a complete tendon disruption. 

Examination should include an assessment of the patellar tendon for localized thickening, nodularity, crepitus, and focal suprapatellar tenderness. The muscle-tendon function should be evaluated by assessing knee mobility and strength of the quads via straight leg raise, decline squat, or single leg squats.12 The Victorian Institute of Sport Assessment (VISA) questionnaire can be used to quantify the symptoms and to help track the patient’s progress throughout therapy.31 There are no proven special tests or radiologic studies to aid in the diagnosis of patellar tendinopathy,14 but magnetic resonance imaging (MRI) can be used for further evaluation when findings are equivocal.35

 

 

Treatment. A wide range of options, from eccentric training—eg, 3 sets of 15 repetitions performed twice a day for 12 weeks—and physical therapy to platelet-rich plasma (PRP) injections, sclerosing injections, and surgery, are available for the treatment of patellar tendinopathy.13-15 While no specific data have proven the superiority of any one therapy, expert consensus recommends eccentric exercise as initial therapy, performed for 12 weeks.14,15

Three weeks of platelet-rich plasma injections helped 75% of patients with patellar tendinopathy return to their pre-symptom activity level within 90 days. It’s also interesting to note that a recently published study showed that 3 weekly PRP injections helped 75% of patients—all of whom failed to respond to 4 months of eccentric therapy—return to their pre-symptom activity level within 90 days.16 Corticosteroid injections should not be used to treat patellar tendinopathy due to the risk of tendon rupture.15 Orthopedic referral for surgical intervention should be considered for patients who fail to respond after 3 to 6 months of conservative therapy.14

Lateral knee pain

Iliotibial band tendinopathy


Iliotibial band syndrome (ITBS) is a common source of lateral knee pain, particularly in runners, cyclists, and endurance athletes.17-19,36,37 The exact pathophysiology behind this diagnosis is debatable, but the most accepted etiology is inflammation generated from micro trauma to the soft tissues with inadequate healing time, resulting in persistent inflammation. ITBS is often associated with excessive overall running mileage, a sudden increase in mileage, or an abrupt change in training.18,37

Patients with ITBS often complain of persistent nontraumatic knee pain that worsens with repetitive knee flexion. Diagnosis. Patients often complain of persistent nontraumatic lateral knee pain that worsens with repetitive knee flexion (eg, running or cycling).17-19,37 A physical exam will often reveal pain over the lateral femoral condyle and a positive Noble’s test (FIGURE 1). A positive Ober’s test (FIGURE 2) is suggestive of ITBS, as well. The sensitivity and specificity of these tests are not well established, but in patients performing repetitive knee flexion activities with subjective lateral knee pain, pain over the lateral femoral condyle and a positive Ober’s and/or Noble’s test suggest an ITBS diagnosis.18 Imaging is not indicated initially, but MRI should be used in refractory cases to rule out other etiologies.17,19

Treatment. First-line therapy for ITBS is conservative,17-19,36,37 often involving a combination of techniques such as refraining from the activity that triggers the pain, NSAIDs, activity modification to reduce the strain over the ITB, myofascial release via foam rollers, and physical therapy focused on stretching the iliotibial band, tensor fasciae latae, and gluteus medius while strengthening the gluteus medius and core muscles.17 No single program has been shown to be better than another.

Corticosteroid injections are second-line therapy and have been shown to improve pain compared with placebo up to 2 weeks post injection.17,19 When symptoms persist for more than 6 months despite conservative treatment, surgical intervention may be indicated.18,19 Patients who experience temporary pain relief with corticosteroid injections often respond best to surgery.36

Medial knee pain

Medial plica syndrome

Because of its anatomic location, the medial plica—which can be palpated in up to 84% of the population20—is susceptible to impingement by the medial femoral condyle or the patellofemoral joint. Trauma with repetitive knee movement leads to inflammation and thickening of the plica, resulting in medial plica syndrome.20,38 Initial inflammation may be triggered by blunt trauma, a sudden increase in activity, or transient synovitis.22

Diagnosis. Medial plica syndrome is a challenging diagnosis. Patients generally have nonspecific complaints of aching medial knee pain, locking, and catching similar to complaints of a medial meniscal injury.20

A mediopatellar plica test was more accurate than an MRI in diagnosing medial plica syndrome, according to a recent systematic review. Evaluation should include the mediopatellar plica test, which is performed with the patient lying supine with the knee fully extended. Pressure is placed over the inferomedial patellofemoral joint, creating an impingement of the medial plica between the finger and the medial femoral condyle. Elimination or marked diminishing of pain with knee flexion to 90° is considered a positive test.21

A recent systematic review found this test to be more diagnostically accurate than an MRI (sensitivity of the test is 90% and specificity is 89%, vs 77% and 58%, respectively, for MRI) for detection of medial plica syndrome. Ultrasound is almost as accurate, with a sensitivity of 90% and specificity of 83%.39

Treatment of medial plica syndrome centers on physiotherapy and quadriceps strengthening,20 augmented with NSAIDs. Intra-articular corticosteroid injections are considered second-line treatment.20,22 An orthopedics referral is indicated to consider arthroscopic plica removal for refractory cases.20,22

 

 

Pes anserine bursitis

The anserine bursal complex, located approximately 5 cm distal to the medial joint line, is formed by the combined insertion of the sartorius, gracilis, and semitendinosus tendons,39 but the exact mechanism of pain is not well understood. Whether the pathophysiology is from an insertional tendonitis or overt bursitis is unknown, and no studies have focused on prevalence or risk factors. What is known is that overweight individuals and women with a wide pelvis seem to have a greater predilection and those with pes planus, diabetes, or knee osteoarthritis are at increased risk.23

Diagnosis. Medial knee pain reproduced on palpation of the anatomical site of insertion of the pes anserine tendon complex supports a diagnosis of pes anserine bursitis, with or without edema. Radiologic studies are not needed, but may be helpful if significant bony pathology is suspected. Ultrasound, computed tomography (CT), and MRI are not recommended.23

Treatment. Resting the affected knee, cryotherapy, NSAIDs, and using a pillow at night to relieve direct bursal pressure are recommended.33 Weight loss in obese patients, treatment of pes planus, and control of diabetes may be helpful, as well. Although the literature is limited and dated, corticosteroid injection has been found to reduce the pain and may be considered as second-line treatment.24-26

Posterior knee pain

Popliteal (Baker’s) cyst

The popliteal fossa contains 6 of the numerous bursa of the knee; the bursa beneath the medial head of the gastrocnemius muscle and the semimembranosus tendon is most commonly involved in the formation of a popliteal cyst.40 It is postulated that increased intra-articular pressure forces fluid into the bursa, leading to expansion and pain. This can be idiopathic or secondary to internal derangement or trauma to the knee.41 Older age, a remote history of knee trauma, or a coexisting joint disease such as osteoarthritis, meniscal pathology, or rheumatoid arthritis are significant risk factors for the development of popliteal cysts.27

Diagnosis. Most popliteal cysts are asymptomatic in adults and discovered incidentally after routine imaging to evaluate other knee pathology. However, symptomatic popliteal cysts present as a palpable mass in the popliteal fossa, resulting in pain and limited range of motion.

During the physical exam with the patient lying supine, a medial popliteal mass that is most prominent with the knee fully extended is common. A positive Foucher’s sign (the painful mass is palpated posteriorly in the popliteal fossa with the knee fully extended; pain is relieved and/or the mass reduced in size with knee flexion to 45°) suggests a diagnosis of popliteal cyst.27,28

Radiologic studies are generally not needed to diagnose a popliteal cyst. However, if diagnostic uncertainty remains after the history and physical exam, plain knee radiographs and ultrasound should be obtained. This combination provides complementary information and helps rule out a fracture, arthritis, and thrombosis as the cause of the pain.27 MRI is helpful if the diagnosis is still in doubt and for patients suspected of having significant internal derangement leading to cyst formation. Arthrography or CT is generally not needed.27,41

Treatment. As popliteal cysts are often associated with other knee pathology, management of the underlying condition often leads to cyst regression. Keeping the knee in flexion can decrease the available space and assist in pain control in the acute phase.27 Cold packs and NSAIDs can also be used initially. Cyst aspiration and intra-articular steroid injection have been shown to be effective for cysts that do not respond to this conservative approach.27 However, addressing and managing the underlying knee pathology (eg, osteoarthritis, meniscal pathology, or rheumatoid arthritis) will prevent popliteal cysts from recurring.

When the problem is painful knee effusion

A prompt orthopedic referral is essential when you suspect an infectious joint. Nontraumatic knee effusion can be the primary source of knee pain or the result of underlying pathology. We mention it here because clinical suspicion is paramount in diagnosing a septic joint, a serious cause of painful knee effusion that warrants prompt treatment.

As in other causes of knee pain, a detailed history of the character of the pain is essential. Septic arthritis and crystalline disease (gout, pseudogout) should be suspected in patients without a history of trauma who cannot bear weight. Systemic complaints point to an infection and, with the exception of a possible low-grade fever, are not typically seen in crystalline disease. Notable findings include an erythematous, hot, swollen knee and pain with both active and passive movement.

Plain radiographs of the knee should be ordered to rule out significant trauma or arthritis as the etiology. It is important to perform joint aspiration with synovial fluid analysis. Fluid analysis should include a white blood cell (WBC) count with differential, Gram stain and cultures, and polarized light microscopy (not readily available in an outpatient setting).29

 

 

Synovial fluid analysis characteristics suggestive of a septic joint include turbid quality, WBC >50,000 per mm3, an elevated protein content, and a low glucose concentration.30 Gram stain and culture will help identify the infectious agent. Orthopedic referral should not be delayed in patients with a suspected infectious joint. Corticosteroids should not be injected during aspiration if infection is being ruled out.

CASE › When Ms. T returns for a follow-up visit 8 weeks later, she states that the knee pain has resolved and that she has returned to running. She has lost an additional 8 pounds and continues to diet. And, at the advice of her physical therapist, she is continuing her physiotherapy regimen at home to prevent a recurrence of PFPS.

CORRESPONDENCE
Carlton J. Covey, MD, FAAFP, Nellis Family Medicine Residency Program, 4700 Las Vegas Boulevard North, Nellis Air Force Base, NV 89191; carlton.covey@us.af.mil

References

1. Earl JE, Vetter CS. Patellofemoral pain. Phys Med Rehabil Clin N Am. 2007;18:439-458,viii.

2. McGowan HJ, Beutler A. Patellofemoral syndrome. Essential Evidence Plus Web site. Available at: http://www.essentialevidenceplus.com. Accessed: March 20, 2014.

3. Nunes GS, Stapait EL, Kirsten MH, et al. Clinical test for diagnosis of patellofemoral pain syndrome: Systematic review with meta-analysis. Phys Ther Sport. 2013;14:54-59.

4. Rixe JA, Glick JE, Brady J, et al. A review of the management of patellofemoral pain syndrome. Phys Sportsmed. 2013;41: 19-28.

5. Bolgla LA, Boling MC. An update for the conservative management of patellofemoral pain syndrome: a systematic review of the literature from 2000 to 2010. Int J Sports Phys Ther. 2011;6:112-125.

6. Barton C, Balachandar V, Lack S, et al. Patellar taping for patellofemoral pain: a systematic review and meta-analysis to evaluate clinical outcomes and biomechanical mechanisms. Br J Sports Med. 2014;48:417-424.

7. Dutton RA, Khadavi MJ, Fredericson M. Update on rehabilitation of patellofemoral pain. Curr Sports Med Rep. 2014;13: 172-178.

8. Kapur S, Wissman RD, Robertson M, et al. Acute knee dislocation: review of an elusive entity. Curr Probl Diagn Radiol. 2009;38:237-250.

9. Colvin AC, West RV. Patellar instability. J Bone Joint Surg Am. 2008;90:2751-2762.

10. Tscholl PM, Koch PP, Fucentese SF. Treatment options for patellofemoral instability in sports traumatology. Orthop Rev (Pavia). 2013;5:e23.

11. Earhart C, Patel DB, White EA, et al. Transient lateral patellar dislocation: review of imaging findings, patellofemoral anatomy, and treatment options. Emerg Radiol. 2013;20:11-23.

12.  Tan SC, Chan O. Achilles and patellar tendinopathy: current understanding of pathophysiology and management. Disabil Rehabil. 2008;30:1608-1615.

13.  Gaida JE, Cook J. Treatment options for patellar tendinopathy: critical review. Curr Sports Med Rep. 2011;10:255-270.

14. Rodriguez-Merchan EC. The treatment of patellar tendinopathy. J Orthop Traumatol. 2013;14:77-81.

15. Childress MA, Beutler A. Management of chronic tendon injuries. Am Fam Physician. 2013;87:486-490.

16. Charousset C, Zaoui A, Bellaiche L, et al. Are multiple platelet-rich plasma injections useful for treatment of chronic patellar tendinopathy in athletes? A prospective study. Am J Sports Med. 2014;42:906-911.

17. Strauss EJ, Kim S, Calcei JG, et al. Iliotibial band syndrome: evaluation and management. J Am Acad Orthop Surg. 2011;19:728-736.

18. Bellary SS, Lynch G, Housman B, et al. Medial plica syndrome: a review of the literature. Clin Anat. 2012;25:423-428.

19. Hong JH, Kim JS. Diagnosis of iliotibial band friction syndrome and ultrasound guided steroid injection. Korean J Pain. 2013;26:387-391.

20. Bellary SS, Lynch G, Housman B, et al. Medial plica syndrome: a review of the literature. Clin Anat. 2012;25:423-428.

21. Kim SJ, Jeong JH, Cheon YM, et al. MPP test in the diagnosis of medial patellar plica syndrome. Arthroscopy. 2004;20: 1101-1103.

22. Schindler OS. ‘The Sneaky Plica’ revisited: morphology, pathophysiology and treatment of synovial plicae of the knee. Knee Surg Sports Traumatol Arthrosc. 2014;22:247-262.

23. Helfenstein M Jr, Kuromoto J. Anserine syndrome. Rev Bras Rheumatol. 2010;50:313-327.

24. Abeles M. Osteoarthritis of the knee: anserine bursitis as an extra-articular cause of pain. Clin Res. 1983;31:4471-4476.

25. Kang I, Han SW. Anserine bursitis in patients with osteoarthritis of the knee. South Med J. 2000;93:207-209.

26. Yoon HS, Kim SE, Suh YR, et al. Correlation between ultrasonographic findings and the response to corticosteroid injection in pes anserinus tendinobursitis syndrome in knee osteoarthritis patients. J Korean Med Sci. 2005;20:109-112.

27. Stein D, Cantlon M, MacKay B, et al. Cysts about the knee: evaluation and management. J Am Acad Orthop Surg. 2013;21: 469-479.

28. Canoso JJ, Goldsmith MR, Gerzof SG, et al. Foucher’s sign of the Baker’s cyst. Ann Rheum Dis. 1987;46:228-232.

29. Palmer T. Knee pain. Essential Evidence Plus Web site. Available at: http://www.essentialevidenceplus.com. Accessed: December 12, 2013.

30. Franks AG Jr. Rheumatologic aspects of knee disorders. In: Scott WN, ed. The Knee. St. Louis: Mosby; 1994:315-329.

31. Visentini PJ, Khan KM, Cook JL, et al. The VISA score: an index of severity of symptoms in patients with jumper’s knee (patellar tendinosis). Victorian Institute of Sport Tendon Study Group. J Sci Med Sport. 1998;1:22-28.

32. Halabchi F, Mazaheri R, Seif-Barghi T. Patellofemoral pain syndrome and modifiable intrinsic risk factors; how to assess and address? Asian J Sports Med. 2013;4:85-100.

33. Dixit S, DiFiori JP, Burton M, et al. Management of patellofemoral pain syndrome. Am Fam Physician. 2007;75:194-202.

34. Callaghan MJ, Selfe J. Patellar taping for patellofemoral pain syndrome in adults. Cochrane Database Syst Rev. 2012;4:CD006717.

35. Atanda AJ Jr, Ruiz D, Dodson CC, et al. Approach to the active patient with chronic anterior knee pain. Phys Sportsmed. 2012;40:41-50.

36. Ellis R, Hing W, Reid D. Iliotibial band friction syndrome—a systematic review. Man Ther. 2007;12:200-208.

37. Kirk KL, Kuklo T, Klemme W. Iliotibial band friction syndrome. Orthopedics. 2000;23:1209-1217.

38. Stubbings N, Smith T. Diagnostic test accuracy of clinical and radiological assessments for medial patella plica syndrome: a systematic review and meta-analysis. Knee. 2014;21: 486-490.

39. Alvarez-Nemegyei J, Canoso JJ. Evidence-based soft tissue rheumatology IV: anserine bursitis. J Clin Rheumatol. 2004;10:205-206.

40. Fritschy D, Fasel J, Imbert JC, et al. The popliteal cyst. Knee Surg Sports Traumatol Arthrosc. 2006;14:623-628.

41. Handy JR. Popliteal cysts in adults: a review. Semin Arthritis Rheum. 2001;31:108-118.

References

1. Earl JE, Vetter CS. Patellofemoral pain. Phys Med Rehabil Clin N Am. 2007;18:439-458,viii.

2. McGowan HJ, Beutler A. Patellofemoral syndrome. Essential Evidence Plus Web site. Available at: http://www.essentialevidenceplus.com. Accessed: March 20, 2014.

3. Nunes GS, Stapait EL, Kirsten MH, et al. Clinical test for diagnosis of patellofemoral pain syndrome: Systematic review with meta-analysis. Phys Ther Sport. 2013;14:54-59.

4. Rixe JA, Glick JE, Brady J, et al. A review of the management of patellofemoral pain syndrome. Phys Sportsmed. 2013;41: 19-28.

5. Bolgla LA, Boling MC. An update for the conservative management of patellofemoral pain syndrome: a systematic review of the literature from 2000 to 2010. Int J Sports Phys Ther. 2011;6:112-125.

6. Barton C, Balachandar V, Lack S, et al. Patellar taping for patellofemoral pain: a systematic review and meta-analysis to evaluate clinical outcomes and biomechanical mechanisms. Br J Sports Med. 2014;48:417-424.

7. Dutton RA, Khadavi MJ, Fredericson M. Update on rehabilitation of patellofemoral pain. Curr Sports Med Rep. 2014;13: 172-178.

8. Kapur S, Wissman RD, Robertson M, et al. Acute knee dislocation: review of an elusive entity. Curr Probl Diagn Radiol. 2009;38:237-250.

9. Colvin AC, West RV. Patellar instability. J Bone Joint Surg Am. 2008;90:2751-2762.

10. Tscholl PM, Koch PP, Fucentese SF. Treatment options for patellofemoral instability in sports traumatology. Orthop Rev (Pavia). 2013;5:e23.

11. Earhart C, Patel DB, White EA, et al. Transient lateral patellar dislocation: review of imaging findings, patellofemoral anatomy, and treatment options. Emerg Radiol. 2013;20:11-23.

12.  Tan SC, Chan O. Achilles and patellar tendinopathy: current understanding of pathophysiology and management. Disabil Rehabil. 2008;30:1608-1615.

13.  Gaida JE, Cook J. Treatment options for patellar tendinopathy: critical review. Curr Sports Med Rep. 2011;10:255-270.

14. Rodriguez-Merchan EC. The treatment of patellar tendinopathy. J Orthop Traumatol. 2013;14:77-81.

15. Childress MA, Beutler A. Management of chronic tendon injuries. Am Fam Physician. 2013;87:486-490.

16. Charousset C, Zaoui A, Bellaiche L, et al. Are multiple platelet-rich plasma injections useful for treatment of chronic patellar tendinopathy in athletes? A prospective study. Am J Sports Med. 2014;42:906-911.

17. Strauss EJ, Kim S, Calcei JG, et al. Iliotibial band syndrome: evaluation and management. J Am Acad Orthop Surg. 2011;19:728-736.

18. Bellary SS, Lynch G, Housman B, et al. Medial plica syndrome: a review of the literature. Clin Anat. 2012;25:423-428.

19. Hong JH, Kim JS. Diagnosis of iliotibial band friction syndrome and ultrasound guided steroid injection. Korean J Pain. 2013;26:387-391.

20. Bellary SS, Lynch G, Housman B, et al. Medial plica syndrome: a review of the literature. Clin Anat. 2012;25:423-428.

21. Kim SJ, Jeong JH, Cheon YM, et al. MPP test in the diagnosis of medial patellar plica syndrome. Arthroscopy. 2004;20: 1101-1103.

22. Schindler OS. ‘The Sneaky Plica’ revisited: morphology, pathophysiology and treatment of synovial plicae of the knee. Knee Surg Sports Traumatol Arthrosc. 2014;22:247-262.

23. Helfenstein M Jr, Kuromoto J. Anserine syndrome. Rev Bras Rheumatol. 2010;50:313-327.

24. Abeles M. Osteoarthritis of the knee: anserine bursitis as an extra-articular cause of pain. Clin Res. 1983;31:4471-4476.

25. Kang I, Han SW. Anserine bursitis in patients with osteoarthritis of the knee. South Med J. 2000;93:207-209.

26. Yoon HS, Kim SE, Suh YR, et al. Correlation between ultrasonographic findings and the response to corticosteroid injection in pes anserinus tendinobursitis syndrome in knee osteoarthritis patients. J Korean Med Sci. 2005;20:109-112.

27. Stein D, Cantlon M, MacKay B, et al. Cysts about the knee: evaluation and management. J Am Acad Orthop Surg. 2013;21: 469-479.

28. Canoso JJ, Goldsmith MR, Gerzof SG, et al. Foucher’s sign of the Baker’s cyst. Ann Rheum Dis. 1987;46:228-232.

29. Palmer T. Knee pain. Essential Evidence Plus Web site. Available at: http://www.essentialevidenceplus.com. Accessed: December 12, 2013.

30. Franks AG Jr. Rheumatologic aspects of knee disorders. In: Scott WN, ed. The Knee. St. Louis: Mosby; 1994:315-329.

31. Visentini PJ, Khan KM, Cook JL, et al. The VISA score: an index of severity of symptoms in patients with jumper’s knee (patellar tendinosis). Victorian Institute of Sport Tendon Study Group. J Sci Med Sport. 1998;1:22-28.

32. Halabchi F, Mazaheri R, Seif-Barghi T. Patellofemoral pain syndrome and modifiable intrinsic risk factors; how to assess and address? Asian J Sports Med. 2013;4:85-100.

33. Dixit S, DiFiori JP, Burton M, et al. Management of patellofemoral pain syndrome. Am Fam Physician. 2007;75:194-202.

34. Callaghan MJ, Selfe J. Patellar taping for patellofemoral pain syndrome in adults. Cochrane Database Syst Rev. 2012;4:CD006717.

35. Atanda AJ Jr, Ruiz D, Dodson CC, et al. Approach to the active patient with chronic anterior knee pain. Phys Sportsmed. 2012;40:41-50.

36. Ellis R, Hing W, Reid D. Iliotibial band friction syndrome—a systematic review. Man Ther. 2007;12:200-208.

37. Kirk KL, Kuklo T, Klemme W. Iliotibial band friction syndrome. Orthopedics. 2000;23:1209-1217.

38. Stubbings N, Smith T. Diagnostic test accuracy of clinical and radiological assessments for medial patella plica syndrome: a systematic review and meta-analysis. Knee. 2014;21: 486-490.

39. Alvarez-Nemegyei J, Canoso JJ. Evidence-based soft tissue rheumatology IV: anserine bursitis. J Clin Rheumatol. 2004;10:205-206.

40. Fritschy D, Fasel J, Imbert JC, et al. The popliteal cyst. Knee Surg Sports Traumatol Arthrosc. 2006;14:623-628.

41. Handy JR. Popliteal cysts in adults: a review. Semin Arthritis Rheum. 2001;31:108-118.

Issue
The Journal of Family Practice - 63(12)
Issue
The Journal of Family Practice - 63(12)
Page Number
720-728
Page Number
720-728
Publications
Publications
Topics
Article Type
Display Headline
Nontraumatic knee pain: A diagnostic & treatment guide
Display Headline
Nontraumatic knee pain: A diagnostic & treatment guide
Legacy Keywords
nontraumatic knee pain; patellofemoral pain syndrome; PFPS; iliotibial band; ITB; patellofemoral instability (PFI); patellar tendinopathy; jumper's knee; iliotibial band syndrome; ITBS; Noble's test; Ober's test; popliteal cyst; Carlton J. Covey, MD, FAAFP; Matthew K. Hawks, MD
Legacy Keywords
nontraumatic knee pain; patellofemoral pain syndrome; PFPS; iliotibial band; ITB; patellofemoral instability (PFI); patellar tendinopathy; jumper's knee; iliotibial band syndrome; ITBS; Noble's test; Ober's test; popliteal cyst; Carlton J. Covey, MD, FAAFP; Matthew K. Hawks, MD
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Broaching the topic of sexual dysfunction

Article Type
Changed
Display Headline
Broaching the topic of sexual dysfunction

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
 
Author and Disclosure Information

Anita H. Clayton, MD

Anita H. Clayton, MD, is Interim Chair and David C. Wilson Professor of Psychiatry and Neurobehavioral Sciences, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine, Charlottesville, Virginia.

Issue
The Journal of Family Practice - 63(12)
Publications
Topics
Page Number
video
Legacy Keywords
Anita H. Clayton, MD; sexual dysfunction
Author and Disclosure Information

Anita H. Clayton, MD

Anita H. Clayton, MD, is Interim Chair and David C. Wilson Professor of Psychiatry and Neurobehavioral Sciences, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine, Charlottesville, Virginia.

Author and Disclosure Information

Anita H. Clayton, MD

Anita H. Clayton, MD, is Interim Chair and David C. Wilson Professor of Psychiatry and Neurobehavioral Sciences, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine, Charlottesville, Virginia.

Related Articles

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
 

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
 
Issue
The Journal of Family Practice - 63(12)
Issue
The Journal of Family Practice - 63(12)
Page Number
video
Page Number
video
Publications
Publications
Topics
Article Type
Display Headline
Broaching the topic of sexual dysfunction
Display Headline
Broaching the topic of sexual dysfunction
Legacy Keywords
Anita H. Clayton, MD; sexual dysfunction
Legacy Keywords
Anita H. Clayton, MD; sexual dysfunction
Disallow All Ads

Health care reform coverage: Spot on or missing key options?

Article Type
Changed
Display Headline
Health care reform coverage: Spot on or missing key options?

Health care reform: Possibilities & opportunities for primary care” (J Fam Pract. 2014;63:298-304) was terrific. You nailed the opportunities and challenges with implementing advanced primary care.

Joseph Scherger, MD
La Quinta, Calif

 

Your article focuses on so-called “value-based” care and Affordable Care Act (ACA) options and ignores other forms of free market health care, such as concierge and direct primary care, that are growing in popularity with physicians and patients. When patients shop for and pursue self-paid care, they are invested in the process, participate in their own care, and have better outcomes. The free market will bring many diverse options to the table, increase the quality of care, and decrease the price of care to stay competitive.

Physicians must step up for their individual patients and be health care leaders, not followers of government mandates and insurance company policies. Patients deserve nothing less than a free-market, competitive environment, and a variety of care and insurance options—not just a few, as dictated by the ACA.

Craig M. Wax, DO
Mullica Hill, NJ

 

Authors’ response:
We appreciate the comments of Drs. Scherger and Wax. We also agree that there is a move in some areas of the country toward direct primary care, as well as toward concierge medicine. However, it is our opinion that in their current form, these models are a symptom of today’s health care system and not a solution.

The vast majority of Americans cannot afford to pay directly for their care. And since health care is not a free market system, free market reforms are not likely to be the solution for most Americans. However, if concierge medicine or direct primary care could be part of a menu of options through existing insurance, government, or employer models, the potential negative impact (including the exacerbation of the current strained primary care system) could be ameliorated.

We agree that physicians should always advocate on behalf of their patients, but we also believe we should think of all patients and how policy changes may impact society as a whole.

Randy Wexler, MD, MPH
Jennifer Hefner, PhD, MPH
Mary Jo Welker, MD
Ann Scheck McAlearney, ScD, MS
Columbus, Ohio

Article PDF
Issue
The Journal of Family Practice - 63(12)
Publications
Topics
Page Number
696a
Legacy Keywords
health care reform; Affordable Care Act; ACA; concierge; direct primary care; Joseph Scherger, MD; Craig M. Wax, DO; Randy Wexler, MD, MPH; Jennifer Hefner, PhD, MPH; Mary Jo Welker, MD; Ann Scheck McAlearney, ScD, MS;
Sections
Article PDF
Article PDF
Related Articles

Health care reform: Possibilities & opportunities for primary care” (J Fam Pract. 2014;63:298-304) was terrific. You nailed the opportunities and challenges with implementing advanced primary care.

Joseph Scherger, MD
La Quinta, Calif

 

Your article focuses on so-called “value-based” care and Affordable Care Act (ACA) options and ignores other forms of free market health care, such as concierge and direct primary care, that are growing in popularity with physicians and patients. When patients shop for and pursue self-paid care, they are invested in the process, participate in their own care, and have better outcomes. The free market will bring many diverse options to the table, increase the quality of care, and decrease the price of care to stay competitive.

Physicians must step up for their individual patients and be health care leaders, not followers of government mandates and insurance company policies. Patients deserve nothing less than a free-market, competitive environment, and a variety of care and insurance options—not just a few, as dictated by the ACA.

Craig M. Wax, DO
Mullica Hill, NJ

 

Authors’ response:
We appreciate the comments of Drs. Scherger and Wax. We also agree that there is a move in some areas of the country toward direct primary care, as well as toward concierge medicine. However, it is our opinion that in their current form, these models are a symptom of today’s health care system and not a solution.

The vast majority of Americans cannot afford to pay directly for their care. And since health care is not a free market system, free market reforms are not likely to be the solution for most Americans. However, if concierge medicine or direct primary care could be part of a menu of options through existing insurance, government, or employer models, the potential negative impact (including the exacerbation of the current strained primary care system) could be ameliorated.

We agree that physicians should always advocate on behalf of their patients, but we also believe we should think of all patients and how policy changes may impact society as a whole.

Randy Wexler, MD, MPH
Jennifer Hefner, PhD, MPH
Mary Jo Welker, MD
Ann Scheck McAlearney, ScD, MS
Columbus, Ohio

Health care reform: Possibilities & opportunities for primary care” (J Fam Pract. 2014;63:298-304) was terrific. You nailed the opportunities and challenges with implementing advanced primary care.

Joseph Scherger, MD
La Quinta, Calif

 

Your article focuses on so-called “value-based” care and Affordable Care Act (ACA) options and ignores other forms of free market health care, such as concierge and direct primary care, that are growing in popularity with physicians and patients. When patients shop for and pursue self-paid care, they are invested in the process, participate in their own care, and have better outcomes. The free market will bring many diverse options to the table, increase the quality of care, and decrease the price of care to stay competitive.

Physicians must step up for their individual patients and be health care leaders, not followers of government mandates and insurance company policies. Patients deserve nothing less than a free-market, competitive environment, and a variety of care and insurance options—not just a few, as dictated by the ACA.

Craig M. Wax, DO
Mullica Hill, NJ

 

Authors’ response:
We appreciate the comments of Drs. Scherger and Wax. We also agree that there is a move in some areas of the country toward direct primary care, as well as toward concierge medicine. However, it is our opinion that in their current form, these models are a symptom of today’s health care system and not a solution.

The vast majority of Americans cannot afford to pay directly for their care. And since health care is not a free market system, free market reforms are not likely to be the solution for most Americans. However, if concierge medicine or direct primary care could be part of a menu of options through existing insurance, government, or employer models, the potential negative impact (including the exacerbation of the current strained primary care system) could be ameliorated.

We agree that physicians should always advocate on behalf of their patients, but we also believe we should think of all patients and how policy changes may impact society as a whole.

Randy Wexler, MD, MPH
Jennifer Hefner, PhD, MPH
Mary Jo Welker, MD
Ann Scheck McAlearney, ScD, MS
Columbus, Ohio

Issue
The Journal of Family Practice - 63(12)
Issue
The Journal of Family Practice - 63(12)
Page Number
696a
Page Number
696a
Publications
Publications
Topics
Article Type
Display Headline
Health care reform coverage: Spot on or missing key options?
Display Headline
Health care reform coverage: Spot on or missing key options?
Legacy Keywords
health care reform; Affordable Care Act; ACA; concierge; direct primary care; Joseph Scherger, MD; Craig M. Wax, DO; Randy Wexler, MD, MPH; Jennifer Hefner, PhD, MPH; Mary Jo Welker, MD; Ann Scheck McAlearney, ScD, MS;
Legacy Keywords
health care reform; Affordable Care Act; ACA; concierge; direct primary care; Joseph Scherger, MD; Craig M. Wax, DO; Randy Wexler, MD, MPH; Jennifer Hefner, PhD, MPH; Mary Jo Welker, MD; Ann Scheck McAlearney, ScD, MS;
Sections
Disallow All Ads
Alternative CME
Article PDF Media

It takes work-arounds to make EHRs “work”

Article Type
Changed
Display Headline
It takes work-arounds to make EHRs “work”

Dr. Hickner’s editorial “EHRs: Something’s gotta give” (J Fam Pract. 2014;63:558) prompted me to reflect on the elements of electronic health records (EHRs) that cannot change and the ones that can.

The EHR system I use allows the EHR to serve as a 
quality recorder, and it appears 
this is the most important part,
 because the reminders of what
 needs to be documented come first and are color-coded. From a reimbursement point of view, what is important is not the narrative, but the expanded “elements” that make it a billing document. I believe this will not change.

What can change is how the note information is organized, and I think the organization should be different for specific roles. At intake, a medical assistant can review allergies, medication lists, and preventive services; update family history; and take vital signs and history of present illness (HPI). As the physician, I want the note to show the information in the order that I process it during the visit: 1) allergies/medication list, 2) concerns/complaints with brief documentation, 3) vitals, 4) physical, 5) assessment, and 6) plan.

After the note is signed off on, I want a different format for review purposes: 1) assessment/plan (because this is what I look at first for follow-up), 2) HPI/review of systems, 3) physical, 4) allergies, 5) medication list, 6) past medical history, and 7) quality reminders (if they show up at all after the visit is complete).

Is it asking too much for a programmer to make the EHR organize information in this manner?

Edward Friedler, MD
Annandale, Va


I still dictate my notes and they very much tell a story that an EHR cannot. I have been audited repeatedly and I always have all the bullet points and essentials that the insurance company wants, but this information is in a format that everyone—including patients—can read and appreciate.

The move to APSO (assessment, plan, subjective, objective) from SOAP (subjective, objective, assessment, plan) is an example of the tail wagging the dog. Rather than fix the note so the time-honored SOAP format works, we acknowledge that no one actually reads the long template notes and they want to get to the bottom line (ie, the assessment and plan).

My dream is to return to the days when we only listed the positive findings, the assumption being that a competent physician did the exam that was required and it’s unnecessary to state that the examined anatomy was normal. Unfortunately, so much of what we must do is driven by lawyers and insurance companies—not by doctors.

David M. Brill, DO
Rocky River, Ohio


I now take photos of all of the ludicrous choices our EHR tosses at me, such as “laceration of third eyelid” or “injury, crushed by falling aircraft due to terrorist.” Most of my EHR entries now say, “See scanned handwritten note for accuracy.”

The issue of EHRs needs to be kept on the front burner. It is destroying doctor/patient relationships and quality diagnostic care while hiding the important findings in the garbage.

Jay Hammett, MD
Knoxville, Tenn


I’m in a group practice of 10 family physicians and in a typical workday, each of us sees 23 to 25 patients, answers e-mails/phone calls, and reviews labs/studies, which leaves no time for anything else. There’s a constant struggle to stay on top of the quality of the notes. I have preserved the quality of my own notes by free typing. I free type a differential next to my assessment or on the first line of the plan. I don’t use templates; they slow me down too much.

Kelly Luba, DO
Phoenix, Ariz


I was a civil service physician working for the Department of the Navy in 2005 when EHRs were thrust upon me. The system was not particularly user-friendly. Free texting was highly discouraged and it was strongly preferred that we used structured text embedded in the program.

I couldn’t use the program as envisioned, so I found a work-around. I would paste the 4 sections of the SOAP note directly into the appropriate free text sections of the electronic record. My assessment included the correct diagnosis, and I would pick a general EHR diagnosis from the dropdown list. Visually, my records did not look any different from those of other health care providers who used structured text.

I used this method until my civil service retirement in 2014. All of my record peer reviews were outstanding, and I was told that my records were easy to understand. I finally let on to all that I never used structured text and that all of my records were really written the old-fashioned way. I still used a clipboard during the patient visit, and completed all records after the patient left.

 

 

David F. Scaccia, DO, MPH
Kittery, Maine

References

Article PDF
Author and Disclosure Information

Issue
The Journal of Family Practice - 63(12)
Publications
Topics
Page Number
696,696a
Legacy Keywords
electronic health records; EHRs; Edward Friedler, MD; David M. Brill, DO; Jay Hammett, MD; Kelly Luba, DO; David F. Scaccia, DO, MPH
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF
Related Articles

Dr. Hickner’s editorial “EHRs: Something’s gotta give” (J Fam Pract. 2014;63:558) prompted me to reflect on the elements of electronic health records (EHRs) that cannot change and the ones that can.

The EHR system I use allows the EHR to serve as a 
quality recorder, and it appears 
this is the most important part,
 because the reminders of what
 needs to be documented come first and are color-coded. From a reimbursement point of view, what is important is not the narrative, but the expanded “elements” that make it a billing document. I believe this will not change.

What can change is how the note information is organized, and I think the organization should be different for specific roles. At intake, a medical assistant can review allergies, medication lists, and preventive services; update family history; and take vital signs and history of present illness (HPI). As the physician, I want the note to show the information in the order that I process it during the visit: 1) allergies/medication list, 2) concerns/complaints with brief documentation, 3) vitals, 4) physical, 5) assessment, and 6) plan.

After the note is signed off on, I want a different format for review purposes: 1) assessment/plan (because this is what I look at first for follow-up), 2) HPI/review of systems, 3) physical, 4) allergies, 5) medication list, 6) past medical history, and 7) quality reminders (if they show up at all after the visit is complete).

Is it asking too much for a programmer to make the EHR organize information in this manner?

Edward Friedler, MD
Annandale, Va


I still dictate my notes and they very much tell a story that an EHR cannot. I have been audited repeatedly and I always have all the bullet points and essentials that the insurance company wants, but this information is in a format that everyone—including patients—can read and appreciate.

The move to APSO (assessment, plan, subjective, objective) from SOAP (subjective, objective, assessment, plan) is an example of the tail wagging the dog. Rather than fix the note so the time-honored SOAP format works, we acknowledge that no one actually reads the long template notes and they want to get to the bottom line (ie, the assessment and plan).

My dream is to return to the days when we only listed the positive findings, the assumption being that a competent physician did the exam that was required and it’s unnecessary to state that the examined anatomy was normal. Unfortunately, so much of what we must do is driven by lawyers and insurance companies—not by doctors.

David M. Brill, DO
Rocky River, Ohio


I now take photos of all of the ludicrous choices our EHR tosses at me, such as “laceration of third eyelid” or “injury, crushed by falling aircraft due to terrorist.” Most of my EHR entries now say, “See scanned handwritten note for accuracy.”

The issue of EHRs needs to be kept on the front burner. It is destroying doctor/patient relationships and quality diagnostic care while hiding the important findings in the garbage.

Jay Hammett, MD
Knoxville, Tenn


I’m in a group practice of 10 family physicians and in a typical workday, each of us sees 23 to 25 patients, answers e-mails/phone calls, and reviews labs/studies, which leaves no time for anything else. There’s a constant struggle to stay on top of the quality of the notes. I have preserved the quality of my own notes by free typing. I free type a differential next to my assessment or on the first line of the plan. I don’t use templates; they slow me down too much.

Kelly Luba, DO
Phoenix, Ariz


I was a civil service physician working for the Department of the Navy in 2005 when EHRs were thrust upon me. The system was not particularly user-friendly. Free texting was highly discouraged and it was strongly preferred that we used structured text embedded in the program.

I couldn’t use the program as envisioned, so I found a work-around. I would paste the 4 sections of the SOAP note directly into the appropriate free text sections of the electronic record. My assessment included the correct diagnosis, and I would pick a general EHR diagnosis from the dropdown list. Visually, my records did not look any different from those of other health care providers who used structured text.

I used this method until my civil service retirement in 2014. All of my record peer reviews were outstanding, and I was told that my records were easy to understand. I finally let on to all that I never used structured text and that all of my records were really written the old-fashioned way. I still used a clipboard during the patient visit, and completed all records after the patient left.

 

 

David F. Scaccia, DO, MPH
Kittery, Maine

Dr. Hickner’s editorial “EHRs: Something’s gotta give” (J Fam Pract. 2014;63:558) prompted me to reflect on the elements of electronic health records (EHRs) that cannot change and the ones that can.

The EHR system I use allows the EHR to serve as a 
quality recorder, and it appears 
this is the most important part,
 because the reminders of what
 needs to be documented come first and are color-coded. From a reimbursement point of view, what is important is not the narrative, but the expanded “elements” that make it a billing document. I believe this will not change.

What can change is how the note information is organized, and I think the organization should be different for specific roles. At intake, a medical assistant can review allergies, medication lists, and preventive services; update family history; and take vital signs and history of present illness (HPI). As the physician, I want the note to show the information in the order that I process it during the visit: 1) allergies/medication list, 2) concerns/complaints with brief documentation, 3) vitals, 4) physical, 5) assessment, and 6) plan.

After the note is signed off on, I want a different format for review purposes: 1) assessment/plan (because this is what I look at first for follow-up), 2) HPI/review of systems, 3) physical, 4) allergies, 5) medication list, 6) past medical history, and 7) quality reminders (if they show up at all after the visit is complete).

Is it asking too much for a programmer to make the EHR organize information in this manner?

Edward Friedler, MD
Annandale, Va


I still dictate my notes and they very much tell a story that an EHR cannot. I have been audited repeatedly and I always have all the bullet points and essentials that the insurance company wants, but this information is in a format that everyone—including patients—can read and appreciate.

The move to APSO (assessment, plan, subjective, objective) from SOAP (subjective, objective, assessment, plan) is an example of the tail wagging the dog. Rather than fix the note so the time-honored SOAP format works, we acknowledge that no one actually reads the long template notes and they want to get to the bottom line (ie, the assessment and plan).

My dream is to return to the days when we only listed the positive findings, the assumption being that a competent physician did the exam that was required and it’s unnecessary to state that the examined anatomy was normal. Unfortunately, so much of what we must do is driven by lawyers and insurance companies—not by doctors.

David M. Brill, DO
Rocky River, Ohio


I now take photos of all of the ludicrous choices our EHR tosses at me, such as “laceration of third eyelid” or “injury, crushed by falling aircraft due to terrorist.” Most of my EHR entries now say, “See scanned handwritten note for accuracy.”

The issue of EHRs needs to be kept on the front burner. It is destroying doctor/patient relationships and quality diagnostic care while hiding the important findings in the garbage.

Jay Hammett, MD
Knoxville, Tenn


I’m in a group practice of 10 family physicians and in a typical workday, each of us sees 23 to 25 patients, answers e-mails/phone calls, and reviews labs/studies, which leaves no time for anything else. There’s a constant struggle to stay on top of the quality of the notes. I have preserved the quality of my own notes by free typing. I free type a differential next to my assessment or on the first line of the plan. I don’t use templates; they slow me down too much.

Kelly Luba, DO
Phoenix, Ariz


I was a civil service physician working for the Department of the Navy in 2005 when EHRs were thrust upon me. The system was not particularly user-friendly. Free texting was highly discouraged and it was strongly preferred that we used structured text embedded in the program.

I couldn’t use the program as envisioned, so I found a work-around. I would paste the 4 sections of the SOAP note directly into the appropriate free text sections of the electronic record. My assessment included the correct diagnosis, and I would pick a general EHR diagnosis from the dropdown list. Visually, my records did not look any different from those of other health care providers who used structured text.

I used this method until my civil service retirement in 2014. All of my record peer reviews were outstanding, and I was told that my records were easy to understand. I finally let on to all that I never used structured text and that all of my records were really written the old-fashioned way. I still used a clipboard during the patient visit, and completed all records after the patient left.

 

 

David F. Scaccia, DO, MPH
Kittery, Maine

References

References

Issue
The Journal of Family Practice - 63(12)
Issue
The Journal of Family Practice - 63(12)
Page Number
696,696a
Page Number
696,696a
Publications
Publications
Topics
Article Type
Display Headline
It takes work-arounds to make EHRs “work”
Display Headline
It takes work-arounds to make EHRs “work”
Legacy Keywords
electronic health records; EHRs; Edward Friedler, MD; David M. Brill, DO; Jay Hammett, MD; Kelly Luba, DO; David F. Scaccia, DO, MPH
Legacy Keywords
electronic health records; EHRs; Edward Friedler, MD; David M. Brill, DO; Jay Hammett, MD; Kelly Luba, DO; David F. Scaccia, DO, MPH
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Bilateral hand cramping and weakness • broad fingers • coarse facial features • Dx?

Article Type
Changed
Display Headline
Bilateral hand cramping and weakness • broad fingers • coarse facial features • Dx?

THE CASE

A 37-year-old right-hand dominant woman came to our clinic seeking treatment for bilateral generalized hand cramping and weakness that she had been experiencing for approximately 2 to 3 years. She was dropping objects and had finger locking, yet had no numbness, tingling, or morning stiffness.

Ten months earlier, she had given birth to a healthy 3715 g girl. Our patient’s prenatal glucose tolerance test had been normal. Her pregnancy and delivery had been significant for oligohydramnios, failed post-term (41 weeks 4 days) induction, and emergent low transverse cesarean section due to fetal bradycardia. Since giving birth, our patient had 3 menstrual periods while breastfeeding. She had a copper intrauterine device inserted at her 6-week postpartum visit. She also had 2 truncal acrochordons removed 3 months postpartum. She had no history of neck trauma, overuse injury, or occupational exposures.

Her blood pressure and vital signs were within normal limits. Physical exam was notable for subtly coarse facial features and broad fingers (FIGURE 1).

She had normal wrist and hand joint range of motion; her wrist and hand strengths, including grip strength, were 5 out of 5. Tinel’s sign, Phalen’s maneuver, and Finkelstein’s test were negative.

Her upper extremity neurovascular exams were completely normal. Initial laboratory studies—including a comprehensive metabolic panel—were normal. The only exception was her creatine kinase, which was
265 U/L (normal, 24-195 U/L).

At a follow-up appointment 7 weeks later, we gathered a more detailed history and learned that over the past 2 to 3 years, the patient had noticed that her shoe and ring sizes had been increasing. She also mentioned some mild weight gain following her pregnancy.

Occasionally, she had generalized hand swelling, headaches, and saw floaters, but she denied losing peripheral vision. Additional lab work at this time revealed a fasting growth hormone (GH) level of 27.3 ng/mL (normal, 0.05-8 ng/mL) and an insulin-like growth factor 1 (IGF-1) level of 848 ng/mL (normal, 106-368 ng/mL). An anterior pituitary hormone panel and cortisol level were normal. A urine pregnancy test was negative.

THE DIAGNOSIS

Magnetic resonance imaging (MRI) of our patient’s brain revealed a pituitary adenoma (FIGURE 2). Based on that and the patient’s elevated GH and IGF-1 levels, we diagnosed acromegaly due to a pituitary adenoma.

DISCUSSION

Acromegaly is a rare, progressively disfiguring disease with a prevalence of 40 cases per million people.1 It affects middle-aged adults, with no gender difference.2 In most cases, the cause is a benign pituitary adenoma.1-4

Patients with acromegaly may complain
 of carpal tunnel-like symptoms, headaches, and visual disturbances. Physical changes include coarse facial features, generalized expansion of the skull, brow protrusion, ocular distension, prognathism, macroglossia, acral overgrowth, and dental malocclusion; these changes typically occur slowly over a long time period.1-5 For example, when we looked at the 3-year-old photo on our patient’s driver’s license, we noticed only subtle changes from her current appearance. Common clinical manifestations include headache, hyperpigmentation, hypertrichosis, hyperhidrosis, goiter, arthropathy, carpal tunnel syndrome, visual disturbances, and acrochordons.1,5

Acromegaly is associated with an increased risk of cardiovascular disease, metabolic disorders, infertility, sleep apnea, arthritis, thyroid tumors, colon adenomas, and carcinoma.1,2,4,5 Due to the insidious progression of acromegaly’s clinical manifestations, diagnosis is delayed for 4 to 10 years, on average.1 The diagnosis of acromegaly is typically based on an elevation of GH and IGF-1 levels.1,5 A brain MRI is essential in the diagnosis of a pituitary adenoma.1

Pregnancy among patients with acromegaly is uncommon. In fact, fewer than 150 cases have been reported in the literature.2,6 In most cases, it appears that pregnancy among patients with acromegaly is safe for mothers and newborns.6,7

The goals of treatment for acromegaly caused by a pituitary adenoma are to remove/ reduce the tumor and its mechanical effects, relieve symptoms, reduce serum GH and IGF-1, and restore pituitary function. Transsphenoidal surgical resection is the preferred treatment for pituitary adenomas.1,2,4 Radiation therapy and pharmacologic treatment may be necessary as adjuncts to surgery or for patients for whom surgery is contraindicated.1,4,5

Pharmacologic management of acromegaly includes dopamine agonists (cabergoline), somatostatin analogues (octreotide, lanreotide), and GH receptor antagonists (pegvisomant).1,3 Patients who receive effective early treatment of acromegaly have a life expectancy similar to that of the general population.1,5

Our patient

Our patient was referred to Neurosurgery and underwent transnasal transsphenoidal resection of the pituitary adenoma. Two weeks postop, her GH level had decreased to 0.66 ng/mL and her IGF-1 level was down to 386 ng/mL. Four months later, her GH (2.32 ng/mL) and IGF-1 levels (277 ng/mL) were within normal range and our patient reported improvement in all of her symptoms.

 

 

THE TAKEAWAY

Because it may take years for the classical clinical features of acromegaly such as coarse facial features, protruding jaw, and broad fingers to become apparent, diligent history taking is essential to diagnose the condition early. Patients may present with nonspecific and confusing symptoms such as muscle weakness.8 Early nonspecific symptoms and signs in the presence of normal basic laboratory tests should warrant an evaluation of fasting GH and IGF-1. Early treatment with surgery, radiation therapy, or pharmacotherapy may prevent or decrease the intensity of rheumatologic, cardiovascular, respiratory, and metabolic complications of acromegaly.1

References

1.  Scacchi M, Cavagnini F. Acromegaly. Pituitary. 2006;9: 297-303.

2.  Hossain B, Drake WM. Acromegaly. Medicine. 2009;37: 407-410.

3.  Chan MR, Ziebert M, Maas DL, et al. “My rings won’t fit anymore”. Ectopic growth hormone-secreting tumor. Am Fam Physician. 2005;71:1766-1767.

4. Lake MG, Krook LS, Cruz SV. Pituitary adenomas: an overview. Am Fam Physician. 2013;88:319-327.

5. Vilar L, Valenzuela A, Ribeiro-Oliveira A Jr, et al. Multiple facets in the control of acromegaly. Pituitary. 2014;17 suppl 1:S11-S17.

6. Cheng V, Faiman C, Kennedy L, et al. Pregnancy and acromegaly: a review. Pituitary. 2012;15:59-63.

7. Caron P, Broussaud S, Bertherat J, et al. Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab. 2010;95:4680-4687.

8. Saguil A. Evaluation of the patient with muscle weakness. Am Fam Physician. 2005;71:1327-1336.

Article PDF
Author and Disclosure Information

Morteza Khodaee, MD, MPH
Stephanie Gold, MD; Linda C. Montgomery, MD

Department of Family Medicine, University of Colorado School of Medicine, Aurora

morteza.khodaee@ucdenver.edu

The authors reported no potential conflict of interest relevant to this article.

Issue
The Journal of Family Practice - 63(12)
Publications
Topics
Page Number
E9-E11
Legacy Keywords
hand cramping; broad fingers; acromegaly; pituitary adenoma; Morteza Khodaee, MD, MPH; Stephanie Gold, MD; Linda C. Montgomery, MD
Sections
Author and Disclosure Information

Morteza Khodaee, MD, MPH
Stephanie Gold, MD; Linda C. Montgomery, MD

Department of Family Medicine, University of Colorado School of Medicine, Aurora

morteza.khodaee@ucdenver.edu

The authors reported no potential conflict of interest relevant to this article.

Author and Disclosure Information

Morteza Khodaee, MD, MPH
Stephanie Gold, MD; Linda C. Montgomery, MD

Department of Family Medicine, University of Colorado School of Medicine, Aurora

morteza.khodaee@ucdenver.edu

The authors reported no potential conflict of interest relevant to this article.

Article PDF
Article PDF

THE CASE

A 37-year-old right-hand dominant woman came to our clinic seeking treatment for bilateral generalized hand cramping and weakness that she had been experiencing for approximately 2 to 3 years. She was dropping objects and had finger locking, yet had no numbness, tingling, or morning stiffness.

Ten months earlier, she had given birth to a healthy 3715 g girl. Our patient’s prenatal glucose tolerance test had been normal. Her pregnancy and delivery had been significant for oligohydramnios, failed post-term (41 weeks 4 days) induction, and emergent low transverse cesarean section due to fetal bradycardia. Since giving birth, our patient had 3 menstrual periods while breastfeeding. She had a copper intrauterine device inserted at her 6-week postpartum visit. She also had 2 truncal acrochordons removed 3 months postpartum. She had no history of neck trauma, overuse injury, or occupational exposures.

Her blood pressure and vital signs were within normal limits. Physical exam was notable for subtly coarse facial features and broad fingers (FIGURE 1).

She had normal wrist and hand joint range of motion; her wrist and hand strengths, including grip strength, were 5 out of 5. Tinel’s sign, Phalen’s maneuver, and Finkelstein’s test were negative.

Her upper extremity neurovascular exams were completely normal. Initial laboratory studies—including a comprehensive metabolic panel—were normal. The only exception was her creatine kinase, which was
265 U/L (normal, 24-195 U/L).

At a follow-up appointment 7 weeks later, we gathered a more detailed history and learned that over the past 2 to 3 years, the patient had noticed that her shoe and ring sizes had been increasing. She also mentioned some mild weight gain following her pregnancy.

Occasionally, she had generalized hand swelling, headaches, and saw floaters, but she denied losing peripheral vision. Additional lab work at this time revealed a fasting growth hormone (GH) level of 27.3 ng/mL (normal, 0.05-8 ng/mL) and an insulin-like growth factor 1 (IGF-1) level of 848 ng/mL (normal, 106-368 ng/mL). An anterior pituitary hormone panel and cortisol level were normal. A urine pregnancy test was negative.

THE DIAGNOSIS

Magnetic resonance imaging (MRI) of our patient’s brain revealed a pituitary adenoma (FIGURE 2). Based on that and the patient’s elevated GH and IGF-1 levels, we diagnosed acromegaly due to a pituitary adenoma.

DISCUSSION

Acromegaly is a rare, progressively disfiguring disease with a prevalence of 40 cases per million people.1 It affects middle-aged adults, with no gender difference.2 In most cases, the cause is a benign pituitary adenoma.1-4

Patients with acromegaly may complain
 of carpal tunnel-like symptoms, headaches, and visual disturbances. Physical changes include coarse facial features, generalized expansion of the skull, brow protrusion, ocular distension, prognathism, macroglossia, acral overgrowth, and dental malocclusion; these changes typically occur slowly over a long time period.1-5 For example, when we looked at the 3-year-old photo on our patient’s driver’s license, we noticed only subtle changes from her current appearance. Common clinical manifestations include headache, hyperpigmentation, hypertrichosis, hyperhidrosis, goiter, arthropathy, carpal tunnel syndrome, visual disturbances, and acrochordons.1,5

Acromegaly is associated with an increased risk of cardiovascular disease, metabolic disorders, infertility, sleep apnea, arthritis, thyroid tumors, colon adenomas, and carcinoma.1,2,4,5 Due to the insidious progression of acromegaly’s clinical manifestations, diagnosis is delayed for 4 to 10 years, on average.1 The diagnosis of acromegaly is typically based on an elevation of GH and IGF-1 levels.1,5 A brain MRI is essential in the diagnosis of a pituitary adenoma.1

Pregnancy among patients with acromegaly is uncommon. In fact, fewer than 150 cases have been reported in the literature.2,6 In most cases, it appears that pregnancy among patients with acromegaly is safe for mothers and newborns.6,7

The goals of treatment for acromegaly caused by a pituitary adenoma are to remove/ reduce the tumor and its mechanical effects, relieve symptoms, reduce serum GH and IGF-1, and restore pituitary function. Transsphenoidal surgical resection is the preferred treatment for pituitary adenomas.1,2,4 Radiation therapy and pharmacologic treatment may be necessary as adjuncts to surgery or for patients for whom surgery is contraindicated.1,4,5

Pharmacologic management of acromegaly includes dopamine agonists (cabergoline), somatostatin analogues (octreotide, lanreotide), and GH receptor antagonists (pegvisomant).1,3 Patients who receive effective early treatment of acromegaly have a life expectancy similar to that of the general population.1,5

Our patient

Our patient was referred to Neurosurgery and underwent transnasal transsphenoidal resection of the pituitary adenoma. Two weeks postop, her GH level had decreased to 0.66 ng/mL and her IGF-1 level was down to 386 ng/mL. Four months later, her GH (2.32 ng/mL) and IGF-1 levels (277 ng/mL) were within normal range and our patient reported improvement in all of her symptoms.

 

 

THE TAKEAWAY

Because it may take years for the classical clinical features of acromegaly such as coarse facial features, protruding jaw, and broad fingers to become apparent, diligent history taking is essential to diagnose the condition early. Patients may present with nonspecific and confusing symptoms such as muscle weakness.8 Early nonspecific symptoms and signs in the presence of normal basic laboratory tests should warrant an evaluation of fasting GH and IGF-1. Early treatment with surgery, radiation therapy, or pharmacotherapy may prevent or decrease the intensity of rheumatologic, cardiovascular, respiratory, and metabolic complications of acromegaly.1

THE CASE

A 37-year-old right-hand dominant woman came to our clinic seeking treatment for bilateral generalized hand cramping and weakness that she had been experiencing for approximately 2 to 3 years. She was dropping objects and had finger locking, yet had no numbness, tingling, or morning stiffness.

Ten months earlier, she had given birth to a healthy 3715 g girl. Our patient’s prenatal glucose tolerance test had been normal. Her pregnancy and delivery had been significant for oligohydramnios, failed post-term (41 weeks 4 days) induction, and emergent low transverse cesarean section due to fetal bradycardia. Since giving birth, our patient had 3 menstrual periods while breastfeeding. She had a copper intrauterine device inserted at her 6-week postpartum visit. She also had 2 truncal acrochordons removed 3 months postpartum. She had no history of neck trauma, overuse injury, or occupational exposures.

Her blood pressure and vital signs were within normal limits. Physical exam was notable for subtly coarse facial features and broad fingers (FIGURE 1).

She had normal wrist and hand joint range of motion; her wrist and hand strengths, including grip strength, were 5 out of 5. Tinel’s sign, Phalen’s maneuver, and Finkelstein’s test were negative.

Her upper extremity neurovascular exams were completely normal. Initial laboratory studies—including a comprehensive metabolic panel—were normal. The only exception was her creatine kinase, which was
265 U/L (normal, 24-195 U/L).

At a follow-up appointment 7 weeks later, we gathered a more detailed history and learned that over the past 2 to 3 years, the patient had noticed that her shoe and ring sizes had been increasing. She also mentioned some mild weight gain following her pregnancy.

Occasionally, she had generalized hand swelling, headaches, and saw floaters, but she denied losing peripheral vision. Additional lab work at this time revealed a fasting growth hormone (GH) level of 27.3 ng/mL (normal, 0.05-8 ng/mL) and an insulin-like growth factor 1 (IGF-1) level of 848 ng/mL (normal, 106-368 ng/mL). An anterior pituitary hormone panel and cortisol level were normal. A urine pregnancy test was negative.

THE DIAGNOSIS

Magnetic resonance imaging (MRI) of our patient’s brain revealed a pituitary adenoma (FIGURE 2). Based on that and the patient’s elevated GH and IGF-1 levels, we diagnosed acromegaly due to a pituitary adenoma.

DISCUSSION

Acromegaly is a rare, progressively disfiguring disease with a prevalence of 40 cases per million people.1 It affects middle-aged adults, with no gender difference.2 In most cases, the cause is a benign pituitary adenoma.1-4

Patients with acromegaly may complain
 of carpal tunnel-like symptoms, headaches, and visual disturbances. Physical changes include coarse facial features, generalized expansion of the skull, brow protrusion, ocular distension, prognathism, macroglossia, acral overgrowth, and dental malocclusion; these changes typically occur slowly over a long time period.1-5 For example, when we looked at the 3-year-old photo on our patient’s driver’s license, we noticed only subtle changes from her current appearance. Common clinical manifestations include headache, hyperpigmentation, hypertrichosis, hyperhidrosis, goiter, arthropathy, carpal tunnel syndrome, visual disturbances, and acrochordons.1,5

Acromegaly is associated with an increased risk of cardiovascular disease, metabolic disorders, infertility, sleep apnea, arthritis, thyroid tumors, colon adenomas, and carcinoma.1,2,4,5 Due to the insidious progression of acromegaly’s clinical manifestations, diagnosis is delayed for 4 to 10 years, on average.1 The diagnosis of acromegaly is typically based on an elevation of GH and IGF-1 levels.1,5 A brain MRI is essential in the diagnosis of a pituitary adenoma.1

Pregnancy among patients with acromegaly is uncommon. In fact, fewer than 150 cases have been reported in the literature.2,6 In most cases, it appears that pregnancy among patients with acromegaly is safe for mothers and newborns.6,7

The goals of treatment for acromegaly caused by a pituitary adenoma are to remove/ reduce the tumor and its mechanical effects, relieve symptoms, reduce serum GH and IGF-1, and restore pituitary function. Transsphenoidal surgical resection is the preferred treatment for pituitary adenomas.1,2,4 Radiation therapy and pharmacologic treatment may be necessary as adjuncts to surgery or for patients for whom surgery is contraindicated.1,4,5

Pharmacologic management of acromegaly includes dopamine agonists (cabergoline), somatostatin analogues (octreotide, lanreotide), and GH receptor antagonists (pegvisomant).1,3 Patients who receive effective early treatment of acromegaly have a life expectancy similar to that of the general population.1,5

Our patient

Our patient was referred to Neurosurgery and underwent transnasal transsphenoidal resection of the pituitary adenoma. Two weeks postop, her GH level had decreased to 0.66 ng/mL and her IGF-1 level was down to 386 ng/mL. Four months later, her GH (2.32 ng/mL) and IGF-1 levels (277 ng/mL) were within normal range and our patient reported improvement in all of her symptoms.

 

 

THE TAKEAWAY

Because it may take years for the classical clinical features of acromegaly such as coarse facial features, protruding jaw, and broad fingers to become apparent, diligent history taking is essential to diagnose the condition early. Patients may present with nonspecific and confusing symptoms such as muscle weakness.8 Early nonspecific symptoms and signs in the presence of normal basic laboratory tests should warrant an evaluation of fasting GH and IGF-1. Early treatment with surgery, radiation therapy, or pharmacotherapy may prevent or decrease the intensity of rheumatologic, cardiovascular, respiratory, and metabolic complications of acromegaly.1

References

1.  Scacchi M, Cavagnini F. Acromegaly. Pituitary. 2006;9: 297-303.

2.  Hossain B, Drake WM. Acromegaly. Medicine. 2009;37: 407-410.

3.  Chan MR, Ziebert M, Maas DL, et al. “My rings won’t fit anymore”. Ectopic growth hormone-secreting tumor. Am Fam Physician. 2005;71:1766-1767.

4. Lake MG, Krook LS, Cruz SV. Pituitary adenomas: an overview. Am Fam Physician. 2013;88:319-327.

5. Vilar L, Valenzuela A, Ribeiro-Oliveira A Jr, et al. Multiple facets in the control of acromegaly. Pituitary. 2014;17 suppl 1:S11-S17.

6. Cheng V, Faiman C, Kennedy L, et al. Pregnancy and acromegaly: a review. Pituitary. 2012;15:59-63.

7. Caron P, Broussaud S, Bertherat J, et al. Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab. 2010;95:4680-4687.

8. Saguil A. Evaluation of the patient with muscle weakness. Am Fam Physician. 2005;71:1327-1336.

References

1.  Scacchi M, Cavagnini F. Acromegaly. Pituitary. 2006;9: 297-303.

2.  Hossain B, Drake WM. Acromegaly. Medicine. 2009;37: 407-410.

3.  Chan MR, Ziebert M, Maas DL, et al. “My rings won’t fit anymore”. Ectopic growth hormone-secreting tumor. Am Fam Physician. 2005;71:1766-1767.

4. Lake MG, Krook LS, Cruz SV. Pituitary adenomas: an overview. Am Fam Physician. 2013;88:319-327.

5. Vilar L, Valenzuela A, Ribeiro-Oliveira A Jr, et al. Multiple facets in the control of acromegaly. Pituitary. 2014;17 suppl 1:S11-S17.

6. Cheng V, Faiman C, Kennedy L, et al. Pregnancy and acromegaly: a review. Pituitary. 2012;15:59-63.

7. Caron P, Broussaud S, Bertherat J, et al. Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab. 2010;95:4680-4687.

8. Saguil A. Evaluation of the patient with muscle weakness. Am Fam Physician. 2005;71:1327-1336.

Issue
The Journal of Family Practice - 63(12)
Issue
The Journal of Family Practice - 63(12)
Page Number
E9-E11
Page Number
E9-E11
Publications
Publications
Topics
Article Type
Display Headline
Bilateral hand cramping and weakness • broad fingers • coarse facial features • Dx?
Display Headline
Bilateral hand cramping and weakness • broad fingers • coarse facial features • Dx?
Legacy Keywords
hand cramping; broad fingers; acromegaly; pituitary adenoma; Morteza Khodaee, MD, MPH; Stephanie Gold, MD; Linda C. Montgomery, MD
Legacy Keywords
hand cramping; broad fingers; acromegaly; pituitary adenoma; Morteza Khodaee, MD, MPH; Stephanie Gold, MD; Linda C. Montgomery, MD
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Prescribing statins for patients with ACS? No need to wait

Article Type
Changed
Display Headline
Prescribing statins for patients with ACS? No need to wait
PRACTICE CHANGER

Prescribe a high-dose statin before any patient with acute coronary syndrome (ACS) undergoes percutaneous coronary intervention (PCI); it may be reasonable to extend this to patients being evaluated for ACS.1

Strength of recommendation

A: Based on a meta-analysis

Navarese EP, Kowalewski M, Andreotti F, et al. Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Am J Cardiol. 2014;113:1753-1764.

 

Illustrative case

A 48-year-old man comes to the emergency department with chest pain and is diagnosed with ACS. He is scheduled to have PCI within the next 24 hours. When should you start him on a statin?

Statins are the mainstay pharmaceutical treatment for hyperlipidemia, and are used for primary and secondary prevention of coronary artery disease and stroke.2,3 Well-known for their cholesterol-lowering effect, they also have benefits that are independent of their effects on lipids, including improving endothelial function, decreasing oxidative stress, and decreasing vascular inflammation.4-6

Compared to patients with stable angina, patients with ACS experience markedly higher rates of coronary events, especially immediately before and after PCI and during the subsequent 30 days.1 American College of Cardiology/American Heart Association (ACC/AHA) guidelines for the management of non-ST elevation myocardial infarction (NSTEMI) advocate starting statins before patients are discharged from the hospital, but they don’t specify precisely when.7

Considering the higher risk of coronary events before and after PCI and statins’ pleiotropic effects, it is reasonable to investigate the optimal time for starting statins in patients with ACS.

STUDY SUMMARY: Meta-analysis of 20 RCTs shows
 statins before PCI cuts risk of MI

Navarese et al1 performed a systematic review and meta-analysis of studies comparing the clinical outcomes of patients with ACS who received statins before or after PCI (statins group) vs those who received low-dose statins or no statins (control group). The authors searched PubMed, Cochrane, Google Scholar, and CINAHL databases as well as key conference proceedings for studies published before November 2013. Using reasonable inclusion and exclusion criteria and appropriate statistical methods, they analyzed the results of 20 randomized controlled trials that included 8750 patients. Four studies enrolled only patients with ST elevation MI, 8 were restricted to NSTEMI, and the remaining 8 studies enrolled patients with any type of MI or unstable angina.

For patients who were started on a statin before PCI, the mean timing of administration was 0.53 ± 0.42 days before. For those started after PCI, the average time to administration was 3.18 ± 3.56 days after.

Administering statins before PCI resulted
 in a greater reduction in the odds of MI than starting them afterward. Whether administered before or after PCI, statins reduced the incidence of MIs. The overall 30-day incidence of MIs was 3.4% (123 of 3621) in the statins group and 5% (179 of 3577) in the control group. This resulted in an absolute risk reduction of 1.6% (number needed to treat=62.5), and a reduction of the odds of MI by 33% (odds ratio [OR]=0.67; 95% confidence interval [CI], 0.53-0.84; P=.0007). There was also a trend toward reduced mortality in the statin group (OR=0.66; 95% CI, 0.43-1.02; P=.06).

In addition, administering statins before PCI resulted in a greater reduction in the odds of MI at 30 days (OR=0.38; 95% CI, 0.24-0.59; P<.0001) than starting them post-PCI (OR=0.85; 95% CI, 0.64-1.13; P=.28) when compared to the controls. The difference between the pre-PCI OR and the post-PCI OR was statistically significant (P=.002). These findings persisted past 30 days (P=.06).

 

 

 

WHAT'S NEW: Early statin administration 
is most effective

According to ACC/AHA guidelines, all patients with ACS should be receiving a statin by the time they are discharged. However, when to start the statin is not specified. This meta-analysis is the first report to show that administering a statin before PCI can significantly reduce the risk of subsequent MI.

CAVEATS: Benefits might vary
 with different statins


The studies evaluated in this meta-analysis used various statins and dosing regimens, which could have affected the results. However, sensitivity analyses found similar benefits across different types of statins. In addition, most of the included trials used high doses of statins, which minimized the potential discrepancy in outcomes from various dosing regimens. And while the included studies were not perfect, Navarese et al1 used reasonable methods to identify potential biases.

CHALLENGES TO IMPLEMENTATION: No barriers 
to starting statins earlier


Implementing this intervention may be as simple as editing a standard order. This meta-analysis also suggests that the earlier the intervention, the greater the benefit, which may be an argument for starting a statin when a patient first presents for evaluation for ACS, since the risks of taking a statin are quite low. We believe it would be beneficial if the next update of the ACC/AHA guidelines7 included this recommendation.

ACKNOWLEDGEMENT
The PURLs Surveillance System was supported in part by Grant Number UL1RR024999 from the National Center For Research Resources, a Clinical Translational Science Award to the University of Chicago. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources or the National Institutes of Health.

Files
References

1. Navarese EP, Kowalewski M, Andreotti F, et al. Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Am J Cardiol. 2014;113:1753-1764.

2. Pignone M, Phillips C, Mulrow C. Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials. BMJ. 2000;321:983-986.

3. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med. 1998;339:1349-1357.

4. Liao JK. Beyond lipid lowering: the role of statins in vascular protection. Int J Cardiol. 2002;86:5-18.

5. Li J, Li JJ, He JG, et al. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway. Cardiovasc Ther. 2010;28:8-14.

6. Tandon V, Bano G, Khajuria V, et al. Pleiotropic effects of statins. Indian J Pharmacol. 2005;37:77-85.

7. Wright RS, Anderson JL, Adams CD, et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;57:e215-e367.

Article PDF
Author and Disclosure Information

Hanna Gov-Ari, MD
James J. Stevermer, MD, MSPH


Department of Family 
and Community Medicine, University of Missouri-Columbia

PURLs EDITOR
Bernard Ewigman, MD, MSPH
Department of Family Medicine, The University of Chicago

Issue
The Journal of Family Practice - 63(12)
Publications
Topics
Page Number
735,738
Legacy Keywords
statins; ACS; acute coronary syndrome; percutaneous coronary intervention; PCI; non-ST elevation myocardial infarction; NSTEMI; MI; myocardial infarction; Hanna Gov-Ari, MD; James J. Stevermer, MD, MSPH
Sections
Files
Files
Author and Disclosure Information

Hanna Gov-Ari, MD
James J. Stevermer, MD, MSPH


Department of Family 
and Community Medicine, University of Missouri-Columbia

PURLs EDITOR
Bernard Ewigman, MD, MSPH
Department of Family Medicine, The University of Chicago

Author and Disclosure Information

Hanna Gov-Ari, MD
James J. Stevermer, MD, MSPH


Department of Family 
and Community Medicine, University of Missouri-Columbia

PURLs EDITOR
Bernard Ewigman, MD, MSPH
Department of Family Medicine, The University of Chicago

Article PDF
Article PDF
Related Articles
PRACTICE CHANGER

Prescribe a high-dose statin before any patient with acute coronary syndrome (ACS) undergoes percutaneous coronary intervention (PCI); it may be reasonable to extend this to patients being evaluated for ACS.1

Strength of recommendation

A: Based on a meta-analysis

Navarese EP, Kowalewski M, Andreotti F, et al. Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Am J Cardiol. 2014;113:1753-1764.

 

Illustrative case

A 48-year-old man comes to the emergency department with chest pain and is diagnosed with ACS. He is scheduled to have PCI within the next 24 hours. When should you start him on a statin?

Statins are the mainstay pharmaceutical treatment for hyperlipidemia, and are used for primary and secondary prevention of coronary artery disease and stroke.2,3 Well-known for their cholesterol-lowering effect, they also have benefits that are independent of their effects on lipids, including improving endothelial function, decreasing oxidative stress, and decreasing vascular inflammation.4-6

Compared to patients with stable angina, patients with ACS experience markedly higher rates of coronary events, especially immediately before and after PCI and during the subsequent 30 days.1 American College of Cardiology/American Heart Association (ACC/AHA) guidelines for the management of non-ST elevation myocardial infarction (NSTEMI) advocate starting statins before patients are discharged from the hospital, but they don’t specify precisely when.7

Considering the higher risk of coronary events before and after PCI and statins’ pleiotropic effects, it is reasonable to investigate the optimal time for starting statins in patients with ACS.

STUDY SUMMARY: Meta-analysis of 20 RCTs shows
 statins before PCI cuts risk of MI

Navarese et al1 performed a systematic review and meta-analysis of studies comparing the clinical outcomes of patients with ACS who received statins before or after PCI (statins group) vs those who received low-dose statins or no statins (control group). The authors searched PubMed, Cochrane, Google Scholar, and CINAHL databases as well as key conference proceedings for studies published before November 2013. Using reasonable inclusion and exclusion criteria and appropriate statistical methods, they analyzed the results of 20 randomized controlled trials that included 8750 patients. Four studies enrolled only patients with ST elevation MI, 8 were restricted to NSTEMI, and the remaining 8 studies enrolled patients with any type of MI or unstable angina.

For patients who were started on a statin before PCI, the mean timing of administration was 0.53 ± 0.42 days before. For those started after PCI, the average time to administration was 3.18 ± 3.56 days after.

Administering statins before PCI resulted
 in a greater reduction in the odds of MI than starting them afterward. Whether administered before or after PCI, statins reduced the incidence of MIs. The overall 30-day incidence of MIs was 3.4% (123 of 3621) in the statins group and 5% (179 of 3577) in the control group. This resulted in an absolute risk reduction of 1.6% (number needed to treat=62.5), and a reduction of the odds of MI by 33% (odds ratio [OR]=0.67; 95% confidence interval [CI], 0.53-0.84; P=.0007). There was also a trend toward reduced mortality in the statin group (OR=0.66; 95% CI, 0.43-1.02; P=.06).

In addition, administering statins before PCI resulted in a greater reduction in the odds of MI at 30 days (OR=0.38; 95% CI, 0.24-0.59; P<.0001) than starting them post-PCI (OR=0.85; 95% CI, 0.64-1.13; P=.28) when compared to the controls. The difference between the pre-PCI OR and the post-PCI OR was statistically significant (P=.002). These findings persisted past 30 days (P=.06).

 

 

 

WHAT'S NEW: Early statin administration 
is most effective

According to ACC/AHA guidelines, all patients with ACS should be receiving a statin by the time they are discharged. However, when to start the statin is not specified. This meta-analysis is the first report to show that administering a statin before PCI can significantly reduce the risk of subsequent MI.

CAVEATS: Benefits might vary
 with different statins


The studies evaluated in this meta-analysis used various statins and dosing regimens, which could have affected the results. However, sensitivity analyses found similar benefits across different types of statins. In addition, most of the included trials used high doses of statins, which minimized the potential discrepancy in outcomes from various dosing regimens. And while the included studies were not perfect, Navarese et al1 used reasonable methods to identify potential biases.

CHALLENGES TO IMPLEMENTATION: No barriers 
to starting statins earlier


Implementing this intervention may be as simple as editing a standard order. This meta-analysis also suggests that the earlier the intervention, the greater the benefit, which may be an argument for starting a statin when a patient first presents for evaluation for ACS, since the risks of taking a statin are quite low. We believe it would be beneficial if the next update of the ACC/AHA guidelines7 included this recommendation.

ACKNOWLEDGEMENT
The PURLs Surveillance System was supported in part by Grant Number UL1RR024999 from the National Center For Research Resources, a Clinical Translational Science Award to the University of Chicago. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources or the National Institutes of Health.

PRACTICE CHANGER

Prescribe a high-dose statin before any patient with acute coronary syndrome (ACS) undergoes percutaneous coronary intervention (PCI); it may be reasonable to extend this to patients being evaluated for ACS.1

Strength of recommendation

A: Based on a meta-analysis

Navarese EP, Kowalewski M, Andreotti F, et al. Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Am J Cardiol. 2014;113:1753-1764.

 

Illustrative case

A 48-year-old man comes to the emergency department with chest pain and is diagnosed with ACS. He is scheduled to have PCI within the next 24 hours. When should you start him on a statin?

Statins are the mainstay pharmaceutical treatment for hyperlipidemia, and are used for primary and secondary prevention of coronary artery disease and stroke.2,3 Well-known for their cholesterol-lowering effect, they also have benefits that are independent of their effects on lipids, including improving endothelial function, decreasing oxidative stress, and decreasing vascular inflammation.4-6

Compared to patients with stable angina, patients with ACS experience markedly higher rates of coronary events, especially immediately before and after PCI and during the subsequent 30 days.1 American College of Cardiology/American Heart Association (ACC/AHA) guidelines for the management of non-ST elevation myocardial infarction (NSTEMI) advocate starting statins before patients are discharged from the hospital, but they don’t specify precisely when.7

Considering the higher risk of coronary events before and after PCI and statins’ pleiotropic effects, it is reasonable to investigate the optimal time for starting statins in patients with ACS.

STUDY SUMMARY: Meta-analysis of 20 RCTs shows
 statins before PCI cuts risk of MI

Navarese et al1 performed a systematic review and meta-analysis of studies comparing the clinical outcomes of patients with ACS who received statins before or after PCI (statins group) vs those who received low-dose statins or no statins (control group). The authors searched PubMed, Cochrane, Google Scholar, and CINAHL databases as well as key conference proceedings for studies published before November 2013. Using reasonable inclusion and exclusion criteria and appropriate statistical methods, they analyzed the results of 20 randomized controlled trials that included 8750 patients. Four studies enrolled only patients with ST elevation MI, 8 were restricted to NSTEMI, and the remaining 8 studies enrolled patients with any type of MI or unstable angina.

For patients who were started on a statin before PCI, the mean timing of administration was 0.53 ± 0.42 days before. For those started after PCI, the average time to administration was 3.18 ± 3.56 days after.

Administering statins before PCI resulted
 in a greater reduction in the odds of MI than starting them afterward. Whether administered before or after PCI, statins reduced the incidence of MIs. The overall 30-day incidence of MIs was 3.4% (123 of 3621) in the statins group and 5% (179 of 3577) in the control group. This resulted in an absolute risk reduction of 1.6% (number needed to treat=62.5), and a reduction of the odds of MI by 33% (odds ratio [OR]=0.67; 95% confidence interval [CI], 0.53-0.84; P=.0007). There was also a trend toward reduced mortality in the statin group (OR=0.66; 95% CI, 0.43-1.02; P=.06).

In addition, administering statins before PCI resulted in a greater reduction in the odds of MI at 30 days (OR=0.38; 95% CI, 0.24-0.59; P<.0001) than starting them post-PCI (OR=0.85; 95% CI, 0.64-1.13; P=.28) when compared to the controls. The difference between the pre-PCI OR and the post-PCI OR was statistically significant (P=.002). These findings persisted past 30 days (P=.06).

 

 

 

WHAT'S NEW: Early statin administration 
is most effective

According to ACC/AHA guidelines, all patients with ACS should be receiving a statin by the time they are discharged. However, when to start the statin is not specified. This meta-analysis is the first report to show that administering a statin before PCI can significantly reduce the risk of subsequent MI.

CAVEATS: Benefits might vary
 with different statins


The studies evaluated in this meta-analysis used various statins and dosing regimens, which could have affected the results. However, sensitivity analyses found similar benefits across different types of statins. In addition, most of the included trials used high doses of statins, which minimized the potential discrepancy in outcomes from various dosing regimens. And while the included studies were not perfect, Navarese et al1 used reasonable methods to identify potential biases.

CHALLENGES TO IMPLEMENTATION: No barriers 
to starting statins earlier


Implementing this intervention may be as simple as editing a standard order. This meta-analysis also suggests that the earlier the intervention, the greater the benefit, which may be an argument for starting a statin when a patient first presents for evaluation for ACS, since the risks of taking a statin are quite low. We believe it would be beneficial if the next update of the ACC/AHA guidelines7 included this recommendation.

ACKNOWLEDGEMENT
The PURLs Surveillance System was supported in part by Grant Number UL1RR024999 from the National Center For Research Resources, a Clinical Translational Science Award to the University of Chicago. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources or the National Institutes of Health.

References

1. Navarese EP, Kowalewski M, Andreotti F, et al. Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Am J Cardiol. 2014;113:1753-1764.

2. Pignone M, Phillips C, Mulrow C. Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials. BMJ. 2000;321:983-986.

3. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med. 1998;339:1349-1357.

4. Liao JK. Beyond lipid lowering: the role of statins in vascular protection. Int J Cardiol. 2002;86:5-18.

5. Li J, Li JJ, He JG, et al. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway. Cardiovasc Ther. 2010;28:8-14.

6. Tandon V, Bano G, Khajuria V, et al. Pleiotropic effects of statins. Indian J Pharmacol. 2005;37:77-85.

7. Wright RS, Anderson JL, Adams CD, et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;57:e215-e367.

References

1. Navarese EP, Kowalewski M, Andreotti F, et al. Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Am J Cardiol. 2014;113:1753-1764.

2. Pignone M, Phillips C, Mulrow C. Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials. BMJ. 2000;321:983-986.

3. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med. 1998;339:1349-1357.

4. Liao JK. Beyond lipid lowering: the role of statins in vascular protection. Int J Cardiol. 2002;86:5-18.

5. Li J, Li JJ, He JG, et al. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway. Cardiovasc Ther. 2010;28:8-14.

6. Tandon V, Bano G, Khajuria V, et al. Pleiotropic effects of statins. Indian J Pharmacol. 2005;37:77-85.

7. Wright RS, Anderson JL, Adams CD, et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;57:e215-e367.

Issue
The Journal of Family Practice - 63(12)
Issue
The Journal of Family Practice - 63(12)
Page Number
735,738
Page Number
735,738
Publications
Publications
Topics
Article Type
Display Headline
Prescribing statins for patients with ACS? No need to wait
Display Headline
Prescribing statins for patients with ACS? No need to wait
Legacy Keywords
statins; ACS; acute coronary syndrome; percutaneous coronary intervention; PCI; non-ST elevation myocardial infarction; NSTEMI; MI; myocardial infarction; Hanna Gov-Ari, MD; James J. Stevermer, MD, MSPH
Legacy Keywords
statins; ACS; acute coronary syndrome; percutaneous coronary intervention; PCI; non-ST elevation myocardial infarction; NSTEMI; MI; myocardial infarction; Hanna Gov-Ari, MD; James J. Stevermer, MD, MSPH
Sections
PURLs Copyright

Copyright © 2014 Family Physicians Inquiries Network. All rights reserved.

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Article PDF Media
Media Files

Pneumococcal vaccines for older adults: Getting the timing right

Article Type
Changed
Display Headline
Pneumococcal vaccines for older adults: Getting the timing right

In August 2014, the Advisory Committee on Immunization Practices (ACIP) decided to add the 13-valent pneumococcal conjugate vaccine (PCV13) to the routine immunization schedule for adults ages 65 years and older; previously, it had recommended that these patients receive only the 23-valent pneumococcal polysaccharide vaccine (PPSV23).1 The US Food and Drug Administration (FDA) had approved PCV13 for use in adults ages 50 years and older in late 2011. The delay between FDA approval and this new ACIP recommendation occurred for 2 reasons: The epidemiology of pneumococcal disease (pneumonia, meningitis, and bacteremia) in older adults is evolving due to the widespread use of PCV13 in children, and a large clinical trial looking at the efficacy of this vaccine in individuals 65 and older was still underway.

Pneumococcal disease 
in older adults remains a problem

Routine use of the 7-valent pneumococcal conjugate vaccine (PCV7) in children began in 2000. In 2010, the vaccine was expanded to include 6 more antigens (PCV13). The routine use of this vaccine has markedly reduced pneumococcal disease in children and, by way of indirect protection, in adults. Between 2010 and 2013, the incidence of invasive pneumococcal disease (eg, meningitis and bacteremia) caused by the 13 serotypes in the vaccine had decreased by 50% in adults ages 65 years and older.1 However, in this age group, there are still more than 13,000 cases of invasive pneumococcal disease each year.1 Approximately 20% of these cases—and 10% of cases community-acquired pneumonia (CAP) in this age group—are still caused by one of the PCV13 serotypes. This epidemiology left ACIP to consider whether to recommend PCV13 for older adults even though the incidence of pneumococcal disease was declining without the use of the vaccine. ACIP took a middle-of-the-road position on August 13, 2014 by recommending the vaccine now but agreeing to reexamine the issue again in 2018.1

PCV13 substantially cuts the rate of pneumococcal disease

In June 2014, ACIP reviewed the results of a large randomized, placebo-controlled clinical trial of PCV13 in 85,000 adults ages 65 years and older that was conducted in the Netherlands from 2008 to 2013.1 PCV13 reduced the rate of disease caused by the vaccine serotypes by 45.6% for pneumonia and 75% for invasive pneumococcal disease.

Because the population in this study was PPSV23-naïve, the added advantage of PCV13 in patients who have been vaccinated with PPSV23 has not been determined. Twelve of the 13 serotypes in PCV13 are in PPSV23. And while PPSV23 can protect against invasive pneumococcal disease, its effectiveness against CAP is less well proven.

Using modeling that took into consideration anticipated rates of vaccination with both PCV13 and PPSV23 in adults and children, the Centers for Disease Control and Prevention estimated that adding PCV13 to the adult immunization schedule would prevent 230 cases of invasive pneumococcal disease and 12,000 cases of CAP over the lifetime of a cohort of 65 year olds.1 With time, however, and the increasing indirect protection from routine use of PCV13 in children, these numbers would decline.

Timing of administration depends on patients’ vaccine history


Adults 65 years of age and older should receive both PCV13 and PPSV23, but not at the same time. In those who have not received any pneumococcal vaccine, the preferred sequence is to first administer PCV13 and then PPSV23 6 to 12 months later (FIGURE); the minimum acceptable interval between PCV13 and PPSV23 is 8 weeks.1 If PPSV23 is administered first, PCV13 should not be given until at least 12 months after the PPSV23 dose. This is because the immune response to PCV13 is not as robust when PCV13 follows PPSV23.

For patients who have been vaccinated with PPSV23 before age 65, PCV13 should be administered at least 12 months after PPSV23, followed by another dose of PPSV23 that should be administered 6 to 12 months after PCV13, but no sooner than 5 years since the previous PPSV23 (FIGURE).

Coadministration of PCV13 with trivalent influenza vaccine results in a slight decrease in the immune response to each vaccine;1 this is unlikely to be clinically important. Coadministration with other vaccines has not been studied.

Who’ll reimburse for the PCV13 vaccine? One issue that could delay the use of both vaccines in older adults is that currently, Medicare pays for only one pneumococcal vaccine in patients who are 65 and older. The Centers for Medicare and Medicaid Services will attempt to amend this policy, but how quickly this will occur is unknown.

Different recommendations 
for patients at higher risk

There are 2 sets of recommendations for use of pneumococcal vaccines: one for routine use for most patients, and a separate set of recommendations for those with conditions that put them at higher risk of infections and/or complications from pneumococcal disease.1-4 PPSV23 is recommended for children (starting at age 2 years) and adults with certain high-risk medical conditions, such as chronic heart, lung, or liver disease, and diabetes; functional or anatomical asplenia; or immunocompromising conditions such as human immunodeficiency virus infection, chronic renal failure, leukemia, or lymphoma.3 PPSV23 should be repeated 5 years after the first dose in patients with asplenia, those who are immunocompromised, and for everyone age 65 and older who received it before age 65. No more than 3 doses of PPSV23 should be given to anyone.

 

 

PCV13 is recommended for previously unvaccinated children and adults who have cochlear implants, cerebrospinal fluid leaks, functional or anatomical asplenia, or are immunocompromised.

References

1. Tomczyk S, Bennett NM, Stoecker C, et al; Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014;63:822-825.

2. Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012;61:816-819.

3. Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2013;62:521-524.

4. Nuorti JP, Whitney CG; Centers for Disease Control and Prevention (CDC). Prevention of pneumococcal disease among infants and children - Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;59:1-18.

Article PDF
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA

Medical Director, Mercy Care Plan, Phoenix, Ariz

campos-outcalt@mercycareplan.com

Issue
The Journal of Family Practice - 63(12)
Publications
Topics
Page Number
730,732-733
Legacy Keywords
pneumococcal vaccines; PCV13; PPSV23' 13-valent pneumococcal conjugate vaccine; 23-valent pneumococcal polysaccharide vaccine; 7-valent pneumococcal conjugate vaccine; PCV7; community-acquired pneumonia; CAP; Doug Campos-Outcalt, MD, MPA
Sections
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA

Medical Director, Mercy Care Plan, Phoenix, Ariz

campos-outcalt@mercycareplan.com

Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA

Medical Director, Mercy Care Plan, Phoenix, Ariz

campos-outcalt@mercycareplan.com

Article PDF
Article PDF
Related Articles

In August 2014, the Advisory Committee on Immunization Practices (ACIP) decided to add the 13-valent pneumococcal conjugate vaccine (PCV13) to the routine immunization schedule for adults ages 65 years and older; previously, it had recommended that these patients receive only the 23-valent pneumococcal polysaccharide vaccine (PPSV23).1 The US Food and Drug Administration (FDA) had approved PCV13 for use in adults ages 50 years and older in late 2011. The delay between FDA approval and this new ACIP recommendation occurred for 2 reasons: The epidemiology of pneumococcal disease (pneumonia, meningitis, and bacteremia) in older adults is evolving due to the widespread use of PCV13 in children, and a large clinical trial looking at the efficacy of this vaccine in individuals 65 and older was still underway.

Pneumococcal disease 
in older adults remains a problem

Routine use of the 7-valent pneumococcal conjugate vaccine (PCV7) in children began in 2000. In 2010, the vaccine was expanded to include 6 more antigens (PCV13). The routine use of this vaccine has markedly reduced pneumococcal disease in children and, by way of indirect protection, in adults. Between 2010 and 2013, the incidence of invasive pneumococcal disease (eg, meningitis and bacteremia) caused by the 13 serotypes in the vaccine had decreased by 50% in adults ages 65 years and older.1 However, in this age group, there are still more than 13,000 cases of invasive pneumococcal disease each year.1 Approximately 20% of these cases—and 10% of cases community-acquired pneumonia (CAP) in this age group—are still caused by one of the PCV13 serotypes. This epidemiology left ACIP to consider whether to recommend PCV13 for older adults even though the incidence of pneumococcal disease was declining without the use of the vaccine. ACIP took a middle-of-the-road position on August 13, 2014 by recommending the vaccine now but agreeing to reexamine the issue again in 2018.1

PCV13 substantially cuts the rate of pneumococcal disease

In June 2014, ACIP reviewed the results of a large randomized, placebo-controlled clinical trial of PCV13 in 85,000 adults ages 65 years and older that was conducted in the Netherlands from 2008 to 2013.1 PCV13 reduced the rate of disease caused by the vaccine serotypes by 45.6% for pneumonia and 75% for invasive pneumococcal disease.

Because the population in this study was PPSV23-naïve, the added advantage of PCV13 in patients who have been vaccinated with PPSV23 has not been determined. Twelve of the 13 serotypes in PCV13 are in PPSV23. And while PPSV23 can protect against invasive pneumococcal disease, its effectiveness against CAP is less well proven.

Using modeling that took into consideration anticipated rates of vaccination with both PCV13 and PPSV23 in adults and children, the Centers for Disease Control and Prevention estimated that adding PCV13 to the adult immunization schedule would prevent 230 cases of invasive pneumococcal disease and 12,000 cases of CAP over the lifetime of a cohort of 65 year olds.1 With time, however, and the increasing indirect protection from routine use of PCV13 in children, these numbers would decline.

Timing of administration depends on patients’ vaccine history


Adults 65 years of age and older should receive both PCV13 and PPSV23, but not at the same time. In those who have not received any pneumococcal vaccine, the preferred sequence is to first administer PCV13 and then PPSV23 6 to 12 months later (FIGURE); the minimum acceptable interval between PCV13 and PPSV23 is 8 weeks.1 If PPSV23 is administered first, PCV13 should not be given until at least 12 months after the PPSV23 dose. This is because the immune response to PCV13 is not as robust when PCV13 follows PPSV23.

For patients who have been vaccinated with PPSV23 before age 65, PCV13 should be administered at least 12 months after PPSV23, followed by another dose of PPSV23 that should be administered 6 to 12 months after PCV13, but no sooner than 5 years since the previous PPSV23 (FIGURE).

Coadministration of PCV13 with trivalent influenza vaccine results in a slight decrease in the immune response to each vaccine;1 this is unlikely to be clinically important. Coadministration with other vaccines has not been studied.

Who’ll reimburse for the PCV13 vaccine? One issue that could delay the use of both vaccines in older adults is that currently, Medicare pays for only one pneumococcal vaccine in patients who are 65 and older. The Centers for Medicare and Medicaid Services will attempt to amend this policy, but how quickly this will occur is unknown.

Different recommendations 
for patients at higher risk

There are 2 sets of recommendations for use of pneumococcal vaccines: one for routine use for most patients, and a separate set of recommendations for those with conditions that put them at higher risk of infections and/or complications from pneumococcal disease.1-4 PPSV23 is recommended for children (starting at age 2 years) and adults with certain high-risk medical conditions, such as chronic heart, lung, or liver disease, and diabetes; functional or anatomical asplenia; or immunocompromising conditions such as human immunodeficiency virus infection, chronic renal failure, leukemia, or lymphoma.3 PPSV23 should be repeated 5 years after the first dose in patients with asplenia, those who are immunocompromised, and for everyone age 65 and older who received it before age 65. No more than 3 doses of PPSV23 should be given to anyone.

 

 

PCV13 is recommended for previously unvaccinated children and adults who have cochlear implants, cerebrospinal fluid leaks, functional or anatomical asplenia, or are immunocompromised.

In August 2014, the Advisory Committee on Immunization Practices (ACIP) decided to add the 13-valent pneumococcal conjugate vaccine (PCV13) to the routine immunization schedule for adults ages 65 years and older; previously, it had recommended that these patients receive only the 23-valent pneumococcal polysaccharide vaccine (PPSV23).1 The US Food and Drug Administration (FDA) had approved PCV13 for use in adults ages 50 years and older in late 2011. The delay between FDA approval and this new ACIP recommendation occurred for 2 reasons: The epidemiology of pneumococcal disease (pneumonia, meningitis, and bacteremia) in older adults is evolving due to the widespread use of PCV13 in children, and a large clinical trial looking at the efficacy of this vaccine in individuals 65 and older was still underway.

Pneumococcal disease 
in older adults remains a problem

Routine use of the 7-valent pneumococcal conjugate vaccine (PCV7) in children began in 2000. In 2010, the vaccine was expanded to include 6 more antigens (PCV13). The routine use of this vaccine has markedly reduced pneumococcal disease in children and, by way of indirect protection, in adults. Between 2010 and 2013, the incidence of invasive pneumococcal disease (eg, meningitis and bacteremia) caused by the 13 serotypes in the vaccine had decreased by 50% in adults ages 65 years and older.1 However, in this age group, there are still more than 13,000 cases of invasive pneumococcal disease each year.1 Approximately 20% of these cases—and 10% of cases community-acquired pneumonia (CAP) in this age group—are still caused by one of the PCV13 serotypes. This epidemiology left ACIP to consider whether to recommend PCV13 for older adults even though the incidence of pneumococcal disease was declining without the use of the vaccine. ACIP took a middle-of-the-road position on August 13, 2014 by recommending the vaccine now but agreeing to reexamine the issue again in 2018.1

PCV13 substantially cuts the rate of pneumococcal disease

In June 2014, ACIP reviewed the results of a large randomized, placebo-controlled clinical trial of PCV13 in 85,000 adults ages 65 years and older that was conducted in the Netherlands from 2008 to 2013.1 PCV13 reduced the rate of disease caused by the vaccine serotypes by 45.6% for pneumonia and 75% for invasive pneumococcal disease.

Because the population in this study was PPSV23-naïve, the added advantage of PCV13 in patients who have been vaccinated with PPSV23 has not been determined. Twelve of the 13 serotypes in PCV13 are in PPSV23. And while PPSV23 can protect against invasive pneumococcal disease, its effectiveness against CAP is less well proven.

Using modeling that took into consideration anticipated rates of vaccination with both PCV13 and PPSV23 in adults and children, the Centers for Disease Control and Prevention estimated that adding PCV13 to the adult immunization schedule would prevent 230 cases of invasive pneumococcal disease and 12,000 cases of CAP over the lifetime of a cohort of 65 year olds.1 With time, however, and the increasing indirect protection from routine use of PCV13 in children, these numbers would decline.

Timing of administration depends on patients’ vaccine history


Adults 65 years of age and older should receive both PCV13 and PPSV23, but not at the same time. In those who have not received any pneumococcal vaccine, the preferred sequence is to first administer PCV13 and then PPSV23 6 to 12 months later (FIGURE); the minimum acceptable interval between PCV13 and PPSV23 is 8 weeks.1 If PPSV23 is administered first, PCV13 should not be given until at least 12 months after the PPSV23 dose. This is because the immune response to PCV13 is not as robust when PCV13 follows PPSV23.

For patients who have been vaccinated with PPSV23 before age 65, PCV13 should be administered at least 12 months after PPSV23, followed by another dose of PPSV23 that should be administered 6 to 12 months after PCV13, but no sooner than 5 years since the previous PPSV23 (FIGURE).

Coadministration of PCV13 with trivalent influenza vaccine results in a slight decrease in the immune response to each vaccine;1 this is unlikely to be clinically important. Coadministration with other vaccines has not been studied.

Who’ll reimburse for the PCV13 vaccine? One issue that could delay the use of both vaccines in older adults is that currently, Medicare pays for only one pneumococcal vaccine in patients who are 65 and older. The Centers for Medicare and Medicaid Services will attempt to amend this policy, but how quickly this will occur is unknown.

Different recommendations 
for patients at higher risk

There are 2 sets of recommendations for use of pneumococcal vaccines: one for routine use for most patients, and a separate set of recommendations for those with conditions that put them at higher risk of infections and/or complications from pneumococcal disease.1-4 PPSV23 is recommended for children (starting at age 2 years) and adults with certain high-risk medical conditions, such as chronic heart, lung, or liver disease, and diabetes; functional or anatomical asplenia; or immunocompromising conditions such as human immunodeficiency virus infection, chronic renal failure, leukemia, or lymphoma.3 PPSV23 should be repeated 5 years after the first dose in patients with asplenia, those who are immunocompromised, and for everyone age 65 and older who received it before age 65. No more than 3 doses of PPSV23 should be given to anyone.

 

 

PCV13 is recommended for previously unvaccinated children and adults who have cochlear implants, cerebrospinal fluid leaks, functional or anatomical asplenia, or are immunocompromised.

References

1. Tomczyk S, Bennett NM, Stoecker C, et al; Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014;63:822-825.

2. Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012;61:816-819.

3. Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2013;62:521-524.

4. Nuorti JP, Whitney CG; Centers for Disease Control and Prevention (CDC). Prevention of pneumococcal disease among infants and children - Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;59:1-18.

References

1. Tomczyk S, Bennett NM, Stoecker C, et al; Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014;63:822-825.

2. Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012;61:816-819.

3. Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2013;62:521-524.

4. Nuorti JP, Whitney CG; Centers for Disease Control and Prevention (CDC). Prevention of pneumococcal disease among infants and children - Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;59:1-18.

Issue
The Journal of Family Practice - 63(12)
Issue
The Journal of Family Practice - 63(12)
Page Number
730,732-733
Page Number
730,732-733
Publications
Publications
Topics
Article Type
Display Headline
Pneumococcal vaccines for older adults: Getting the timing right
Display Headline
Pneumococcal vaccines for older adults: Getting the timing right
Legacy Keywords
pneumococcal vaccines; PCV13; PPSV23' 13-valent pneumococcal conjugate vaccine; 23-valent pneumococcal polysaccharide vaccine; 7-valent pneumococcal conjugate vaccine; PCV7; community-acquired pneumonia; CAP; Doug Campos-Outcalt, MD, MPA
Legacy Keywords
pneumococcal vaccines; PCV13; PPSV23' 13-valent pneumococcal conjugate vaccine; 23-valent pneumococcal polysaccharide vaccine; 7-valent pneumococcal conjugate vaccine; PCV7; community-acquired pneumonia; CAP; Doug Campos-Outcalt, MD, MPA
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media